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Molybdenum (Mo) is a crucial element for the survival of most species, which is due to its vital duty for Mo-
dependent enzymes. However, in the cell, Mo is biologically inactive unless it is complexed within a 
distinctive scaffold referred to as molybdopterin (MPT). Insertion of Mo into MPT yields the physiologically 
active molybdenum cofactor (Moco) found in the active site of Mo-enzymes. Molybdenum insertases (Mo-
insertases) catalyze the Mo-insertion reaction into MPT. These consist of two functional domains referred to 
as G- and E- domain. With one known exception, in eukaryotes, the two domains are fused together, 
however, in prokaryotes, they are separate entities. In Escherichia coli, these are annotated as MogA and 
MoeA, while in Arabidopsis thaliana and Homo sapiens, the Mo-insertase is named Cnx1 and gephyrin, 
respectively. Synthesis of Moco relies on the directed interaction of the Mo-insertase E- and G-domain within 
the Mo-insertase complex, thus ensuring the protein protected metabolite transfer here. However, any 
structural and biochemical information about the Mo-insertase complex is missing so far. This work presents 
the first structural insight into the assembly of prokaryotic and eukaryotic E- and G-domains within the Mo-
insertase complex. For the MoeA-MogA complex, native mass spectrometry (native MS) gave first insights 
into the stoichiometry and size of the complex. Crosslinking based mass spectrometry (XL-MS) and 
computational modelling subsequently revealed how MogA interacts with MoeA, which was confirmed by 
negative staining electron microscopy (EM). For the eukaryotic Mo-insertases Cnx1 and gephyrin, a novel 
purification approach was established, ensuring both recombinant proteins to be co-purified with minimal 
degradation products. My XL-MS based structural proteomics approach revealed the Cnx1 G-domain to bind 
to two distinctive interaction sites on the E-domain, which ultimately results in the formation of a closed 
complex consisting of 3 E-domain dimers and 2 G-domain trimers. Other stoichiometries may occur, 
assuming that in cellula, G-domain trimers exist as separate entities. Formation of these may result from 
Cnx1 degradation, which allows it to speculate that in cellula Mo-insertase complex formation underlies 
dynamic and potentially demand driven processes. Further insights into the Cnx1 structure was obtained by 
an combined structural proteomics ab initio modelling approach of the linker which revealed consistency 
with respect to the Cnx1 closed complex model presented here. In order to further substantiate the obtained 
results for the plant Mo-insertase Cnx1, structure-guided mutagenesis was done, targeting potentially critical 
residues within the interaction interfaces determined. As an important finding, recombinant biochemistry 
revealed variants with an impaired metabolite transfer capacity. Notably, any of these variants was traced 
back to one of the two identified interaction sites, which thus was confirmed as a “metabolic interaction” 
site and accordingly, the second interaction site was identified as a “structural interaction” site. Consistent 
results were obtained for the human gephyrin, as negative staining EM also reveals two defined G-domain 
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1.1. Molybdenum and Molybdenum Cofactor 
 
1.1.1. Overview  
 
In nature, Molybdenum (Mo) is one of the 90 naturally existing elements and it is classified 
as a transition element, or a metal, in the periodic table (Mendel, 2013). Mo is also known 
to be a ‘’refractory metal’’ of extraordinary heat and wear resistance. Thus it is widely used 
in high-temperature furnaces, material testing equipment, aerospace gears and defense 
components (Lunk et al., 2017). Mo can be ubiquitously found everywhere on earth existing 
as MoO4 or MoS2, the crustal abundance of Mo is equivalent to 1-15 ppm, while 10 µg/L in 
sea water, as the most widespread transition metal in open sea water (Smedley et al., 2017). 
Most species rely on Mo for normal biological functions, including energy production and 
waste products removal. Nevertheless, Mo is needed in minuscule amounts for the various 
organisms (Mendel, 2013). The first hint on the distribution of Mo in different species goes 
back to 1932, by the work of Meulen, in which Mo was acknowledged as an essential metal 
for various organisms (Meulen, 1932). For humans, 45 ug/day is the daily Recommended 
Dietary Allowance (RDA), which is easily obtained in the everyday diet (FDA, 2016). 
Although it is doubtful to have excessive Mo intake above 2 mg/day, Mo is lethal above the 
tolerable levels for different species (ATSDR, 2020). Notably, Mo is not biologically active 
or readily used by different organisms. Conversely, it needs to be complexed in a unique 
scaffold, referred to as metal-containing petrin (MPT), which forms the biologically active 






1.1.2. A brief history of the molybdenum cofactor 
 
In 1963, the first experimental evidence on the existence of Moco was observed while 
characterizing gene mutations in Aspergillus nidulans by Cove and Patman (Cove & Patman, 
1963). Remarkably, in the late 60s Mudd, showed for the first time the impact of sulfite 
oxidase deficiency in humans (Mudd et al., 1967), while in 1971, sulfite oxidase was 
characterized as a Mo- containing protein (Cohen et al., 1971). In 1976, the first Moco-
mutant plants were generated (Mendel & Müller, 1976), while the first Mo-repair of cnx 
mutants was shown in 1981 by R. R. Mendel (Mendel et al., 1981). The eukaryotic Moco 
biosynthesis prevailed from 1985 to 1992 (Mendel et al., 1986; Müller & Mendel, 1989) 
(Figure 1). From there on, numerous studies were published that deciphered the ambiguities 
of Moco and Moco biosynthesis. These studies included the characterization of Moco 
intermediates, Moco-dependent enzymes, and Moco biosynthesis proteins as well as their 
structures (Mendel, 2013; Schwarz et al., 2009; Mendel & Kruse, 2012). Up till now, 
although we have a good understanding about the relevancy of Mo and Moco in different 
organisms, however, there are still plenty of mysteries regarding Moco and Mo in biological 




Figure 1. Timeline of key events and discoveries of Moco. Timeline showing fundamental 
discoveries and events which are the foundation of our current knowledge about Moco. 
 
1.1.3. The significance of the molybdenum cofactor 
 
The importance of Moco is due to the inevitable involvement of Mo in all Mo-dependent 
enzymes. These enzymes are essential for different biochemical processes in the overall 
metabolism of carbon, nitrogen and sulfur (Mayr et al., 2020). With the exclusion of 
nitrogenase, different variants of Moco form part of the active center of Mo-dependent 
enzymes needed for the different species. There are four Mo-dependent enzymes out of 
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seven known in eukaryotes are found in humans, while five enzymes are present in plants 
(Figure 2). These enzymes are sulfite oxidase (SO), mitochondria amidoxime-reducing 
component (mARC), xanthine oxidase (XO) and Aldehyde oxidase (AO) (Mendel, 2013).  
 
Figure 2. Moco dependent enzymes and their biological importance. The transition metal Mo with atomic number 42 is 
not biologically active unless it is complexed in a scaffold that forms Moco. In prokaryotes, there are more than 50 known 
Mo-dependent enzymes. However, in eukaryotes, seven enzymes are known. Sulfite oxidase (SO), mitochondria 
amidoxime-reducing component (mARC), xanthine oxidase (XO) and Aldehyde oxidase (AO) are the four Mo-depended 
enzymes needed for humans (red). For plants, XO, AO, SO, mARC and nitrate reductase (NR) are the five Mo-dependent 
enzymes needed. Additionally, pyridoxal oxidase in drosophila melanogaster and nicotinate dehydrogenase in Aspergillus 
nidulans. Mo-dependent enzymes are essential for the different species for their nitrogen, sulfur and carbon as well as the 
detoxification of many metabolites such as sulfite by sulfite oxidase. Moreover, proper brain and nerve function and 




While the two isoforms of mARC are important in the metabolism of N-hydroxlated 
compounds used as prodrugs, SO, which localize in the intermembrane space of the 
mitochondria, is involved in the crucial oxidation of sulfite into sulfate (Havemeyer et al., 
2011; Hille, 1996). Moreover, XO is crucial for purine catabolism by converting 
hypoxanthine into xanthine, which is subsequently converted into uric acid (Keyelle et al. 
2010; Hille, 1996). The oxidation of different heterocyclic aldehydes into carboxylic acids 
to release hydrogen peroxide and superoxide anions rely on AO (Terao et al., 2020). In 
addition to the four enzymes required by humans, nitrate reductase (NR) is needed for plants, 
algae and fungi. NR is critical for these plants as it reduces nitrate to nitrite, which is the 
most important source of nitrogen in the soil utilized by NR in different mechanisms 
(Wajmann et al., 2020; Mendel, 2013).  
Consequently, any gene defect in the Moco biosynthesis would result in Moco – deficiency 
(MoCD) which is fatal for most organisms because of the improper functionality of these 
enzymes (Schwarz, 2016). For instance, in humans, malfunctional Moco biosynthesis leads 
to severe neurological symptoms, seizures, dislocation in the ocular lenses as well as other 
symptoms, which ultimately results in the death of the affected patients (J. Reiss et al., 2011). 
There are three known types of MoCD known, deficiency of MOCS1 as type A, deficiency 
of MOCS2 or MOCS3 as type B and deficiency of gephyrin as type C, which all result in 
improper function of Mo-dependent enzymes (Bayram et al., 2013; Schwarz, 2016). Most 
importantly, the defect in SO would promote the accumulation of toxic sulfite. The 
underlying molecular reason for the MoCD phenotype is S-sulfocystein (SSC) formation, a 
glutamate orthologue that is neurotoxic, which causes mental retardation in humans and 
seizure-like behaviour effects in zebrafish (Plate et al. 2019).   
  
1.1.4. Molybdenum cofactor biosynthesis 
 
The biosynthesis of Moco is conserved, which could be tracked to the most primaeval 
biological processes known to life (Zhang and Gladyshey, 2008). Even though Moco 
biosynthesis is highly conserved among bacteria, plants and humans, however, they are 
relatively diverse on the gene level (Mayr et al., 2020). In bacteria and archaea, eight genes 
are required for the biosynthesis of Moco. On the other hand, six genes are required in plants 
and only four in humans. On the protein level, both plants and humans have a total of six 
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proteins regardless of the number of genes encoding them (Mendel, 2013) (Figure 3). 
Another two proteins are known to be involved in the Moco biosynthesis in bacteria and 
archaea for the additional step in order to generate MPT cytosine dinucleotide (MCD) or 
MPT guanosine dinucleotide (generates bis-MGD) (Leimkuhler, 2020).  
In eukaryotes, the three-step biosynthesis of Moco starts in the mitochondria with the aid of 
two proteins, MOCS1A and MOCS1B in humans, Cnx2 and Cnx3 in plants, while MoaA 
and MoaC in bacteria. The two proteins help in the conversion of guanosine triphosphate 
(GTP) into cyclic pyranopetrin monophosphate (cPMP), which is then exported outside of 
the mitochondria and converted to MPT (Mendel & Kruse, 2012). MoaA is part of the 
superfamily of radical S-adenosylmethionine (SAM), and it is characterized by [4Fe-4S] 
cluster that cleaves SAM producing adenosyl radical, which forms a +2 oxidized form of the 
[4Fe-4S] (Yokoyama et al., 2018). SAM in both MoaA and MOCS1A is solvent accessible 
and not profoundly buried within the active site of the protein. Although MoaA was known 
to play the central role in the pyranopterin formation and for the synthesis of the intermediate 
3′,8-cyclo-7,8-dihydro-guanosine 5′-triphosphate (3′,8-cH2GTP), structural and functional 
characterization of MoaC showed the crucial involvement of MoaC in the conversion of 
3′,8-cH2GTP to cPMP (Yokoyama, 2018).                
The conversation of cPMP to MPT is done by the MPT-synthesis complex in a two 
subsequent sulfur transfer reaction. The MPT-synthesis is composed of two small subunits of 
MOCS2A and two large subunits of MOCS2B in humans. In plants, MOCS2A and MOCS2B 
are referred to as Cnx6 and Cnx7, while MoaD and MoaE in bacteria, respectively (Rudolph 
et al., 2001; Mendel, 2013). Initially, cPMP binds to MoaE (Cnx6 or MOCS2B) to establish 
the first thiol, which is near the MoaD (Cnx7 or MOCS2A) double glyine motifs. This leads 
to ring-opening of the cyclic phosphate, then introducing the first thiol and subsequently, 
the second thiol by MoaD to form the dithiolene moiety. The resulferation of MoaD is 
facilitated by the sulfarase protein MOCS3, Cnx5 in plant or MoeB in bacteria, in which a 
sulfur atom is provided in an ATP and Mg
+2
 dependent manner (Rudolph et al., 2001; 
Wuebbens et al., 2003).  
Finally, a two-domain protein in eukaryotes or the separately expressed MoeA and MogA in 
prokaryotes (Cnx1 in plants and gephyrin in humans) are responsible for adenylating MPT, 
in an ATP-Mg
+2
 dependent manner (Krausze et al., 2017). The result is the formation of MPT- 
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AMP (Kuper et al., 2004). Subsequently, the removal of the AMP and insertion of molybdate, 
which results in the formation of Moco. Afterwards, Moco is either 1) sulfurated by ABA3 in 
plants and HMCS in humans for the transfer to XO or AO (Ichida et al., 2001; Heidenreich 
et al., 2005), or 2) carried by a Moco carrier protein (MCP) or a Moco binding protein (MoBP) 
(Kruse et al., 2010; Krausze et al., 2020), or 3) possibly handed over directly to the Moco 
user enzymes. While Moco biosynthesis is prevalent amongst all species, surprisingly, some 
few eukaryotic species are known to lack Moco biosynthesis completely. Prominent 
examples are Schizosaccharomyces pombe and Saccharomyces cerevisiae (Zhang & 
Gladyshev, 2008).   
 
Figure 3. The Moco biosynthesis. The biosynthetic pathway is divided into three steps which start in the 
mitochondria, shown on the right (schematic gray mitochondrium). On the left, the names of the proteins 
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in humans (red), plants (green) and bacteria (blue) involving in the respective step. In eukaryotes, the first 
step is the circularization of GTP to cPMP in the mitochondria, which includes an intermediate 3’,8-
cH2GTP product in a Mg-ATP dependent manner. In the second step, after export to the cytoplasm via 
ATM3 (plants), cPMP is converted to MPT by the aid of heterotetrameric MPT-synthase complex and the 
dithiolene group is formed. The MPT sulfurase is responsible for reloading the small subunits of the MPT-
synthase complex with sulfur. In the third step, MPT is adenylated to form MPT-AMP by the G-domain 
of the two-domain Mo-insertase protein. Subsequently, MPT-AMP is deadenylated and Mo is inserted by 
the E-domain of the Mo-insertase. Moco-AMP is a possible intermediate form in the last step of 
biosynthesis. Once Moco is formed, it can be either directly transferred to the user enzymes or sulfurated 
by HMCs in humans & ABA3 in plants (purple) or alternatively indirectly transferred by a MCP (algea 
and some cyanobacteria) or MoBP (plants).     





The final step in the eukaryotic Moco biosynthesis is catalyzed by a multi-domain protein 
that combines the function of two separate bacterial proteins. This protein is referred to as 
Mo-insertase, due to the fact that the aid of this protein inserts Mo. As evolution took its 
course, two different gene fusion events occurred to combine both G- and E- domains of the 
Mo-insertases (Mendel, 2013; Krausze et al., 2017). In general, the crystal structures 
obtained of G-domains from different species showed the formation of trimers, while dimer 
formation for the E-domain in solution. The overall structure of the different G- and E- 
domains is highly similar (Figure 4), with slight differences in the individual monomers of 
different species (Schwarz et al., 2001; Kuper et al., 2004; Kasaragod & Schindelin, 2016). 
Similarly, on the sequence level, Mo-insertases tend to have high sequence similarity and 
plenty of strictly conserved residues (Krausze et al., 2018).  
Cnx1 in plants is a fusion of both domains via a linker with N-terminal E-domain and C-
terminal G-domain orientation. On the other hand, gephyrin in humans has a longer linker 
and the reverse orientation of domains, N-terminal G-domain and C-terminal E-domain 
(Schwarz et al., 2001). The initial Moco biosynthesis steps were extensively studied and 
explained, nonetheless, the final step is enigmatic, specifically the mechanism behind 
molybdate insertion into the MPT-AMP dithiolene. The final step of Moco biosynthesis is 
divided into two reaction steps. Initially, the adenylation of MPT and subsequently, Mo-
insertion and MPT-AMP hydrolysis to release Moco (Hercher et al., 2020). In the first stage, 
the MPT, bound to a highly conserved binding site in the G-domain, is adenylated with the 
aid of Mg
2+ 
and ATP. The binding site consists of three parts, a proline-glycin motif, two 
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aspartates and a glycine-glycine-threonine motif, remarkably, all three parts are functionally 
important (Llamas et al., 2006; Kuper et al., 2004; Kuper et al., 2003).  
The subsequent reaction step involves the E-domain, and it includes two sub-steps. At first, 
the insertion of Mo in the MPT-AMP dithiolene moiety and then the hydrolysis of the MPT-
AMP, which results in the cleavage of the AMP (Krausze et al., 2017; Hercher et al., 2020). 
Furthermore, recent works prevailed the presence of a potential novel intermediate, which 
is referred to as Moco-AMP (Probst et al., 2021). Thus formed Moco is physiologically active. 
 
In contrast to eukaryotes, prokaryotes have an additional step, including the attachment of 
a nucleotide moiety to Moco to form MGD. This last additional step is done with the aid of 
two co-transcribed proteins, namely MobA and MobB (Mendel, 2013; Leimkuhler, 2020). 
In bacteria such as Escherichia coli, there are different Moco forms for the various enzyme 
families, including a di-oxo Moco for sulfite oxidase family, sulfurated molybdopterin 
cytosine dinucleotide cofactor (MCD) for the xanthine oxidase family, and finally a bis-MGD 




Figure 4.  Mo-insertases in 
mammals, plants and bacteria. 
Throughout the different known 
species, the Mo-insertases are 
composed of a homotrimeric 
G-domain and a homodimeric 
E-domain. The structures are 
very similar when comparing 
bacteria, plants and mammals. 
In bacteria (blue) the G-domain 
MogA (PDB: 1DI6) and E-
domain MoeA (PDB: 2NQQ) 
are separately expressed. In 
plants, the fused N-terminus E-
domain ‘’Cnx1E’’ (PDB: 5G2R) 
and the C-terminus G-domain 
‘’Cnx1G’’ (PDB: 1UUY) form 
Cnx1. Gephyrin in mammals 
are composed of N-terminus G-
domain ‘’Geph-G (PDB: 1EAV) 
and C-terminus E-domain 
‘’Geph-E’’ (PDB: 4TK3).  
 
 
1.2.2. MogA and MoeA 
 
In prokaryotes, both MogA and MoeA are responsible for the Moco formation. The two 
proteins are known to have a function solely related to Moco biosynthesis, unlike eukaryotes 
(Nichols & Rajagopalan, 2002). The inevitable interaction between MogA and MoeA was 
first described using a bacterial two-hybrid assay. This study also demonstrated an 
interaction between the MPT-synthase complex, MoaD and MoaE complex with the Mo-
insertase complex in the Moco biosynthesis of bacteria (Magalon et al., 2002). Despite the 
fact that MogA and MoeA have been proven to bind MPT with different affinities, MPT 
handover by the MPT-synthases complex directly to MogA would be expected (Schwarz et 
al., 1997; Kuper et al., 2000). Subsequently, MPT is adenylated, handed over to MoeA and 
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Mo is inserted to release Moco. Additionally, MoeA and MogA are known to interact with 
MobB and MobA from the subsequent step to form bis-MGD used by DMSO reductase 
family enzymes (Magalon et al., 2002) (Figure 5). 
 
 
Figure 5. Moco biosynthesis in bacteria and protein-protein interaction in the 
pathway. The biosynthetic pathway in bacteria is composed of 4 steps. 
Nomenclatures of enzymes is described according to E. coli. In each of the steps, a 
direct protein-protein interaction is shown with an arrow (yellow). MoaA interacts 
with MoaC from the first step. In the second step, MoaE interacts with MoaD, which 
interacts with MoeB. Both MoaE and MoaD interacts with MogA from the third step. 




Similarly to bacteria, in plants, Cnx1 resemble a part of Moco biosynthetic complex 
including other three cytosolic proteins namely Cnx5, Cnx6 and Cnx7 in order to protect 
the delicate intermediates (Kaufholdt et al. 2016). As shown in (figure 6), Cnx2 and Cnx3 
are interaction partners responsible for the first step of the biosynthesis. These insights were 
shown using in vivo interaction methods including bimolecular fluorescence 
complementation (BiFC) as well as split-luciferase assay (Kaufholdt et al. 2016). Furthermore, 
in the same way that its mammalian homolog gephyrin does in neuronal cells, Cnx1 binds 
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to the cytoskeleton, signifying a hypothetical model for the Moco-biosynthetic anchoring 




















Figure 6. Moco biosynthesis in plants, including the protein interactions involved. Dashed arrows indicate direct 
protein-protein interaction within the Moco biosynthesis complex in plants (Interactions strength is variable).  The 
biosynthesis starts in the mitochondria with cPMP synthesis by Cnx2 and Cnx3. Next, MPT synthesis requires 
Cnx6 (pink) and Cnx7 (dark blue). Cnx7 interacts with the sulfurase Cnx5 (grey). The final step of Mo-insertion is 
catalyzed by the two-domain protein Cnx1 which is composed of the trimeric Cnx1G (cyan) and the dimeric 








In 1982, gephyrin was discovered by Heinrich Betz’s group as an unknown protein co-
purified with glycine receptors (Pfeiffer et al., 1982). From then on, gephyrin was extensively 
studied from the cellular and biochemical perspective. Astonishingly, in the 90s, gephyrin 
was identified as the homolog of 
Cnx1, the insect protein 
‘’cinnamon’’ and three other 
Escherichia coli proteins 
(Kamdar et al., 1994). 
Henceforth, the biochemical 
analysis showed that gephyrin 
could reconstitute Moco 
biosynthesis in bacteria, plants, 
and mammalian cells. These 
studies showed that gephyrin is 
the Mo-insertase in mammals 
and that it has significance in 
neural functions and particular 
importance in Moco biosynthesis (Stallmeyer et al., 1999).  
For organizing the inhibitory postsynaptic network, gephyrin is the most comprehensively 
studied scaffold, which is crucial for the clustering of γ-aminobutyric acid type A (GABAA) 
and glycine receptors. The function of gephyrin in clustering receptors is of absolute 
importance for the transmission of the inhibitory synapse (Tyagarajan & Fritschy, 2014). In 
addition, gephyrin was shown to bind with numerous classes of inhibitory synaptic entities 
(Figure 7) (Choii & Ko, 2015). 
Interestingly, most of the interaction partners are interacting directly with the linker region 
or the E-domain. The different protein-protein interactions with other partners proved the 
essential role of gephyrin for normal synaptic function, plasticity, and formation (Tyagarajan 
& Fritschy, 2014). In cultured rat neurons, gephyrin accumulation was observed at the 
developing postsynaptic membrane specialization, which showed aggregates that were 
visualized by immunostaining (Kirsch et al., 1993). Interactions of gephyrin with 




cytoskeleton elements as well as glycine receptor subunit β were proven to be of absolute 
importance for the localization of glycine receptor proteins (Allison et al., 2000). 
Consequently, gephyrin knock-out mice die soon after birth with symptoms resulting from 
non-functional glycine receptors (Kneussel et al., 1999). Although advancement has been 
made with our understanding of gephyrin and its roles yet, the protein remains a mystery in 
many different aspects, primarily due to the linker. The linker region in gephyrin is known 
to be necessary for a normal receptor anchoring function. Most of the identified interactions 
with gephyrin include the linker region and/or the E-domain.  
Due to the high flexibility of the long linker region, there is no structure of the linker or the 
full-length gephyrin or cnx1. Additionally, post-translational modifications (PTMs), which 
probably induce conformational changes that influences the structure of the linker as well 
as the G- and E- domains (Fritschy et al., 2008). There are 22 phosphorylation sites known 
in the linker region and one site in the E-domain as well as palmitoylation and other 
modifications (Choii & Ko, 2015). Although there is no crystal structure known for the full-
length gephyrin and the complex, anongoing hypothesis of gephyrin clustering in the 
neurons was assumed (Kneussel & Betz, 2000; Groeneweg et al., 2018). The trimeric 3-fold 
symmetry and the 2-fold symmetry of the dimer would form a so-called ‘’hexagonal mesh’’ 
which would be a platform for the anchoring function in the postsynaptic membrane (Figure 
8). This theory was supported by a SAXs study, showing a relaxed and compact form of 
gephyrin, however, there are no atomic or near-atomic resolution as evidence for this theory 




   
Figure 8. The long-ongoing mesh hypothesis. Since the discovery of gephyrin and the elucidation of the 
trimeric Geph-G (orange) and the dimeric Geph-E (grey) structures, a full picture of the complex assembly 
of gephyrin has never been shown. However, due to the 3-fold symmetry of the trimer and the 2-fold 
symmetry of the dimer, a hexagonal mesh arrangement hypothesis was proposed or the ‘’propeller model’’ 
(Kneussel & Betz, 2000). The composition of the mesh would be seeded by a trimer, in which each of its 
monomers is connected to one monomer of the dimer, the other monomer of the dimmer is then connected 
to another monomer of another trimer (shown on the right). The final hexagonal mesh arrangement would 








1.3. Protein complex assembly and evolution 
 
1.3.1. Overview on protein complex assemblies 
 
Proteins are continuously in physical contact with other proteins within the crowded 
intracellular environment. In a dynamic cellular context, protein complexes are molecular 
machineries that execute a vast range of biological functions that is crucial for organisms 
(Ellis, 2001). Many of the protein complexes are known to have a defined molecular 
function, which is understood based on a well-experimental characterization, conversely, 
there are plenty of complexes that are functionally and/or structurally unknown. This is due 
to the fact that these complexes are possibly not stable or transient (Landry et al., 2013). 
Additionally, our techniques are not sophisticated enough to let us dig deeper into a dynamic 
living cell and have a complete picture of how protein complexes are assembled. Our 
understanding of protein complexes relies primarily on our techniques and, additionally, on 
the nature of the protein-protein interaction within the complex (Levy et al., 2012). There is 
immense diversity when it comes to the specificity, rate, and duration of these interactions, 
as well as the nature of protein assemblies (Ellis, 2001).   
 
1.3.2. Evolutionary aspect 
 
The cell is full of short-lived interaction with unknown or little biological importance, but 
also with highly conserved protein assemblies that develop gradually throughout the 
evolutionary history of complexes. The resemblance of sequence identity usually correlates 
to a similar protein assembly (Landry et al., 2013; Perkins et al., 2010). For instance, proteins 
with 90% or greater sequence identity showed to have nearly conserved quaternary 
structures. However, 30 to 40 % identity of sequences decreases the likelihood of 
conservation of quaternary structures by 30% (Levy et al., 2008). Moreover, the 
stoichiometry of protein complex assembly is evolutionary in constant alteration. Proteins 
tend to evolve based on the high demand for natural-selection and the need for new 
functional roles. Preferred self-assembly of the same symmetric subunits of a complex 
appears to be the common evolutionary transition (Perkins et al., 2010). For example, a 
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monomeric protein forming a dimeric or cyclic C2 or Cn symmetry can evolve into a dihedral 
Dn. 
On the other hand, the uneven stoichiometry of complexes is observed due to the existence 
of the same subunits in different environments. Strikingly, uneven stoichiometry across 
evolution is more enriched for bacterial complexes compared with eukaryotes (Marsh et al. 
2014). Additionally, the uneven symmetry of protein complexes is shown to be observed 
more frequently in vivo than in the crystal structure (Marsh and Teichmann, 2014).  
Interestingly, throughout the course of evolution, protein complexes tend to gain or lose 
protein subunits (Hashimoto and Panchenko, 2010). For instance, one of the prominent 
examples, the bacterial NADH-ubiquinone oxidoreductase (Complex I) has 14 distinct 
subunits, however, the same complex in the mammalian mitochondria has 46. An important 
example is the Mo-insertases, which is the focus of this work. The evolutionary Mo-insertase 
domain in prokaryotes is separately expressed. Conversely, later on, in the course of natural 
selection, the individual genes are fused in eukaryotes (Mendel, 2013). Accordingly, before 
forming complicated and multi-functioning complex structures in eukaryotes, a simplified 
Mo-insertase complex was formed in bacteria that is only responsible for Mo insertion (Xiang 
et al., 2001; Krausze et al., 2018). On the other hand, the splitting of genes into two or the 
reverse of gene fusion is less likely to occur than gene fusion. In general, the tendency of 
conserved interactions in different species is high. Almost all of the subunits of the protein 
complexes in yeast tend to be co-purified in comparison with their orthologs of human 
proteins (Krogan et al., 2006; Van Dam & Snel, 2008). 
 
1.3.3. Structural characterization of quaternary structures 
 
Quaternary structures are the architectural assembly of which different distinct protein 
chains (subunits or tertiary structures) of a complex are structured according to one another 
(Klotz et al., 1970). Quaternary structures can be homomeric, repeated copies of the same 
subunit for self-assembly, or heteromeric which is composed of different distinct protein 
subunits. In order to characterize these structures, different techniques could be 
implemented, including x-ray crystallography, nuclear magnetic resonance (NMR), electron 
microscopy (EM) or cryo-electron microscopy (Cryo-EM), Crosslinking Mass Spectrometry 
(XL-MS), native mass spectrometry (Native MS), small angle x-ray scattering (SAXs) and 
18 
 
computational modelling as well as others (Marsh and Teichmann, 2015) (Figure 9). Each 
technique has its advantages and disadvantages, nevertheless, combining various methods 
could lead to overcoming the drawbacks of the individual techniques. For example, it is not 
very reliable to get precise structural data from SAXs, as a standalone. On the other hand, 
combining XL-MS and Native MS with SAXs can generate accurate structural data (Blanchet 
& Svergun, 2013; Sinz et al., 2015). There are many examples of combining techniques to 
shed light on protein complex assemblies. For instance, recently, the structure of the 
Neurotensin receptor 1 was prevailed in complex with β-arrestin using a combination of 
cryo-EM, XL-MS, as well as other additional methods and the same regarding the nuclear 
pore complex (Huang et al., 2020; Bui et al., 2013). Moreover, the structure of the tumour 
suppressor p53 was probed by XL-MS, native-MS and SAXs (Arlt et al., 2015). Nevertheless, 





Figure 9. Methods to determine the quaternary structure of proteins. The amino acid sequence is 
referred to as the primary structure, and the secondary structure is an interaction between sections of a 
polypeptide chain, which includes α-helix and β-pleated sheet structures. Tertiary structure is a three-
dimensional folding, while the quaternary structure is an alignment of subunits or multi-subunits to form 
small or large protein complexes. There are different methods in order to determine the quaternary 
structure, and these include direct and indirect methods. A combination of the different techniques is 
the most favoured option in order to have a better understanding of these protein complexes. 
 
1.3.3.1. Crosslinking mass spectrometry (XL-MS) 
 
To gain insight on conformation of a protein complex, crosslinking can be employed in order 
to covalently stabilize interaction partners in vivo. Chemical crosslinking relies on a covalent 
bond introduction between two functional groups of amino acids of different interaction 
partners or within the protein by a chemical substance (Sinz, 2006). Subsequently, the 
proteins of interest are enzymatically digested, and the peptides resulting are analyzed by 
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mass spectrometry with different approaches. The cross-linkers used are usually bi-
functional with the same ‘’homobifunctional’’ or different ‘’heterobifunctional’’ reactive 
groups with a specified linker length range) (Sinz et al., 2015). Upon analysis of the 
crosslinked products, the cross-linkers form ‘’molecular rulers’’ in order to know more 
detailed structural insights of amino acids close in space, not in sequence (Mintseris & Gygi, 
2020. Improvements in the mass spectrometers, enrichment methods, analysis methods, and 
the cross-linker reagents served in a more convenient as well as accurate identification of 
protein complexes with minimal false negatives (Bullock et al., 2018; Sinz, 2006). Therefore, 
due to the continues advancements in XL-MS, many studies showed details about protein 
complex structures using chemical crosslinking as an additional or standalone tool.  
1.3.3.2. Cryo-electron microscopy 
 
In order to obtain information about macromolecular structures, cryo-electron microscopy 
(Cryo-EM) has been used, which relies on a particle beam of electrons shot at a frozen 
sample that illuminates a specimen to create a highly magnified image. The process starts 
with preparation of a homogenous protein sample, applied to a carbon grid, which is shock-
freezed, and then the grid is inserted in an electron microscope. Subsequently, images are 
taken of 2D projections and particles are picked, aligned and averaged in order to create a 
3D map. The map is processed into a 3D model of the protein structure (Renaud et al., 2018; 
Murata & Wolf, 2018). For Cryo-EM, it is problematic to obtain structural data of complexes 
in high resolution (less than 2 or 1 Å). Furthermore, big complexes (>150 kDa) are more 
favored than smaller complexes (<150 kDa) and only in a near-atomic resolution (Lyumkis, 
2019). Until recently, for the first time, method optimization of the EM lead to a Cryo-EM 
structure of β3 GABAA receptor homopentamer and Apoferritin at an atomic resolution of 
1.7 Å and 1.22 Å, respectively (Nakane et al., 2020). 
1.3.3.3. Computational modelling 
 
There is a large influx of near-atomic and atomic resolution structures of protein complexes 
using the previously discussed methods, however, vast numbers of complexes are still 
ambiguous due to the complexity and flexibility of such protein complexes (Marsh and 
Teichmann, 2015). Computational methods are an alternative in order to predict and 
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visualize protein complexes on a molecular level. There are different types of computational 
modelling, for example, template-based modelling and protein-protein docking (Wells et al., 
2018). The results from modelling are usually either confirmed, disregarded, or altered by 
experimental methods. Many protein structures turned out to be almost identical to the 
predicted models using different modelling softwares such as Rosetta, Modeller, iTasser 
(Simons et al., 1999; Webb & Sali. 2016; Roy et al., 2010). Some modellers demonstrated 
to be advantageous in ab initio modelling and protein-protein docking specifically, such as 
HADDOCK, which will be further discussed in this work. Massive improvement has recently 
been made with the computational prediction of protein structures (Koukos et al., 2020). 
Fascinatingly, by deep learning, a group was capable of training a neural network in order 
to predict accurate information about structures and contact pairs of amino acids with 0.7 

















1.4. Outstanding questions (gaps of knowledge) 
 
One of the significant gaps of knowledge that we have is due to the fact that there is no 
structure of the full-length gephyrin and/or cnx1. Hence, it is impossible to deduce: what is 
the architecture of the Mo-insertase complex? Is there a generic complex, or are there other 
possible conformations, and therefore, are the complexes homologues across the different 
species? 
Another enigmatic question that evolves due to our lack of knowledge is; what is the exact 
domain conformation upon the product/substrate shuffling? Which amino acids are of 
absolute necessity for complex formation and for the transfer specifically? Is the complex 
present in the absence of the substrate and/or product? Furthermore, there is no evidence on 
direct interaction between Mo-insertase and the user enzyme.  
 
1.5. Research aims of this work 
 
This thesis aims to describe Mo-insertase complexes from different species, including 
Escherichia coli, Arabidopsis thaliana, and Homo sapiens, focusing on the conserved 
binding sites of Moco and its intermediates. Essentially, elucidating the structural design of 
the complex would explain the ‘’handshake’’ that happens between the G- and E- domain 
as well as understanding the stoichiometry, which would shed light on the bigger picture of 
both cnx1 and gephyrin oligomerization. To that end, this thesis will focus on amino acid 
residues that impact complex formation in addition to the metabolic transfer. Lastly, the 














2.1.1. Equipment and instrumentation 
 
Table 1. All equipment and instrumentation used in this work. The table lists the name of the device, model name and 
company. 
General name of the device Model name Company 
Anion exchange chromatography 
column 
SOURCE™ 15Q GE Healthcare Life Sciences 
Autoclave FV13/11 proface Ibs tecno mara 
Balance Precision balance 572 KERN 
Balance Sartorius portable 
SARTORIUS (FISCHER- WAA 
GEN) 
Balance Sartorius Analytics 
SARTORIUS (FISCHER- WAA 
GEN) 
Bench top centrifuge My FUGE mini Benchmark 
Bucket for harvesting rotor 1000 ml buckets Beckman Coulter 
Cell lysis system (Fast prep) FastPrep-24™ MP Biomedicals 
Cell lysis system (French Press) FRENCH® pressure cell press SLM Aminco® 
Cell lysis system (homogenizer) Emulsiflex-C5 AVESTIN 
Centrifuge  Heraeus™ Pico™ 17 Thermo Fisher Scientific 
Centrifuge  
 
Heraeus™ Fresco™ 21 
Thermo Fisher Scientific 
Centrifuge for falcons and 
concentrators 
Heraeus™ Multifuge™ X3R Thermo Fisher Scientific 
Centrifuge for harvesting Avanti J-25 Beckman Coulter 
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Chromatography fractionator for 
gel filtration and ion exchange 
Frac 920 Amersham Pharmacia Biotech 
Chromatography system for gel 
filtration and ion exchange 
ÄKTA basic Amersham Pharmacia Biotech 
Chromatography system for gel 
filtration and ion exchange 
ÄKTA purifier Amersham Pharmacia Biotech 
Chromatography system for 
HPLC 
1100 Series Agilent 
Freezer -20 230P-20  LIEBHERR 
Freezer -80 MDF-U5386S SANYO 
Gel electrophoresis gel imagining 
system 
ChemiDoc™ XRS+ Bio-Rad 
Gel electrophoresis power supply 
for SDS gels 
PHERO-stab.300 BIOTEC fischer 
Gel electrophoresis power supply 
for SDS gels 
PowerPac HC Bio-Rad 
Gel electrophoresis system for 
Agarose gels 
Wide Mini-Sub Cell GT Cell Bio-Rad 
Gel electrophoresis system for 
Agarose gels 
Mini-Sub Cell GT Cell Bio-Rad 
Gel electrophoresis system for 
SDS gels 
Julaloo F10 Julaloo 
Gel electrophoresis system for 
SDS gels 
Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell 
Bio-Rad 
Gel filtration column 
Superdex 200 Increase 10/300 
GL 
GE Healthcare Life Sciences 
Gel filtration column Superdex 75 Increase 5/150 GL GE Healthcare Life Sciences 
Gel filtration column Superdex 200 10/300 GL GE Healthcare Life Sciences 
HPLC column ReproSil-Pur Basic-C18-HD TECHLAB Gmbh 
Ice machine CoolNat ZIEGRA 
Incubator Ecotron INFORS HT 
Incubator Multitron standard INFORS HT 
Incubator BODE BODE 
Laminar Flow Hood HLB 2472 Kendro 
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Magnetic stirrer RET basic JK IKA labortechnik 
Magnetic stirrer Magnetrührwerk MOBIL 200 VARIOMAG 
Mass spectrometer for LC MS/MS 
Nano‐HPLC system coupled to a 
Nanospray Flex Ion Source of an 
Orbitrap Fusion Tribrid mass 
spectrometer  
Thermo Fisher Scientific 
Mass spectrometer for Native MS 
Modified high‐mass QToF II 
instrument 
Waters Micromass/MS Vision 
Microplate Spectrophotometer Multiskan go thermo Thermo Fisher Scientific 
Microwave Klarstein MaxiWave Klarstein 
PCR cycler Life ECO BIO ER 
PCR cycler Flex cycler Analytik Jena 
pH meter ph-meter 763 Multi-calimotrices Knick 
Pipettes Pipetman Gilson 
Pipettes Pipet-lite XLS Rainin 
Protein storage LS 750 TechLab Gmbh 
Refrigerator 4° C IK 1920-20 LIEBHERR 
Rotor for falcons and 
concentrators 
Fiberlite™ F15-8 x 50cy Thermo Fisher Scientific 
Rotor for harvesting JLA-9.1000 Beckman Coulter 
Shaker W55 Edmund Bühler 
Shaker 3015 GFL Wilh. O. Schmidt Gmbh 
Sonication bath Bandelin Sonorex Reichmann 
Talos electron microscope FC200 
Thermo Fisher Scientific 
 
Thermoblock ThermoStat Plus Eppendorf 
Thermomixer Thermomixer C Eppendorf 
Thermomixer Thermomixer comfort Eppendorf 
Transfer system for Western 
blotting 
Trans-Blot Turbo Bio-Rad 
UV/Vis Spectrophotometer Ultrospec™ 2100 pro Amersham Bioscience 
UV/Vis Spectrophotometer Lambda 25 PerkinElmer 
Vacuum pump system Membran-Vakuumpumpe VACUUBRAND Gmbh 
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Vortex mixer Vortex GENEIE 2 Scientific industries  




Table 2. All kits used in this work. The table includes the name of the kit used, the purpose of use and the company 
supplying it. 
Name of the kit Purpose of use Company 
BSA standard kit 
Standard for concentration 
determination 
Thermo Fisher Scientific 
Gel Filtration Calibration Kit 
HMW 
Protein standard for the 
calibration for gel filtration 
columns 
GE Healthcare Life Sciences 
Kit for Molecular Weights 29,000 
– 700, 000 For Gel Filtration 
Chromatography 
Protein standard for the 
calibration for gel filtration 
columns 
Sigma Aldrich 
Monarch® DNA Gel Extraction 
Kit 
Isolation of DNA from agarose 
gel 
New England Biolabs 
Monarch® Plasmid Miniprep Kit  Plasmid DNA isolation New England Biolabs 
NEBuilder® HiFi DNA Assembly 
Cloning Kit 
Seamless cloning  New England Biolabs 
Q5® Site-Directed Mutagenesis 
Kit 
Amino acid site directed 
mutagenesis 
New England Biolabs 
SERVALight Eos Visualization of western blot SERVA 
TGX Stain-Free™ FastCast™ 
Acrylamide Solutions 
Casting SDS PAGE gels Bio-Rad 
Trans-Blot® Turbo™ Transfer 








2.1.3. Consumables  
 
Table 3 All consumables used in this work. The table includes the material used 
and the company supplying it. 
Material used Company 
1.5 ml tubes SARSTEDT 
10 µl pipette tips SARSTEDT 
10 ml columns Bio-Rad 
1000 µl pipette tips SARSTEDT 
14 ml tubs SARSTEDT 
15 ml tubes SARSTEDT 
2 ml tubes SARSTEDT 
200 µl pipette tips SARSTEDT 
25 ml columns Bio-Rad 
5 ml pipette tips SARSTEDT 
50 ml syringes VWR 
50 ml tubes SARSTEDT 
Cryo micro tubes  SARSTEDT 
Cuvettes SARSTEDT 
Disposable graduated transfer 
pipets  
VWR 
Eppendorf conical tubes Eppendorf 
KIMTECH Kimberly-clark professional 
Microtest plate 96 well SARSTEDT 
Multiply® PCR Tubes SARSTEDT 
Parafilm Curwood/ Fisher scientific  
PD10 columns GE Healthcare Life Sciences 
Petridish 92 x 16 mm SARSTEDT 
Rotilabo® Aluminumfoile 30 µm Carl Roth 
Roti-protect nitrite gloves Carl Roth 
S1 Disposable bags SARSTEDT 
Syringe filters, Filtropur S 0.2  SARSTEDT 
Transfer pipettes SARSTEDT 
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Vivaspin® 15 10,000 MWCO Sartorius 
Vivaspin® Turbo 4 10,000 
MWCO 
Sartorius 




2.1.4. Chemicals  
 
Table 4. All chemicals used in this work. The table includes the chemical name and the 
company supplying it. 
Chemical  Company 
1,5-difluoro-2,4-dinitrobenzene 
(DNDFB) 





2- propanol Carl Roth 
2-mercaptoethanol Sigma-Aldrich 
Acetic acid Merck 
Acetone VWR 
Agarose standard Carl Roth 
Alkaline phosphatase New England Biolabs/Roche 
Ammonium persulfate SERVA 
Ascorbic acid Sigma-Aldrich 
Bacillol AF HARTMANN 
Bis-Tris Carl Roth 
Bromophenol Blue Merck 
cOMPLETE tablets Roche 
D-desthiobiotin IBA 
Dimethyl sulfoxide Sigma-Aldrich 
Disuccinimidyl dibutyric urea (DSBU) Thermo Fisher Scientific 
Disuccinimidyl suberate (DSS) TCI 
Disuccinimidyl sulfoxide (DSSO) Thermo Fisher Scientific 
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Disuccinimidyl tartrate (DST) Thermo Fisher Scientific 
DNase I Roche 
EDTA SERVA 
Ethanol  Sigma-Aldrich 
Formaldehyde Merck 
Glycerin Carl Roth 
Guanidinium hydrochloride SERVA 
HEPES SERVA 




Methanol HPLC grade Fischer scientific 
Nickel sulfate Sigma-Aldrich 
Ni-NTA agarose Qiagen 
Phosphodiesterase Abnova 
ROTI®Quant Carl Roth 
Serva Blue G SERVA 
Serva Blue R SERVA 
Skimmed milk powder Heirler 
Sodium chloride Carl Roth 
Sodium dodecyl sulfate SERVA 
Sodium hydroxide Sigma-Aldrich 
Sodium Molybdate Sigma-Aldrich 
Strep-Tactin® Superflow® high capacity 
resin  
IBA 
Tris Hydrochloride Duchefa Biochemie 
Tris ultra-pure Duchefa Biochemie 
Triton-X Carl Roth 
Tryptone Duchefa Biochemie 
Tween 20 Carl Roth 
UREA Duchefa Biochemie 
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Yeast extract Duchefa Biochemie 
 
2.1.5. Sample loading buffers and ladders 
 
Table 5. All sample loading buffers and ladders used in this work. The table includes the name of the buffer or ladder, the 
purpose of use and the company supplying it. 
Name  Purpose of use Company 
Color Prestained Protein 
Standard, Broad Range 
Protein ladder New England Biolabs 
GeneRuler 100 bp DNA ladder Thermo Fisher Scientific 
GeneRuler 1KB DNA ladder Thermo Fisher Scientific 
Green loading dye DNA loading & tracking dye Thermo Fisher Scientific 
Midori Green 
In-gel staining of DNA agarose 
gel 
NIPPON Genetics Europe 
Prestained Ladder Protein ladder Thermo Fisher Scientific 
Prestained Pageruler Protein 
Ladder 
Protein ladder Thermo Fisher Scientific 
Purple loading dye DNA loading & tracking dye New England Biolabs 
Spectra HR Ladder Protein ladder Thermo Fisher Scientific 
Unstained Pageruler Protein 
Ladder 
Protein ladder Thermo Fisher Scientific 
 
2.1.6. Buffers and other solutions 
 
Table 6. All buffers and solutions used in this work. The table includes buffer or solution name and composition. 
Buffer name Composition 
5x loading buffer for SDS 10% SDS, 500mM DTT, 50% Glycerol, 250mM 
Tris-HCl pH 6.8 and 0.5% bromophenol blue 
dye 




E.coli glycerol storage buffer 65 % glycerin, 100 mM MgSO4 and 25 mM 
Tris-HCl 
Gel filtration buffer  100 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 
mM EDTA 
Gel filtration buffer for crosslinking 100 mM HEPES (pH 7.5), 300 mM NaCl, 1 mM 
EDTA 
Ion-exchange high salt buffer 20 mM Tris-HCl pH 7 and 1 M NaCl 
Ion-exchange low salt buffer 20 mM Tris-HCl pH 7 
Native running buffer 12.5 mM Tris pH 8-9, 96 mM glycine 
Ni-NTA elution buffer 100 mM HEPES, 300 mM NaCl, 250 mM 
Imidazol and 10 % (v/v) Glycerol 
Ni-NTA lysis buffer 100 mM HEPES, 300 mM NaCl, 10 mM 
Imidazol and 10 % (v/v) Glycerol 
Ni-NTA regeneration 1 6 M GuHCl and 0.2 M acetic acid 
Ni-NTA regeneration 2 100 mM NiSO4 
Ni-NTA wash buffer 100 mM HEPES, 300 mM NaCl, 20 mM 
Imidazol and 10 % (v/v) Glycerol 
Strep-tactin elution buffer  100 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 
mM EDTA, 10 % (v/v) Glycerol and 5 mM 
Desthiobiotin 
Strep-tactin elution buffer for crosslinking 100 mM HEPES (pH 7.5), 300 mM NaCl, 1 mM 
EDTA, 5 % (v/v) Glycerol and 5 mM 
Desthiobiotin 
Strep-tactin lysis buffer  100 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10 
mM EDTA, 10 % (v/v) Glycerol 
Strep-tactin lysis buffer for crosslinking 100 mM HEPES (pH 7.5), 300 mM NaCl, 1 mM 
EDTA, 5 % (v/v) Glycerol 
Strep-tactin wash buffer 100 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 
mM EDTA, 10 % (v/v) Glycerol 
Strep-tactin wash buffer for crosslinking 100 mM HEPES (pH 7.5), 300 mM NaCl, 1 mM 
EDTA, 5 % (v/v) Glycerol 
TAE buffer 2 M Tris-HCl pH 8.0, 1 M acetic acid and 14.6 
mg/ml EDTA 
TBS (10x) 24 mg/ml Tris pH 7.6 and 88 mg/ml NaCl 
TBS-T (50x) 100 ml of TBS (10x) with 4 ml of 25 % 
Tween20 per 1 liter 






2.1.7.1. Primers  
 
All primers were purchased from Sigma Aldrich/ Merch. Primers were either manually 
prepared, and Tm was measured using NEB primer design online tool OR using SnapGene 
(GSL Biotech LLC). 
Table 7. All primers used for this work. The table includes the name of the primer and the sequence 
Primer name Sequence Purpose of use 
Build_Cnx1E_D088A_For CACTCCAAGAGCGGTAACACCTGAAGCAACGAAA
AAGG 

























built_hs_geph_P2_for CAGCAGCTATTGCTGCAAAGATTCCAG Generation of Homo sapien 
gephyrin isoform 2 
built_hs_geph_P2_rev GCAGCAATAGCTGCTGCAGTAATATG 
Cnx1E_D160A_for CTATTGAGAAAGATGCAACTGTAC Generation of D155A 
mutant 
Cnx1E_D160A_rev CACAACCCACTCTACGGA 





Cnx1E_R156A_for GCAGTGGGTTGTGATATTGAGAAAG Generation of R151A 
mutant 
Cnx1E_R156A_rev ACGGATATCGGTGCCTTT 
Cnx1E_R407A_for GCGCTTTTAAGTATGAGGTCG Generation of R402A 
mutant, 
generation of R402A, E607A 
mutant, and generation of 
R402A, E610A mutant 
Cnx1E_R407A_rev ACTGCTCATCTGATGTCC 
Cnx1FL_S269D_D274S_for CATTTCGTCAAGCCATTGCTC Generation of S269D, D274S 
mutant in Cnx1 
Cnx1FL_S269D_D274S_rev CCTGTCTCCCATATCAAC 
Cnx1FL_S269D_for GATATGGGAGACAGGGATTTC Generation of S269D 
mutant in Cnx1 
Cnx1FL_S269D_rev AACACCACCAGAAGTTAAAATAATATC 
Cnx1G_E152A_for CGTGTATGGAGGCTCTGTTACCTG Generation of E607A 
mutant and generation of 
R402A, E607A mutant 
Cnx1G_E152A_rev CGGCCACTGCGTTTGGGT 
Cnx1G_E155A_for CGGCTCTGTTACCTGCATTG Generation of E610A 
mutant and generation of 
R402A, E610A mutant 
Cnx1G_E155A_rev CCATACACTCGGCCACTG 
Cnx1G_N146A_for GCCCCAAACGCAGTGGCCGA Generation of N601A 
mutant 
Cnx1G_N146A_rev TCCAGGCATGTTGATTATCAATGTTGAG 
Cnx1G_N148A_for GCCGCAGTGGCCGAGTGTAT Generation of N603A 
mutant 
Cnx1G_N148A_rev TGGGTTTCCAGGCATGTTG 
F_470_Cnx1G_for TGAAGCGCTATTAAAGAGGAGAAATTAACTATGGT Generation of 7saltbridges 






Primer 1614 Split Amp rev GAGCACTTTTAAAGTTCTGCTATGTGGC Gibson assembly  
Primer 1621 Split Amp for GCAGAACTTTAAAAGTGCTCATCATTGGAAA 
V_Cnx1G_470_for ACTCACTAAAGCGCTAAGCTTAATTAGCT Generation of 7saltbridges 




QE-for GTATCACGAGGCCCTTTCG for sequencing 
QE-rev GTTCTGAGGTCATTACTGG 
 
2.1.7.2. Gene synthesis 
 
Table 8. Gene synthesized for this work. The table includes the name and sequence of the constructs. 



























2.1.8. Antibiotics, lac-operon inductor and Medium 
 
For all constructs, ampicillin (Carl Roth/ SERVA) used was in 100 mg/ml concentration 
obtained from Carl Roth. Unless stated otherwise, 1 mM final concentration of Isopropyl-β-
D-thiogalactopyranosid (IPTG) was used as lac-operon inducer. The medium type and 
preparation components used are shown in the table below (Table 9). 
Table 9. All medium used in this work. The table contains the names and components of all medium prepared 
 2YT LB SOC 
NaCl 5 g/L 10 g/L 0.5 g/L 
Other components  None None 2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM Glucose 
Tryptone/ Peptone 16 g/L 10 g/L 20 g/L 




Table 10. Antibodies used in this work. The table includes names and references of the antibodies 
Primary antibodies used for immunoblotting 
7G8 - Strep-tag® II (Ringel et al., 2015) 
Anti-MoeA (generated in this work) 
Anti-Nit-9 (Ringel et al., 2013) 
Secondary antibody used for immunoblotting  




2.1.10. Escherichia Coli strains 
 
Table 11. All strains used in this work. The table includes strain name, genotype and source 
Strain Name Genotype Source 
BL21(DE3) 
F- ompT gal dcm lon hsdSB(rB -mB - ) λ(DE3 [lacI lacUV5-T7 
gene1 ind1 sam7 nin5]) 
Studier and Moffatt, 
1986 
DH5α 
supE 44Δlac U169 (Δ80lacZΔM15) hsdR17 
recA endA1 gyrA96 thi-1 relA1 
Hanahan, 1983 
KJW2-A Nonpolar Keio E. coli K-12 derivative: ΔMoaA 
K. Warnhoff and G. 
Ruvkun, 2019 
KJW3-A Nonpolar Keio E. coli K-12 derivative: ΔMoaC 
K. Warnhoff and G. 
Ruvkun, 2019 
NEB® 10-beta 
Δ(ara-leu) 7697 araD139 fhuA ΔlacX74 galK16 galE15 e14- 
ϕ80dlacZΔM15 recA1 relA1 endA1 nupG rpsL (StrR) rph spoT1 
Δ(mrr-hsdRMS-mcrBC) 
New England Biolabs 
NEB® 5-alpha 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi1 hsdR17 
New England Biolabs 
RK5204 RK4353 chlA204::Mu cts 
Studier and Moffatt, 
1986 
RK5206 RK4353 chlA206::Mu cts 
Studier and Moffatt, 
1986 
SE1581 BW545 moeA101 
Adnan Hasona et al., 
1998 
TP1000 
F´ ΔlacU169 araD139 rpsL150 relA1 ptsF 
rbsR flbB Δ(mobAB) 
Palmer et al., 1996 
 
2.1.11. Vectors 
Table 12. All vectors used in this work. 










2.1.12. Expression constructs 
 
Table 13. All constructs used for protein expression in this work. The table contains construct 
name, insert name, vector and mutation 
Construct 
number 








#471 Cnx1E wt pG+ None 






#557 Nit9 pTwo-C None 
#559 Cnx1FL pTwo-C None 
#561 MoeA pTwo-C None 
#562 MogA pTwo-C None 
#614 MoeA-Cnx1G pG+ None 
#615 Cnx1E-MogA pG+ None 
#619 MoeAMogA pG+ None 
#657 StrepII-C none None 
#658 StrepII-N none None 
#718  MogA S117A pEX-A128 S117A 
#721 MoeA switch v2 pEX-A 128 None 
#750 





#751 Cnx1E S269D D27A R407A pG+  
#752 
Cnx1E S269D D27A Cnx1G 
E155A pG+ 






Cnx1E S269D D27A D160A 
pG+ 
Cnx1: S269D D27A, 
D155A 
#754 
Cnx1E S269D D27A Cnx1G 
N146A 
pG+ 
Cnx1: S269D D27A, 
N601A 
#755 
Cnx1E S269D D27A R155A 
pG+ 
Cnx1: S269D D27A, 
R150A 
#756 
Cnx1E S269D D27A Cnx1G 
E152A 
pG+ 
Cnx1: S269D D27A, 
E607A 
#757 
Cnx1E S269D D27A Cnx1G 
E155A 
pG+ 
Cnx1: S269D D27A, 
E610A 
#758 
Cnx1G 7salt bridges 
pUC75 
Cnx1G: 6 mutations 
included in 
supplemental    
#759 
Cnx1G 7salt bridges 3charges 
pUC75 
Cnx1G: 6 mutations 
included in 
supplemental    
#760 
Cnx1E S269D D27A Cnx1G 
N148A 
pG+ 
Cnx1: S269D D27A, 
N603A 
#761 
Cnx1E S269D D27A Cnx1E 
R156A 
pG+ 
Cnx1: S269D D27A, 
R151A 
#762 Gephyrin rn P1 pTWO-C None 
#763 Gephyrin rn P2 pTWO-C None 
#764 
Cnx1G 7salt bridges 
pG+ 
Cnx1G: 6 mutations 
included in 
supplemental    
#765 
Cnx1G 7salt bridges 3charges 
pG+ 
Cnx1G: 6 mutations 
included in 
supplemental    
#766 Gephyrin hs P2 pTWO-C None 
#767 
Cnx1E S269D D27A Cnx1G 
D088A 
pG+ 
Cnx1: S269D D27A, 
D548A 
#768 
Cnx1E S269D D27A Cnx1G 
E040A K041A 
pG+ 
Cnx1: S269D D27A, 
E500A, K501A 
#769 
Cnx1E S269D D27A K149A 
K150A 
pG+ 





Cnx1E S269D D27A E162A 
K163A 
pG+ 





Table 14. All enzymes used in this work. The table includes the enzyme name, 
and the company supplied it. 
Enzyme name Company 
BamHI 
Thermo Fisher Scientific/ New 
England Biolabs 
Eco47III (AfeI) 
Thermo Fisher Scientific/ New 
England Biolabs 
HindIII 
Thermo Fisher Scientific/ New 
England Biolabs 
KLD enzyme mix New England Biolabs 
PstI Thermo Fisher Scientific 
Q5 high fidelity New England Biolabs 
SmaI Thermo Fisher Scientific 
Taq DNA polymerese New England Biolabs 
XhoI Thermo Fisher Scientific 
XmaI Thermo Fisher Scientific 
 
2.1.14. Software and servers 
 
Table 15. All software and servers used in this work. The table includes software name, company or source and purpose 
of use. 
Software name Company and/or source  Purpose 
ATLAS Thermo Fisher Scientific 
Negative staining and 
microscopy 
autoPROC Global Phasing Ltd 
Data set processing for 
crystalization 
BUSTER Bricogne et al. 2017 Struture refinement 
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Chromas Technelysium Sanger sequencing analysis 
ClusPro 
Vajda Lab and ABC Group 




European Molecular Biology 
Laboratory EMBL-EBI 
Multiple sequence alignment 
Conserved Domain NCBI Shennan Lu et al. Domain structure comparison  
Coot 
Paul Emsley (MRC-LMB at 
Cambridge) 
Structural editing 
Cport Bonvin Lab 
Generation of active and passive 
residues for modelling 
CX-Circos  Chait Lab Visualization of the cross-links 
EPU theromos Thermo Fisher Scientific 
Negative staining and 
microscopy 
ExPASy PeptideMass 
Swiss Institute of Bioinformatics 
(SIB) 
In silico digestion of proteins 
ExPASy ProtParam 
Swiss Institute of Bioinformatics 
(SIB) 
Protein parameters  
FiberDock 
E. Mashiach, R. Nussinov and H. 
J. Wolfson 
Backbone refinement in 
molecular docking 
GraphPad Prism  GSL Biotech LLC Analysis and graph presentation 
HADDOCK Bonvin Lab 
Modelling/ protein-protein 
docking 
Image Lab Bio-Rad 
Visualization and documentation 
of SDS PAGE and agarose gels 
I-TASSER 
Ambrish Roy 
, Alper Kucukural 
 & Yang Zhang 
Modelling 
MeroX Michael Götze & Sinz Lab Analysis of the Cross-links 
MobaXterm Mobatek 
SSH terminal, telnet, EDP, VNC 
and Mosh for windows 
Multialign Florence Corpet Sequence alignment 
OpenMS Strum M, et al., 2008 MS results analysis 
PDB Flex GodzikLab Protein flexibility analysis tool 
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Phaser McCoy et al., 2007 
Solving the crystallographic 
phase problem 
PHENIX D. Liebschner et. al 2019 
Structural manipulation and 
refinements 
Phyre2 
Structural Bioinformatics Group, 
Imperial College, London 




European Molecular Biology 
Laboratory EMBL-EBI 
Protein interface exploration tool 
Proteome Discoverer Thermo Fisher Scientific MS results analysis 
PyMOL Schrödinger, Inc. 
Structural visualization and 
editing 
RELION Scheres 2012 
Image analysis, 2D and 3D 
classifications 
Robetta Baker Lab Ab initio modelling 
SnapGene GSL Biotech LLC 
DNA cloning, visualization and 
planning  
STARANISO Global Phasing Ltd Anisotropy 
TEM user software Thermo Fisher Scientific 
Negative staining and 
microscopy 
UCSF Chimera 
Resource for Biocomputing, 
Visualization, and Informatics 
(RBVI) – University of California 
Structural visualization and 
editing 
UCSF ChimeraX 
Resource for Biocomputing, 
Visualization, and Informatics 
(RBVI) – University of California 
Structural visualization and 
editing 
Xcalibur Thermo Fisher Scientific Software for fusion/Orbitap 
 
2.2. Methods  
 




2.2.1.1. Transformation of Escherichia Coli 
 
10-100 ng of target DNA was added to 10 to 100 µl aliquots of chemically competent E. 
coli cells on ice for 30 min. Afterwards, the cells were heat-shocked for 30 to 60 sec (30 sec 
for NEB®5α and NEB®10β, while 60 sec for BL21 (DE3), RK5204, RK5206, TP1000 and 
SE1581) in a Thermomixer (Eppendorf). The cells were then incubated on ice for 3 min, and 
900 µl of LB or SOC medium were added. Afterwards, the cells were shaken for 60 min in 
Ecotron incubator (INFRON HF) at 37°C, for NEB®5α, TP1000, SE1581 and NEB®10β, and 
at 28°C, for RK5204 and RK5206 at 130 - 200 rpm. Subsequently, the cells were applied on 
an LB-agar plate with 100 mg/ml ampicillin (Carl Roth/SERVA) and incubated at 37°C or 
28°C overnight. The plates were wrapped in parafilm and stored at 4°C for further cloning 
or expression usage.  
 
Table 16. Strains used for transformation. The table includes the strain names, temperature and heat shock time 
required 
 NEB®5α NEB®10β BL21 
(DE3) 
TP1000 SE1581 RK5204 RK5206 
Temperature 37°C 37°C 37°C 37°C 37°C 28°C 28°C 
Heat Shock 
time 
30 sec 30 sec 50 - 60 
sec 
50 - 60 
sec 
50 - 60 
sec 
50 - 60 
sec 




2.2.1.2. Cultivation of Escherichia Coli 
 
The E. coli colonies were grown in Lysogeny Broth (LB), 2YT or SOC medium (New England 
Biolabs) at 37 °C or 28 °C depending on the strain (see 2.1.10). For recombinant gene 
expression or to obtain more DNA, single colonies were picked and transferred into tubes 
with 2 – 5 ml of medium, including 100 mg/ml ampicillin. The liquid medium was shaken 
at 130 – 200 rpm for 12 – 16 hrs. To prepare LB solid medium with 100 mg/ml ampicillin, 




2.2.1.3. Storage of Escherichia Coli 
 
In order to prepare glycerol stocks, 500 µl of a solution of 65% (v/v) glycerol,100 mM MgSO4 
and 25 mM Tris-HCl pH 8.0 was used with an equal amount of 500 µl of overnight culture, 
which was shock frozen in liquid nitrogen and kept at in – 80 °C Freezer. 
 
2.2.1.4. DNA concentration determination 
 
In order to assess the quality and concentration of DNA, Multiskan go thermos (Thermo 
Fischer Scientific) was used. Primarily, concentration measurement was done by measuring 
UV-VIS absorbance at 260 nm (A260). Other contaminants were checked for by measuring 
absorbance from 230 to 320 nm. The A260/A280 ratio in the range of 1.7 to 2.0 was further 
used. Secondarily, another method was used by comparing the DNA loaded on an agarose 
gel with a DNA quantitation standard or ladder. 
 
2.2.1.5. DNA gel electrophoresis 
 
Agarose gel electrophoresis was used for the assessment of the quality and size of DNA. The 
agarose gel contained 0.5 to 1% (w/v) agarose standard (Carl Roth) in 1x TAE buffer. For in-
gel staining, 3 µl of Midori Green (NIPPON Genetics Europe) per 50 mL gel. The DNA 
samples were mixed with purple (New England Biolabs) or green (Thermo Fischer Science) 
loading buffer and loaded on the casted agarose gel in the Wide or Mini-Sub Cell GT Cell 
(Bio-Rad). A DNA ladder, 1kb or 100 bp ladder (Thermo Fischer Scientific), was used as a 
standard to size the DNA. The gel was subjected to gel electrophoresis in 1x TAE buffer for 
a duration of 30 – 45 min at a voltage of 120 V. ChemiDoc™ XRS+ system (Bio-Rad) was 
used to visualize the gel using ImageLab software (Bio-Rad). The gel was visualized using 






2.2.1.6. Plasmid purification 
 
After chemical transformation, single colonies were picked and added to the LB medium or 
2YT medium with the appropriate ampicillin amount. The cells were incubated overnight at 
37 °C at 130 – 200 rpm. The plasmid purification was done using Monarch® Plasmid 
Miniprep Kit (New England Biolabs). 2 – 4 ml of the bacterial cell was centrifuged for 30 sec 
then the supernatant was discarded. Pellet was resuspended in 200 µl resuspension buffer 
then mixed, 200 µl of lysis buffer was added then genteelly mixed, 400 µl of neutralization 
buffer was added then incubated for 2 min. The lysate was clarified by spinning at 16,000 x 
g for 2 – 5 min. The supernatant was transferred to a spin column and centrifuged for 1 min, 
then 200 µl of primary wash buffer was added and then centrifuged for at 16,000 x g 1 min. 
Afterwards, 400 µl of secondary wash buffer was added then centrifuged again at 16,000 x 
g 1 min. Finally, 20 – 30 µl of elution buffer was added to elute the DNA. 
 
2.2.1.7. Restriction digest of DNA 
 
Digestion of purified DNA or plasmid DNA of PCR product was used for analysis, checking 
and/or cloning by using NEB FastDigest enzymes (New England Biolabs) or FastDigest 
enzymes (Thermo Fischer Scientific). For a preparative digest reaction, 2 µl of 10x FastDigest 
buffer, 1 µl of each of the two FastDigest restriction enzymes, <1µg of DNA and 20 µl water 
was added. For analytical test digestion, 1 µl of 10x FastDigest buffer, 0.3 µl for the 
FastDigest enzymes, 2 µl of DNA and 6.5 µl water was added. 
 
2.2.1.8. Polymerase chain reaction  
 
For linearization, amplification and isolation of DNA fragments, Polymerase chain reaction 
(PCR) was used. Typical PCR was done using the Q5 high fidelity DNA polymerase or Taq 
DNA polymerase (New England Biolabs) after designing primer pairs that target a specific 
DNA fragment using Snapgene (GSL Biotech LLC). All the primers were ordered from 
Sigma/Merck (see 2.1.7.1.). The colony PCR was done by picking single colonies with a 
pipet tip which is transferred into the reaction mix. The component of a typical PCR 
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component is shown in table 17, while the program used for the PCR cycles is shown in 
table 18. 
 
  Table 17. Master mix reaction for PCR. Tables include components of Q5 DNA polymerase and Taq DNA polymerase 
Component Q5 DNA polymerase 
 
Component Taq DNA polymerase 
 
5x Q5 reaction 
buffer 
4 µl  10x Taq reaction 
buffer 
2 µl 
10 µm forward 
primer 
1 µl  10 µm forward 
primer 
1 µl 
10 µm reverse 
primer 
1 µl  10 µm reverse 
primer 
1 µl 
10 mM dNTPs 0.4 µl  10 mM dNTPs 0.4 µl 
Template DNA 1 pg – 1 µg  Template DNA 1 pg – 1 µg 
Polymerase used  0.2 µl   Polymerase used  0.1 µl 
Nuclease-free 
water 
up to 20 µl  Nuclease-free 
water 





Table 18. PCR protocol for Q5 DNA polymerase and Taq DNA polymerase. The table includes the temperature, time 
and cycle of each step 
Q5 DNA polymerase  Taq DNA polymerase 
 Temperature Time Cycle   Temperature Time Cycle 
Step   Step  
Initial step 98 °C 30 sec   Initial step 95 °C 30 sec  


















Extension 70 °C 30 sec 
per 1 kb 
 Extension 70 °C 60 sec 
per 1 kb 
Final 
extension 
70 °C 2 min   Final 
extension 
70 °C 5 min  
Hold 4 – 12 °C ∞   Hold 4 – 12 °C ∞  
 
 
2.2.1.9. Seamless cloning and DNA assembly 
 
Cloning and DNA assembly were carried out using the NEBuilder HiFi Assembly Master Mix 
(New England Biolabs), which is also known as Gibson assembly, by designing primers from 
Snapgene (GSL Biotech LLC). The primers were designed to have an overall Tm of 50 - 60 
°C depending on the overlapping bases. The reaction was done following the manufacturer’s 
recommendation of the molar ration, vector: insert ratio of 1:2, and the total amount of 
fragments of 0.03 to 0.2 pmols. Afterwards, the sample was incubated for one hr at 50 °C. 
Additionally, NEBuilder (New England Biolabs) was used for mutagenesis by creating 
primers with the desired mutation. All transformations of final cloning steps were carried out 
as described in section 2.2.1.1. 
 
 
2.2.1.10. Site-directed mutagenesis 
 
A Q5 Site-Directed Mutagenesis kit (New England Biolabs) was used for single or double 
amino acid residue exchange. The PCR mix and cycles are pointed out in section 2.2.1.8. 
After the PCR, 1 µl of KLD enzyme mix (New England Biolabs) is composed of Kinase, Ligase 
and DpnI. The reaction was followed up by a transformation which is described in section 
2.2.1.1. Primers were created by either NEBaseChanger (New England Biolabs) or Snapgene 




2.2.1.11. DNA gel extraction 
 
Gel extraction of DNA was done using Monarch DNA gel Extraction Kit (New England 
Biolabs). DNA extraction was done by following the manufacturer’s protocol. Samples were 
incubated at 50 – 55 °C prior to DNA elution. DNA was eluted with 8 to 25 µl of elution 
buffer. 
 
2.2.1.12. DNA sequencing and analysis 
 
In order to validate the DNA sequences, Sanger sequencing was done by Microsynth SeqLab 
and Eurofins Genomics companies. The sequencing was done using custom-designed 
primers or slandered primers offered by the companies. Custom made primers were designed 
either manually while checking Tm online with NEB Tm calculator or via Snapgene (GSL 
Biotech LLC). The sequences were analyzed using Chromas (Technelysium), Multialign 
(Florence Corpet), or Snapgene(GSL Biotech LLC). 
 
2.2.2. Protein biochemical methods 
 
2.2.2.1. Protein expression 
 
For the general recombinant protein expression, recombinant genes were expressed in the 
different strains shown in 2.1.10. Cells were picked directly from already prepared glycerol 
stocks or freshly transformed cells on LB-Amp plates. Primarily, 400 ml of liquid 2YT or LB 
was autoclaved and pre-warmed before usage with the appropriate antibiotic concentration 
of 50 - 100 mg/ml. Pre-cultures were prepared by inoculating single colonies to 60 - 40 ml 
of sterile LB or 2YT that was previously prepared. The optical density was recorded, and the 
appropriate amount of pre-culture was used based on the optical density (OD). The amount 
was calculated by adjusting the appropriate volume, in millilitres, for an OD600 of 2.0 as a 
standard. For example, 5 ml of pre-culture at OD600 2.0 means 5.263 ml for pre-culture at 
OD600 of 1.9. To start the expression, 500 µl of ampicillin was added, of a stock of 50 mg/ml, 
in pre-warmed 500 ml autoclaved 2YT or LB medium. An appropriate volume of pre-culture 
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added, then the flasks were incubated in Multitron standard (INFROS HT) at 28 to 37 °C at 
130 rpm (see table 16). At OD600 of 0.5 to 0.6, 1mM final concentration of sodium molybdate 
or Na2MoO4 (Sigma-Aldrich) was added. This was done using 500 µl of a 1M stock solution. 
Afterwards, the temperature was lowered to 22 °C until reaching OD600 of 0.8 – 1.0, was 
cells was induced by adding 1 mM final concentration of IPTG (500 µl of 1M stock solution 
or 5 ml of a 100 mM stock solution). The expression cultures were incubated overnight at 
22 °C at 130 rpm. 
Recombinant expression of both Cnx1 and gephyrin full-length was done in the E. coli strain 
BL21 DE3 or TP1000 (see 2.1.10.). The initial recombinant expression procedure was the 
same as the general protein expression. However, the temperature was lowered to 19 °C in 
case of Cnx1 full length and 16 °C in case of gephyrin constructs and kept overnight in that 
temperature after induction (0.5 mM and 1 mM final concentration of IPTG for Cnx1 full 
length and gephyrin full-length, respectively). Additionally, no sodium molybdate was 
added for gephyrin. However, 1 mM final concentration was added to Cnx1. All OD600 was 
recorded using a UV/Vis Spectrophotometer Ultrospec™ 2100 pro (Amersham Bioscience) 
or Lambda 25 (PerkinElmer) which was pre-equilibrated and distilled water used as a blank 
for the machine. Afterwards, cells were harvested by centrifugation in Heraeus™ 
Multifuge™ X3R (Thermo Fischer Scientific) for 20 min at 4,500 xg or Avanti J-25 
(Beckmann) for 8 min at 8,000 xg with a temperature generally set at 4 °C. The cell pellet 
was resuspended in the appropriate pre-cooled lysis buffer depending on the subsequent 
step (5 – 3 ml for each 1g of cell pellet). Subsequently, cells were either shock frozen in 
liquid nitrogen and stored at -80 °C or stored directly at -20 °C.  
 
2.2.2.2. Protein purification 
 
2.2.2.2.1. Cells Lysis 
 
For cell lysis, initially, cells thawed at room temperature or with a Mini Therm1 water bath 
(DINKELBERG). Afterwards, a tip of a spatula of DNase I (Roche) was added, and the cells 
was incubated for 5 min. In the case of full-length proteins (Cnx1 or gephyrin), one 
cOMPLETE tablet (Roche) was crushed and added for every 50 ml of resuspended. Lysis was 
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performed twice by either French® press cell (SLM Instruments) or EmulsiFlex-C5 
Homogenizer (Avestin) at 1,000 – 1,500 psi. Next, lysed cells spanned down at 22,222 xg 
for 45 - 60 min at 4 °C, and the supernatant was used for further affinity chromatography 
purification step (See 2.2.2.2.2.). For small volumes of E. coli or Neurospora crassa, FastPrep-
24™ was used (MP Biomedicals) twice for 30s at 6,5 m/s. 
 
2.2.2.2.2. Affinity chromatography 
 
For Strep-tag® purification, recombinant genes were fused with Strep-tag® or Twin-strep 
sequence at the C- or N- terminus of the gene. All affinity chromatography steps were 
performed at 4 to 6 °C. Firstly, 1 or 2 ml of Strep-tactin® (IBA) resin with lysis buffer (see 
2.1.6.) in a 10 or 25 ml column (Bio-Rad) was prepared for purification. The resin was 
equilibrated 10 times each 1 ml of resin with the appropriate pre-cooled lysis buffer. The 
supernatant was then loaded on the resin, and the resin was washed 10 times per 1 ml of 
resin with the pre-cooled wash buffer (e.g. 1 ml resin was equilibrated with 10 ml lysis buffer 
and washed with 10 ml of wash buffer) (see 2.1.6.). The protein elution was done using 6 – 
10 ml of 5 or 25 mM D-desthiobiotin (IBA) dissolved in the wash buffer. The eluted proteins 
were concentrated using Vivaspin® Turbo 4 (Sartorius) spin columns that were pre-
equilibrated with wash buffer. The proteins were concentrated to a volume of 100 to 500 
µl. Proteins were then shock frozen in liquid nitrogen and stored in LS 750 liquid nitrogen 
tank (TechLab Gmbh) or used directly for further protein purification steps (see 2.2.2.2.4. 
and 2.2.2.2.5.) or cross-linking (see 2.2.4.). 
 
2.2.2.2.3. Protein concentration determination 
 
For protein concentration determination of purified proteins, A280, or OD280, was used. 
Proteins were added on a plate reader that was inserted in Multiskan
TM
 GO plate reader 
(Thermo Fisher Scientific), and the extinction coefficient was obtained by submitting the 
sequence on ExPASy ProtParam (https://web.expasy.org/protparam/). The protein 
concertation was finally calculated using the following formula C = A280 /ε b * 20 * MW 
(C for concentration, ε for extension coefficient, b is path length, and MW is the molecular 
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weight). On the other hand, for a mixture of protein or crude extract of E.coli and N. crassa, 
Bradford protein assay was used. For Bradford protein assay, different dilution of the protein 
solution was added to a 1 ml of a Roti Quant (Carl Roth) which was diluted from a 5x stock 
solution. The protein samples were incubated at room temperature for 10 – 15 min, and the 
OD595 was measured using the UV/Vis spectrophotometer Ultrospec™ 2100 pro (Amersham 
Bioscience).  
 
2.2.2.2.4. Size exclusion chromatography 
 
Further purification of proteins/ protein complexes was carried out using gel filtration or size 
exclusion chromatography (SEC) were proteins are separated based on size or hydrodynamic 
radius. In SEC proteins with large molecular weight elute faster than smaller ones (Brusotti 
et al., 2018). For this purpose, firstly, the appropriate column (shown in table 19) were 
connected to the ÄKTA basic or ÄKTA purifier system (Amersham Pharmacia Biotech). 
Secondly, the column was equilibrated with the appropriate buffer with a flow rate shown 
in table 19. Buffers used were shown in 2.1.6., and all the buffers used were filtered and 
degassed for SEC. Fractions of the protein of interest were taken, and the fraction was 
analyzed using SDS PAGE (see 2.2.2.3.1), or the proteins were concentrated for further uses 
by using the Vivaspin® 15 10,000 MWCO (Sartorius). Proteins were then stored on ice for 
further experiments or shock frozen in liquid nitrogen and stored in the protein storage tank.  
Table 19. Columns used for gel filtration. The table includes the name of the column, pressure limit, bed volume, bed 
dimension, flow rate used, sample volume injected and purpose of use 
 Superdex 200 Increase 
10/300 GL 
Superdex 200 10/300 
GL 
Superdex 75 Increase 
5/150 GL 
Pressure limit 3 MPa 1.5 MPa 3 MPa 
Bed volume Approximately 24 ml Approximately 24 ml Approximately 3 ml 
Bed dimension 10 x 300-310 mm 10 x 300-310 mm 5 x 150 mm 
Flow rate used 0.3 – 0.5 ml/min 0.3 – 0.5 ml/min 0.2 – 0.4 ml/min 
Sample volume injected 100 – 500 µl 100 – 500 µl 10 – 50 µl 
Purpose Preparative uses or to 
purify proteins 
Preparative uses or to 
purify proteins 




purity and estimate 
native protein sizes 
 
2.2.2.2.5. Ion-exchange chromatography 
 
Further polishing and separating of proteins/ protein complexes were achieved via Ion 
exchange chromatography (IEX). For this work, Anion exchange was performed using 
SUORCE
TM
 15Q (GE Healthcare Life Sciences) using a pH that was calculated based on the 
isoelectric point (pI) of the protein. The pI of the proteins was obtained by submitting the 
amino acid sequence to ExPASy ProtParam (SIB). The buffer was prepared with a pH of at 
least 1 pH unit (e.g. for a pI of 5.5, 7.2 pH was used) (see 2.1.6.). The proteins were eluted 
by increasing salt concentration, from 0 - 10 mM salt to 1M salt gradient, for 60 to 80 min. 
Before running IEX, PD10 columns (GE Healthcare Life Sciences) was used to buffer 
exchange to the buffer with the appropriate pH. In the case of an IEX following a SEC step, 
the low/no salt buffer was used already in SEC, and there was no need to do another buffer 
exchange step using PD10 columns. More detailed information about SEC is included in the 
previous section (see 2.2.2.2.4.). All buffers were prepared as described in section 2.1.6.  
 
Table 20. Anion exchange chromatography parameters. The table includes information on the ion-exchange runs done 




Starting salt concentration 0 – 10 mM 
Ending salt concentration 1M 
Injected volume 2 to 3.5 ml 
Equilibration flow rate 2-3 ml/min 
Post- sample injection flow rate 1 ml/min 
Gradient time 60 to 80 min 
Starting percentage of first buffer (A) 0 to 10% 
Ending percentage of second buffer (B) 100% 
pH used 7.2 
Fractions volume taken 500 µl 
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Storage condition 20% Ethanol 
 




In order to separate, analyze and evaluate purified proteins or cell lysate, sodium dodecyl 
sulfate-polyacrylamide (SDS-PAGE) was routinely used. Samples loaded on the acrylamide 
gels were separated based on their electrophoretic mobility. For this purpose, samples were 
prepared in 2.5 or 5x loading buffer (see 2.1.6.), and a protein standard was loaded as a 
reference (see 2.1.5.). For cell lysate and crude extract, samples were heated up to 90 °C for 
10 min before loading on the gel. However, for proteins, boiling or heating up was not done 
to avoid aggregation of the protein complexes/ samples. In order to run the SDS gels, two 
different systems were used to run SDS-PAGE. For the regular SDS gels using Julaloo F10 
(Julaloo) with PHERO-stab.300 power supply (BIOTEC fischer) and polyacrylamide gels of 
7.5 - 15 % (w/v) were prepared. The gel electrophoresis ran at 200 V for 45 - 90 min, and 
then the gels were stained overnight with Serva Blue R (SERVA) or Serva Blue G (SERVA). 
The next day, the gels were destained using either 40% ethanol or destaining solution for 1 
hr. Ponceau S was used for extended storage purposes to stain the gels after being transferred 
on a polyvinylidene fluoride (PVDF) membrane (see 2.2.2.3.2). On the other hand, for a 
quick staining-free gel, TGX Stain-Free™ FastCast™ Acrylamide Solutions (BioRad) 
following the manufacturer’s protocol. Stain-free gels ran using Mini-PROTEAN® Tetra 
Vertical Electrophoresis Cell (BioRad) with PowerPac HC (BioRad) power supply at 250 V 
for 30 - 40 min.  In both systems, gel visualization and documentation were done with 
ChemiDocTM XRS+ (Bio-Rad Laboratories) imager.  
 
2.2.2.3.2. Western blot 
 
For Western blot analysis, the SDS gels prepared (see 2.2.2.3.1) was not stained. The gels 
were transferred directly on pre-equilibrated PVDF membranes in transfer buffer (see 2.1.6.) 
after the gel electrophoresis. For semi-dry Western blotting, Trans-Blot Turbo Transfer System 
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(Bio-Rad Laboratories) was used according to the manufacturer’s guidelines. Afterwards, the 
membrane was blocked in 5% (w/v) skimmed milk (Heirler) powder in TBS-T buffer (see..) 
for 1 hr on the W55 (Edmund Bühler) shaker at room temperature or in the cold overnight 
on 3015 GFL (Wilh. O. Schmidt Gmbh) shaker. The membrane was washed 3 times with 
cold TBS-T for 5 min while shaking then the appropriate primary antibody was added (see 
2.1.9.) for 1 hr. After incubation, the primary antibody was collected, and the membrane 
was washed 3 times with cold TBS-T for 5 min while shaking. Subsequently, the membrane 
was incubated with 20 ml of 5% (w/v) skimmed milk for 10 min, and then 2 µl (1: 10,000 
dilution) of the (peroxidase-conjugated AffiniPure Goat Anti-Mouse IgG + IgM (H+L), 
Dianova) secondary antibody was added and incubated for 1 hr shaking at room 
temperature. The membrane was washed 3 times with TBS-T, and proteins were visualized 
and detected using SERVALight Eos (SERVA) and ChemiDocTM XRS+ (Bio-Rad) to image the 
membranes. 
 
2.2.2.3.3. Native PAGE 
 
Typically, the proteins were mixed together for few hrs or overnight prior to the run. Native 
gels were casted using native gel buffer and submerged in 12.5 mM Tris pH 8-9, 96 mM 
glycine buffer. The whole gel cassette was placed in an icebox with an active cooling system 
(Julaloo). The gels were equilibrated for 30 min prior to the run. The gel electrophoresis was 
done using Julaloo F10 (Julaloo) with PHERO-stab. 300 power supply (BIOTEC fischer) at 50 
V for 3 to 4 hrs then the gels were stained overnight with Serva Blue R (SERVA) or Serva Blue 
G (SERVA). 
 
2.2.3. Quantification of MPT, MPT-AMP, Moco, and Moco-AMP 
metabolites  
 
For the quantification of MPT-AMP or Moco-AMP and Moco content, as in an already 
published protocol (Krausze et al., 2017) (Figure 10), proteins were initially set to a 10 mg/ml 
concentration (using A280 – see 2.2.2.2.3.). Subsequently, 2, 5 and 10 µl of the 10 mg/ml 
concentrated proteins were added to an oxidation solution (800 ml of 0.1 M Tris/HCl (pH 
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7.2) + 50 ml of acidic iodine (1% (w/v) I2/2% (w/v) KI in 1 M HCl) which convert the Moco 
content into Form A. The Form A sample was then divided into two, 450 µl of the sample 
with only Alkaline phosphatase to remove the phosphate group and another 450 µl for 
Phosphodiesterase and alkaline phosphatase to remove both phosphate group and the 
phosphodiester bond. Form A samples ran on an HPLC Agilent 1100 using ReproSil-Pur 
Basic-C18-HD (TECHLAB Gmbh) with 250 x 4.6 mm dimensions and 5 µm bead size, as 
well as a fluorescence detector. A synthetic Form A standard was used as a reference. 
 
Figure 10. FormA based quantification of MPT, MPT/Moco-AMP and Moco. The protocol starts on day 1 with the splitting 
of the samples into two sets. Both sets are oxidized by adding acidified I2/KI solution to the samples. For Moco-AMP or 
MPT-AMP, oxidation will yield FormA with phosphate and AMP bound. For Moco, oxidation will leave it with the only 
phosphate. On Day 2, phosphodiesterase I (PDI) is added for the first set, which will remove AMP yielding phosphorylated 
FormA (FormA-Phospho). For the second set, alkaline phosphatase (AP) is added, which results in the removal of the 
terminal phosphate group from FormA but not FormA-AMP. On Day 3, AP is added to the first set yielding FormA 
dephospho for the total quantity of metabolites. After quantification using the HPLC (only detects formA), subtracting the 
results of the second set (only the Moco content but not the adenylated metabolite) from the total metabolite quantity 
resulting from the first set (Both Moco and Moco-AMP/ MPT-AMP), quantifying Moco-AMP/ MPT-AMP is possible (Hercher 
et al., 2020). 
 
2.2.4. Chemical crosslinking 
 
Chemical crosslinking of proteins is done in order to stabilize protein complexes, transient 
or non-transient complexes, to take a ‘’screen shot’’ of how complexes can possibly form. 
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This facilitates our understanding about such complexes by determining their structure (Sinz, 
2006). The general in-vitro protocol for cross-linking with DSS, DFDNB, DST, DSSO and 
DSBU is, initially, a 10 min equilibration of the cross-linker at room temperature (see table 
21). This is due to the moisture sensitivity of such chemicals and to prevent moisture 
condensation in the bottle or vial. A stock solution of 50 mM or 1M solution of the cross-
linker is prepared or approximately 10 mg of the cross-linker in 500 µl DMSO (depending 
on the molecular weight of the cross-linker). The molar excess of the cross-linker is of 
absolute importance. The minimal molar excess used in this work is 10-fold excess (1:10 
protein to cross-linker). The protein is added to the appropriate cross-linker in HEPES buffer 
(a non-amine containing buffer) at an optimal pH of 7.2 (7 – 9 pH range) (see 2.1.6.). The 
reaction was left at room temperature for 25 – 30 min or 2 hrs on ice. The reaction was 
quenched afterwards by adding 50 to 200 mM Tris-HCl and incubated for 10 – 15 min. 
Another approach to eliminate excess cross-linker is either by using PD10 columns (for 
further IEX purification) or loading the proteins on the SEC for downstream procedures. For 
in-vivo cross-linking, the same procedure as the in-vitro cross-linker, however, the 
crosslinking was done to N. crassa or E.coli before lysis. After the crosslinking reaction is 
quenched, cells were lysed using FRENCH® pressure cell press (SLM Aminco®) or FastPrep-
24™ was used (MP Biomedicals) twice for the 30s at 6,5 m/s (see 2.2.2.2.1.). 
 
Table 21. Cross-linkers used in this work. The table contains information about the type and purpose of the cross-linkers 
used, including properties and subsequent techniques used 
 Crosslinking conditions 
for visualizing 
complexes, initial tests 
and optimization for 
other techniques 
Crosslinking for Mass 
Spectrometry 
Crosslinking for Negative 

















Amine to amine 
crosslinking except for 
EDC, which has 
carboxyl- to an amine 
group 
Amine to amine 
crosslinking 




SDS PAGE and SEC SDS PAGE and LC-
MS/MS 
SDS PAGE, SEC, IEX and Cryo-
electron microscope 




Determine amino acids 
that are in close-
proximity in space but 
not in sequence, which 
leads to the 
development of a low-
resolution model 
Obtain/ determine protein 
complex structure 
 
After crosslinking this, the cross-linked proteins were loaded onto a 4-20% polyacrylamide 
gradient gel (Sigma Aldrich) or TGX-stained gels (see 2.2.2.3.1). The protein complexes' 
bands were excised from the gel, then reduced with excessive dithiothreitol (DTT) and 
carbamidomethylated with iodoacetamide (IAA). Subsequently, the samples were incubated 
overnight with GluC (1:20, enzyme: protein ratio) at 37 °C. Subsequently, a 4 hr 
trypsinization step was carried out (Promega). 
 




For LC/MS/MS, a C8 reverse phase (RP) (Thermo Fisher Scientific) was used as a precolumn. 
C18 RP (Thermo Fisher Scientific) was used as a separation column. For the nano-HPLC, the 
HPLC was coupled to the nano-ESI source of the Orbitrap Fusion (Thermo Fisher Scientific). 
To desalt the samples, 0.1% trifluoroacetic acid (TFA) was used on the pre-column for 15 
min. LC-MS grade H2O (VWR) with formic acid (FA) was used as solvent A, and LC-MS 
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grade of 80% acetonitrile (VWR) and 0.08% FA was used as solvent B. An elution gradient 
of flow rate of 300 ml/min was set to 35% of solvent B in 90 min. For data acquisition, data-
dependent MS/MS mode was applied, and Xcalibur (Thermo Fisher Scientific) was used to 
control the data acquisition. 
 
2.2.5.2. Analysis of Results 
 
Cross-linked products were identified using MeroX (version 1.6.6) (Iacobucci et al., 2018). 
Data analysis was done using Mascot generic format (mgf) files. To define the enzymatic 
cleavage sites, C-terminal to K and R was set for trypsin and C-terminal to D and E was set 
for GluC. For amino acid residues K, R, D and E, three missing cleavage sites were allowed. 
The cross-linker name was identified as DSBU with composition C903NH12, and then the 
cross-linking site one was defined for K and site two was defined for K, S, T, Y and N-
terminal. Consecutive peptides as cross-links were ignored. For mass comparison, the 
lower mass limit was set to 200.0 Da and the upper mass limit of 6000.0 Da with ion types 
a, b and y. Rise mode was set on, as well as the cRAP database included. All cross-links 
generated by the software were manually inspected and visualized on the 3D protein 
structure by PyMOL (Schrödinger LLC). 
 
2.2.5.3. Native MS 
 
The proteins were incubated together in equimolar ratio for 60 min then the buffer was 
exchanged to 500 mM ammonium acetate, pH 6.8, with Amicon Ultra centrifugal unit of 
10 kDa cutoff (0.5 mL) before the measurements of the native MS. Using a modified high‐
mass QToF II instrument (Waters Micromass/MS Vision), Native MS measurements were 
obtained. Cone voltage was set to 160 V, source voltage to 1400 V and extraction cone 




2.2.6. Crystallization, data collection and model building 
 
Before crystallization, MogA and MoeA were concentrated to about 40 mg/ml using 
Vivaspin concentrator columns with a 10 kDa molecular weight cut-off. 0.015 M of MgCl2 
and adenosine diphosphate (ADP). MoeA and MogA crystals were obtained from various 
screen conditions. Protein crystals were flash-frozen in liquid nitrogen prior to X-ray 
diffraction experiments 
on beamline P11, operated by DESY at the PETRA III synchrotron (Hamburg, Germany). 
autoPROC was used to process the data set (Vonrhein et al., 2011), and the anisotropy was 
corrected with STARANISO (Tickle et al., 2017), while the crystallographic phase problem 
was fixed with Phaser (McCoy et al., 2007). Structure refinement was implemented using 
BUSTER (Bricogne et al., 2017) and the structure was rebuilt using Coot (Emsley et al., 2009). 
 
2.2.7. Computational Modelling 
 
2.2.7.1. Homology modelling and Ab-initio modelling 
 
Computational docking methods have shown to be helpful in structural prediction. While 
homology modelling is template-based modelling or local docking, ab initio modelling is 
constructing models from scratch (Marsh and Teichmann, 2015). For homology modelling, 
Phyre2 (Kelley et al., 2016) was used. Phyre2 is an automated fold-recognition server for the 
prediction of the structure of proteins. Initially, PDB files were edited by Coot (Emsley et al., 
2009), if necessary, and uploaded on the server for intensive prediction protocol. Afterwards, 
the generated models were checked using FiberDock (Mashiach et al., 2010). FiberDock is 
a method for the flexible refinement of docking proteins. All homology and Ab-initio models 
were uploaded to FiberDock for another final flexibility refinement. For Ab-initio modelling, 
I-TASSER (Roy et al., 2010) or Robetta (Simons et al., 1999) was used. Sequences were 
uploaded to I-TASSER or Robetta, subsequently, a pre-edited PDB file with PyMOL 
(Schrödinger, Inc.) is uploaded for the known structure of the sequence. The result is 5 
ranked models which are not template-based but de novo. 
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2.2.7.2. Global docking 
 
For global docking (no restraint protein-protein docking), ClusPro was used (Kozakov et al., 
2017). ClusPro relies on an unprejudiced selection of protein docking without any previous 
information provided about the individual proteins. Firstly, the PDB structures were prepared 
and edited if necessary, using Coot (Emsley et al., 2009). Afterwards, the first protein was 
added as a receptor, and the second was used as a ligand (or vice versa). The modelling is 
done on three different stages: 1) Rigid body stage where billions of conformations are used 
for sampling, 2) Root-mean-square deviation (RMSD) using clustering of lowest thousand 
energy structures, 3) final refinement of selected structures and subsequent energy 
minimization. In the first stage, PIPER is used as a docking program relying on Fast Fourier 
Transform (FFT) (Kozakov et al., 2017). Initially, the first protein, MoeA in this case, is used 
a receptor in which the protein is placed on a fixed grid at the origin of the coordinate 
system. The second protein, MogA, is placed on a movable grid as a ligand. The correlation 
function is how the interaction energy is written, and the energy functions can be calculated 
precisely using FFT, which results in billions of conformations of the two interacting proteins. 
This enables the unbiased blind selection of protein docking without any previous 
information about the individual proteins. Secondly, the 1000 models with the lowest energy 
based on the root-mean-square deviation (RMSD) clustering are selected. The structures are 
calculated based on finding the structure within 9Å RMSD with the highest number of 
neighbours. The neighbours will then form the second cluster, and up to 30 clusters are 
generated in the same manner. Lastly, using energy minimization, structures are refined, and 
the energy is minimized for the retained structures for 300 steps, resulting in few 
conformational changes (Desta et al., 2020). The output of ClusPro is the 10 most populated 
clusters selected based on electrostatic-favored, hydrophobic-favored, and van der Waals 





Figure 11. ClusPro Workflow. Brief summary of the workflow of ClusPro, starting with the input of structures to generation 
of the models. 
 
Finally, the models obtained from Cluspro were constantly refined using FiberDock 
(Mashiach et al., 2010) for flexible refinement of docking proteins to consider the protein 
flexibility. FiberDock relies on modelling both side-chain and backbone flexibility 
simultaneously as well as performing rigid body optimization on the orientation of the 
ligands. This is important mainly for the flexible parts of the protein structure in which they 
undergo local and global conformation changes, including opening binding sites and 
movement of loops. A side-chain rearrangement subsequently refines the structures in a 
restricted interface manner (Mashiach et al., 2010). FiberDock was used in the case of 
ClusPro protein-protein docking since it adds some flexibility to the protein docking. 
However, this was not necessarily required for HADDOCK modelling since HADDOCK 








2.2.7.3.  Modelling the Cross-links 
 
Modelling with restraints can be done by many different modelling software.  In this work, 
high ambiguity driven protein-protein docking (HADDOCK) was used (Koukos et al., 2020). 
A summary of the crosslinking-based modelling workflow is shown in figure 12. Initially, 
PDB files are prepared by removing all water molecules and ligands using PyMOL. Further 
structural editing was done using Coot (Emsley et al., 2009) in order to renumber sequence 
or chains as well as the identifier. Using PHENIX (Liebschner et al., 2019), all alternative 
conformations were removed, which is necessary to be done or else HADDOCK will not 
accept the structure input files. Afterwards, TBL files are prepared by arranging all the 
restraints in order after manually checking them using PyMOL (Schrödinger, Inc.). TBL files 
are files containing information that the server needs to start the modelling. The information 
includes the residues numbers, locations and specific distance range. The restraint distance 
of Cα to Cα is added in a range of 4 to 30 Å distance (DSBU cross-linker span). It is crucial 
to prepare the TBL files correctly, or else the modelling will fail. For instance, the numbering 
of the PDB sequences, which is slightly different from the actual protein sequence, should 
always be manually checked prior to the preparation of the TBL files. Cport (Vries et al., 
2011), which contains six prediction methods, is used to identify all active and passive 
residues of the individual PDB files. Once the PDB and TBL files are uploaded as well as 
inputting all active and passive residues, the modelling can start. HADDOCK modelling goes 
through 3 stages, firstly, energy minimization of rigid-body, secondly, semi-flexible 
simulated annealing and finally, flexible refinement in a water shell. This result in different 
clusters which all have different Z-scores and RMSD. The lowest Z-score model is used, 
which is checked manually using PyMOL. In case of any unreliable or odd results, TBL files 





Figure 12. Work flow of modelling restraints with HADDOCK. The work flow starts with preparing the PDB files, preparing 
the TBL files, running Cport, running the modeler, analysing, and generating models. The models are subjected to manual 
investigation, resulting in re-modelling after a manual quality control check. 
 
2.2.8. Electron Microscopy and negative staining 
 
Negative staining is a technique that is often used in microscopy to visualize and analyze 
specimens. The samples are stained with a heavy metal buffer, such as uranyl acetate, which 
stains all the background while leaving the actual samples unstained and visible (Ohi et al., 
2004). Negative staining was done at ≈ 20nM proteins in 150 mM HEPES, 300 NaCl buffer. 
The proteins were centrifuged for 20 min at 14,000 gx before negative staining. Carbonfilm 
on 400-square-mesh copper grids were plasma-cleaned using a plasma cleaner (Diener) 
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which was then stained with 2% uranyl acetate (Sigma) twice with a 15-second pause in-
between and dried with filter paper. Using TALOS FC200 (Thermo Fisher Scientific), ≈ 200 
electron micrographs were recorded. EPU thermos, ATLAS and TEM user software (Thermo 
Fisher Scientific) were used to take the micrographs and navigate the microscope. ≈ 10,000 
partials were picked manually using RELION (Scheres 2012). 2D and 3D classification was 
done, which then was visualized using Chimera (RBVI). The crystal structures were fitted in 
the models using Chimera, and all fitting was done automatically by fitting the PDB 



















Chapter three  
 
3. Results and Discussion 
 




MoeA and MogA complex is considered to be the early form of the evolutionary Mo-
insertase complex prior to the introduction of the linker between both proteins (Krausze et 
al., 2018). Therefore, our initial strategy was to explore the prokaryotic MoeA-MogA 
complex assembly (separately expressed E- and G- domains compared to the fused 
eukaryotic Mo-insertases). This would be easier for studying the interaction between the 
domains and compare them with the other homologues Mo-insertase complexes in other 
species. For this purpose, I recombinantly expressed and purified MoeA and MogA 
separately, as well as co-expression of both. I applied various crosslinkers to stabilize the 
complex, isolate the complex, inspected the residues interacting from both proteins via XL-
MS, investigated the complex size and stoichiometry using native-MS, negative staining to 
visualize the protein assembly, and modelled the complex using different computational 
modelling approaches. Furthermore, I complemented the prokaryotic MoeA-MogA with the 
plant Cnx1 separately-expressed domains to examine the differences in complex formation 










3.1.2. Purification and crosslinking of MoeA-MogA complex 
 
To analyze the MoeA-MogA complex, I purified the proteins individually (as described in 
2.2.2.1 & 2.2.2.2) and monitored the protein purity by SDS-PAGE, as shown in figure 10. 
Afterwards, the proteins were mixed in an equimolar ratio then loaded on a pre-calibrated 
gel filtration column. As a control, the individual proteins ran on the gel filtration column 










Figure 13. SDS-PAGE of recombinant MogA and MoeA. A 5 µg quantity of each recombinant protein was loaded onto the 






Figure 14. Gel filtration of MoeA and MogA. The proteins were loaded on a Superdex 200 increase analytical column. All 
proteins were eluted in 100 mM HEPES, 300 mM NaCl, 1 mM EDTA and 5% glycerol. (a) Chromatogram of purified MogA 
that elutes at 13.63 ml. (b) Chromatogram of purified MoeA which elutes at 13.01 ml. (c) In vitro mix of equimolar MogA 
and MoeA chromatogram showing complex elution at 11.53 ml, MoeA at 12.93 ml and MogA at 13.42 ml. All main peak 
fractions were tested with SDS PAGE.  
 
Based on theoretical size calculation, which relies on the calibration of the gel filtration 
column, the MoeA-MogA complex correlates to 165.4 kDa complex size (approximate size 
of a trimeric MogA bound to a dimeric MoeA (Nichols & Rajagopalan, 2002). The main 
peaks were all analyzed with SDS-PAGE to ensure the correct identity of the proteins. In the 
gel filtration profile of MoeA, the prominent peak can be seen at 13.01 ml while 13.63 ml 
for the profile of MogA. For the mixed proteins, 3 peaks appear 11.53, 12.93 and 13.42 ml 
which correlates to MoeA-MogA complex, MoeA and MogA respectively (Figure 14). To 
exclude any influence on other factors on MoeA-MogA interaction, I also co-expressed both 
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proteins in E. coli. Here I used a strep-tagged MoeA as bait or strep-tagged MogA as bait 
(MogA or MoeA routine purification was possible by this approach). Thus I conclude that 
the in vivo co-expression of MoeA & MogA showed the identical band on the SDS-PAGE 
compared to the complex obtained from the in vitro mixture, regardless of the location of 
the StrepTagII
®
 (C-terminus strep-tagged MoeA or C-terminus strep-tagged MogA) 
(Supplemental figure 68). As molybdate was shown to be essential to trigger MPT-AMP 
transfer from G- to E- domain (LIamas et al., 2006), I added molybdate as well as the physio-
chemical highly similar tungstate to my fully defined in vitro approaches. The complex peak 
was monitored under the influence of other conditions, including different pH and salt 
content. However, no observed difference in the complex compared to individual proteins 
in the chromatogram (Supplemental figure 74). 
Interestingly, when comparing the RK5204 E. coli strains with protein purified from E. coli 
strain that lack the first step Moco biosynthesis proteins (knock-out E. coli strains KJW2-A 
(MoaA) and KJW3-A (MoaC) (K. Warnhoff and G. Ruvkun, 2019) (strains provided by T. 
Hercher)), complex formation was found to be depleted only in the chromatograms of 
strains that lack the first step Moco biosynthesis (see supplemental figure 74). Global 
landscape of protein complexes in E. coli using sequential peptide affinity (SPA) tags and 
MS showed an interaction of the first step of Moco biosynthesis (including MoaA and MoaC) 
with MoeA and MogA in a large protein complex with other proteins (Babu et al., 2018). 
This hints that the complex in bacteria requires the first two proteins of Moco biosynthesis 
for the MoeA-MogA complex to be formed. My results further confirm this interpretation. 
 
The results documented so far were obtained without employing any cross-linking reagent 
to stabilize the MoeA-MogA complex. In order to identify the interface(s) of the MoeA-
MogA complex, in the following, I applied various cross-linkers both to the fully defined in 
vitro and in vivo approach. Initial in vivo cross-linking of MoeA and MogA was done using 
different cross-linkers, including formaldehyde, disuccinimidyl suberate (DSS), 
disuccinimidyl tartrate (DST), 1,5-difluoro-2,4-dinitrobenzene (DNDFB). Crosslinking 
efficiency was monitored using SDS-PAGE (Figure 15). When a mixture of DSS and DST (or 
4% formaldehyde) were applied to the higher mixture of MoeA and MogA, a protein species 
of higher molecular weight (≈ 200 kDa) became detectable. A low molar excess of the 
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cross-linker (5-fold) did not show a significant cross-linked product. Nevertheless, the stable 
dimeric MoeA and trimeric MogA could be observed in the SDS PAGE upon crosslinking.  
 
Figure 15. SDS-PAGE of the initial attempt for the in vivo Crosslinking of MoeA and MogA with different cross-linkers. 
In vivo cross-linking was done with a 5-fold molar excess of the cross-linker in the case of DSS, DST, and DFDNB. For DSS 
and DST, a total of 10-fold excess cross-linker was added and 4% formaldehyde. Protein complexes visualized as high 
molecular weight bands (more than 150 kDa) can be observed in the case of DSS + DST and the 4% formaldehyde. 
However, upon the application of DSS, DST, and DFDNB, no MoeA-MogA protein complexes were detected via SDS 
PAGE analysis. 
A gradual increase of the molar excess of the cross-linker was tested to optimise the 
crosslinking conditions using DSS. As shown in figure 16, the increase of molar excess (up 
to 100-fold molar excess) resulted in the increase of the amount of the MoeA-MogA higher 
molecular weight complexes (≈ 200 kDa – 450 kDa). These can consist of a trimeric MogA 
in a complex with a dimeric MoeA. Correspondingly, other stoichiometries could be 
explained (e.g., two trimers and one dimer, 230 kDa), which were all theoretically 
calculated. However, to experimentally validate these results, other approaches, including 




Figure 16. SDS-PAGE of the rising amount of molar excess of the cross-linker for in vitro MoeA and MogA cross-linking. 
DSS was used for all crosslinking reactions. A 12% SDS-PAGE visualized with TGX stain-free. MogA and MoeA were cross-
linked individually with a 100-fold excess cross-linker in the second and third lane. As a control, MoeA and MogA 
equimolar mix was loaded on the SDS PAGE in the fourth lane (45 kDa and 23 kDa, respectively). Further, the increase in 
molar excess from 7.5 x molar excess to 100 x molar excess to investigate the impact of the cross-linker and determine the 
molar excess. At 7.5 x molar excess, only very faint high molecular weight bands can be observed. However, the more 
molar excess used, the more intense the high molecular bands are. Additionally, fading of the monomeric forms of MoeA 
and MogA which are recruited in the high molecular weight bands. 
 
3.1.3. Native MS MoeA-MogA  
 
Native-MS is a very sensitive technique for sizing complexes relying on electrospray 
ionization, which allows the exact determination of the molecular weight of proteins. 
Subsequently, complex stoichiometry could be deduced based on calculations (Natalello 
et al., 2016). Importantly, native MS extract structural information of assemblies in their 
natural form, thus the term ‘’native’’ (Leney & Heck, 2016). To understand more about the 
MoeA-MogA complex, I initially analyzed the separately expressed MoeA and MogA 
proteins as controls, allowing the visualization and size determination of each of their basic 
tertiary structure individually. The proteins were prepared in an appropriate total protein 
amount of ≈ 20 µM to avoid high concentrations (showing noisy signals) and low 
concentrations (showing no signal). For MogA, the distinct trimeric signal was observed 




Figure 17. Native mass spectrum of MogA, MoeA and MoeA-MogA in vitro Mix. (a) Native spectrum of MogA showing 
trimeric species (charge state +14 to + 17) and native mass spectrum artifact of multimeric formation (charge state +25 to 
+30). The trimeric MogA is presented schematically above the designated peaks. (b) Native spectrum of MoeA showing a 
dimeric species (charge state +16 to +20) and native mass spectrum artifact of multimeric formation (charge state +25 to 
+34). The dimeric MoeA is presented schematically above the designated peaks. (c) Native spectrum of trimeric MogA 
(charge state +14 to +17), dimeric MoeA (charge state +16 to +20) and MogA-MoeA complex (charge state +24 to +28). 
The trimeric MogA, dimeric MoeA and the complex are presented schematically above the designated peaks. 
 
Likewise, For MoeA, the mass spectrum showed clear signals of the MoeA dimer observed 
of a molecular weight of 91.9 kDa with a charge state of +16 to +20, which was identical 
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to the theoretically calculated molecular weight from the sequence (Figure 17b). However, 
in both of the cases of MoeA and MogA, tetramers and hexamers are observed after the 
prominent peak in the MS spectrum. The later minute peaks in the spectrum with charge 
state +25 to +34 or +25 to +30 are referred to as ‘’standard native MS artifacts’’. This happens 
when the samples are sprayed from the non-denaturing solvent in the gas phase of the MS, 
causing some minor peaks to appear in the spectrum of the MS (Leney & Heck, 2016), 
therefore they can be ignored.  
After incubating the equimolar mixture of both proteins for one hour, in order to allow 
equilibrium of complex formation, the samples were loaded on the native MS. The 
subsequently obtained MoeA-MogA spectrum showed three distinct species of a trimeric 
MogA, a dimeric MoeA and a heteromer of MoeA-MogA complex of size 69, 91.9 and 161 
kDa, respectively (Figure 17c). At the same time, the charge state of the trimer and dimer 
(+14 to + 17 and +16 to +20, respectively) correlated to the charge states of the individual 
samples that ran as a control (Figure 17a and 17b). An additional, prominent charge state 
of +24 to +28 correlated to the complex of both MoeA and MogA. Due to the technical 
limitation of the equipment, a further resolution was not achievable. Even higher molecular 
weight species could also not be confirmed due to the instrumentation limits. Advanced 
instruments such as UHMR native MS can go for pseudo-MS 3 and measures up to 9.3 MDa 
(Keener et al., 2021). Nonetheless, the molecular weight determination of proteins in all 
the native mass spectrometers is very sensitive with a margin error of approximately 10 Da 
(+ or -) (Vimer et al., 2020). The MoeA dimer of 91.9 kDa and the MogA trimer of 69 kDa 
would add up to 160.9 kDa, which is the actual mass determined for the third visible peak 
of the complex of 161 kDa. Furthermore, as shown in table 22, I theoretically calculated 
Moco and Moco metabolites masses, including MPT, MPT-AMP, and Moco, to make sure 





Table 22. List of masses. The table contains a list of masses of all Moco metabolites and MoeA-MogA protein 
combinations, including theoretical and native MS results.  
 
 
Notably, for all the proteins in the case of native MS, I expressed both proteins in the E. coli  
RK5204 strain, which lacks all metabolites of Moco (Rivers et al., 1993).  
Remarkably, in the field of native MS, it is still a matter of debate whether proteins are fully 
(100%) or mostly in the native form (90 to 99%) (Leney & Heck, 2016). The initial idea of 
partially preserved protein structure came while observing proteins that were 
electrosprayed from an aqueous solution. These proteins resembled narrower charge state 
distributions compared to proteins electrosprayed from an organic solvent (Vimer et al., 
2020). Partly maintained protein structures and not fully maintained, which are also due to 
the possible loss of ligands in the gas phase as an outcome (Leney & Heck, 2016). The 
previously expected theory was that the Mo-insertase complex is formed due to the 
presence of Moco precursors (Magalon et al., 2002). Even though the proteins were 
expressed in a Moco metabolites-free strain, the complex assembly was still observed. 
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Importantly, this shows that the presence of MPT is possibly a reason to recruit more of the 
MoeA-MogA complex. However, it is not essential since the complex can be formed in the 
absence of all the Moco metabolites. As these experiments were conducted in-vitro, 
perhaps the key to enhancing complex assembly is still unknown, e.g., DNA or RNA. On 
the other hand, as briefly described in section 3.1.3, MoaA and MoaC can possibly be the 
initiators of complex formation in bacteria. Nevertheless, as a significant finding, the 
dimeric MoeA and trimeric MogA assembles into an asymmetric heteromer.   
   
3.1.4. Crystallization of MoeA and MogA 
 
For the crystallization of MoeA and MogA, I expressed and purified the proteins. The proteins 
were crystalized in collaboration with J. krausze. The structure of MoeA was firstly published 
by S. Xiang and co-workers in 2001 (Xiang et al., 2001), while, MogA was published by 
Schwarz, G. in 2001 (Schwarz et al. 2001). MoeA and MogA were previously solved in 2.65 
Å and 2.6 Å resolution, respectively. The crystal structure solved in this work of MoeA was 
at 2.1 Å resolution, while 1.9 Å resolution for MogA. A c alpha-based superimposition of 
the structures previously solved with the solved structures in this work is shown in (Figure 
19b and 19c). At first, the crystallization of MoeA and MogA was done after mixing the 
proteins in an equimolar ratio as a trial to obtain a co-crystal structure of the MoeA- MogA 
complex. Later, all the crystals that grew and solved were crystals of the individual proteins 




Figure 18. Example of MoeA, MogA and MoeA-MogA complex crystals. All crystals appeared after mixing 0.2 μL of the 
protein solution (concentration of ≈ 20 mg/ml) with 0.2 μL of the according reservoir. (a) Crystals obtained from 100 mM 
BIS-TRIS and 25% w/v PEG 3350. (b) Crystal growth resulted from 200 mM ammonium acetate, 200 mM BIS-TRIS and 
25% w/v PEG 3350. (c) Crystals obtained from 200 mM MgCl2, 100 mM BIS-TRIS and 25% w/v PEG 3350. (d) Crystal grew 
in 100 mM tri-sodium citrate and 20% w/v PEG 8000. (e) Crystal obtained from 100 mM sodium acetate and 25% w/v 
PEG 3350. (f) Crystals obtained from 200 mM ammonium sulfate, 100 mM HEPES and 35% w/v Poly(acrylic acid sodium 
salt) 2100. (g) Crystals acquired from 100 mM Morpheus buffer, 90 mM Morpheus halogens and 37.5% w/v MPD P1K 
P3350. (h) Crystals were in 8% PEG 4000. (i) Crystal obtained from 800 mM lithium chloride, 100 mM TRIS and 32% w/v 
PEG 4000. (j) Crystals grew in 500 mM lithium chloride, 100 mM TRIS and 28% w/v PEG 6000. (Crystallization was done 
with the help of J. Krausze) 
 
Structural comparison of the MoeA structure reported here with the various E-domain 
structures available in the PDB revealed that the main difference was the hinge region of the 
flexible part of subdomain II and III. Using PDB Flex (Hrabe et al., 2016), the solved MoeA 
structure showed the most extreme opening conformation compared to all E-domains crystal 
structures from the different species (Figure 19d). All E-domains from different crystal 
structures were compared using Conserved Domain (NCBI) (Shennan Lu et al., 2020). For 
MogA, the structure showed similarity overall, with no notable difference (Figure 19b). All 
MoeA-MogA modelling and protein-protein docking was done using the crystal structures 




Figure 19. Crystal structure of MoeA and MogA. (a) Cartoon representation of MogA (this work). (b) Superimposition of 
MogA structure (this work, pale yellow) with the previously solved MogA structure (PDB: 1DI7) (cyan). (c) Cartoon 
representation of MoeA (this work). (d) Superimposition of MoeA (this work, light blue) with the previously solved structure 
of MoeA (PDB: 1G8R). The hinge region connecting subdomain II and III is shown enlarged with RMSD of 1.9 Å (structures 
solved by J. Krausze). 
 
3.1.5. XL-MS MoeA-MogA 
 
The chemical cross-linking of MoeA-MogA was done in vitro (using an equimolar mixture 
of MoeA and MogA) and in vivo (using different E. coli strains which co-expresses MoeA 
and MogA). All XL-MS was done using the MS-cleavable disuccinimidyl sulfoxide (DSSO) 
(Developed by Huang group) or disuccinimidyl dibutyric urea (DSBU) (Developed by Sinz 
group) (Kao et al., 2011; Ihling et al., 2020). DSSO was used to optimize the cross-linking 
condition, whilst DSBU was used for the analysis of the cross-linked products. Prior to XL-
MS experiments, the efficiency of XL was monitored by SDS PAGE revealing a decrease in 
the band of monomeric MoeA and MogA, and an enhanced band corresponding to the 
dimeric MoeA, trimeric MogA as well as multiple complex assemblies of a higher-order 
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structure (Figure 20). In order to confirm the presence of both proteins in the complexes, the 
higher molecular weight bands were excised from the SDS-PAGE gel as well as a control (a 
lower sized band), enzymatically digested them and injected the samples to the LC/MS/MS 
for analysis. The results from the MS analysis of DSSO cross-linked MoeA and MogA showed 
the presence of MoeA and MogA in all of the high molecular weight complex bands 
(Supplemental figure 69). 
On the other hand, the control band excised of size approximate to 90 kDa showed only 
MoeA and the absence of MogA as expected. These results showed the formation of multiple 
complexes of MoeA-MogA, including the 161 kDa complex observed in the native MS (see 
3.1.3). For DSBU, the procedure was identical. Nevertheless, different strains were 
employed for the cross-linking experiments (Figure 20), and the high molecular weight 
bands, as well as controls for LC/MS/MS, was excised. 
 
 
Figure 20. SDS PAGE of MoeA-MogA in vivo crosslinking with DSBU in different E. coli backgrounds. All cross-linking 
was done in vivo with DSBU in a 100-fold excess cross-linker to the proteins. The cross-linking was done using proteins 
expressed and purified from TP1000, RK5206 and RK5204 E. coli strains. However, no significant difference could be 
observed. The proteins were mixed in an equimolar ratio and incubated for an hour prior to crosslinking.  The crosslinking 
showed high molecular weight bands (more than 130 kDa) with decreased intensity of the monomeric proteins. The high 
molecular weight bands were then excised, digested and subjected to LC-MS/MS. 
 
Upon analysis with MeroX, chemical cross-linking of MoeA-MogA with DSBU showed 
plenty of intramolecular cross-links (within MoeA alone or MogA alone), which was 
insignificant for our purpose due to our knowledge of the crystal structures (see 3.1.4). 
Conversely, only two intermolecular cross-linked peptides (between MoeA and MogA) were 
highly reproducible across biological and technical replicates of all high molecular weight 
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complexes, including the ≈160 and ≈240 kDa complexes. The lysine residue number 140 
(from the peptide SIKETLEGVK of MogA; identifier number P0AF03) was cross-linked with 
lysine residue number 341 (from the peptide KTPGR of MoeA; identifier number P12281) as 
well as the lysine residue number 147 (from the peptide SIKETLEGVK of MogA; identifier 
number P0AF03) was cross-linked with lysine residue number 341 (from the peptide KTPGR 
of MoeA; identifier number P12281). 
For chemical cross-linking, the biggest challenge is the analysis of the peptides in order to 
obtain accurate results with minimal false positives (Sinz, 2006). Due to the vast expansion 
of search space in the MS, unique peptides that ‘’stand out’’ are advantageous in the analysis. 
MS-cleavable cross-linkers, which were initially introduced in 2001, such as DSBU, DSSO, 
and CDI, are superior for allowing easier and precise identification of cross-linked peptides 
as they show a unique fragmentation pattern in the gas phase of the MS (Ihling et al., 2020).  
Although DSSO and DSBU are similar in the length of the linker and the chemical structure, 
DSBU is superior in comparison with DSSO because it does not require more than MS/MS 
to identify the two characteristics 26-u doublets in the spectra. On the other hand, DSSO 
requires identification under a third MS (MS
3
), which is more complicated than the case of 
DSBU (Iacobucci et al., 2018). It has to be noted that at first, the bands were digested with 
trypsin only. As a result, the peptides were too long to be analyzed since trypsin only cuts 
from the C-terminal of lysine and arginine (Dau et al., 2019). Hence, another protease 
needed to be applied. For this purpose, in silico analysis of the digestion of MoeA and MogA 
with Trypsin and GluC (using ExPASy PeptideMass) was done. The results showed shorter 
peptide length when digesting with GluC and long peptides with trypsin (See supplemental). 
GluC, a serine protease that cuts glutamic and aspartic acid, was added overnight to ensure 
the short length of the digested peptides to allow the ease of analysis (Dau et al., 2019). For 
the analysis, with MeroX (Sinz lab) software, the longer the peptide, the harder it is for the 
software to discriminate between actual cross-linked peptides and modified peptides with 
others.  
Another hurdle for the MoeA-MogA analysis was the keratin, an abundant essential protein 
for hair, skin and nails, and contamination during the first XL-MS attempt, resulting in keratin 
coverage nearly as high as the coverage of MoeA and MogA. Consequently, the analysis was 
terminated (Supplemental figure 65). All band excision was performed under the fume hood 
with lab safety sleeves and gloves on to avoid this problem.  
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Although the amine-to-amine cross-linker used interacted with amine-reactive residues (Sinz 
et al., 2015), the presence of the same inter-crosslink in MoeA-MogA samples, both in vivo 
and in vitro, can be only explained that the only amine-reactive residue available, in the 
interaction surface of both MoeA and MogA, is the merely one identified by the software. 
These results can be further elucidated by modelling the MoeA-MogA complex, with the 
knowledge that the interface between both proteins should not contain an amine-reactive 
residue in close distance to the identified ones.  
 
3.1.6. Modelling the MoeA-MogA complex  
 
For modelling the MoeA-MogA complex, two modelling approaches were done, including 
global docking (modelling MoeA - MogA docking without any crosslinking guidance) and 
guided-based modelling (using crosslinking restraints). For MoeA-MogA docking, ClusPro 
was used as a server for docking the two directly interacting proteins (Kozakov et al., 2017) 
(see 2.2.7.2.). Following the steps mentioned in 2.2.7, the solved MoeA and MogA structures 
were docked, resulting in 30 models. The resulted models were a balanced set of 
electrostatic-favoured, hydrophobic-favoured and van der Waals electrostatics (Figure 21). 




Figure 21. Global docking of MoeA and MogA. Thirty models were generated using ClusPro. The structures of MoeA and 
MogA in this work was used as a receptor (MoeA) and ligand (MogA) for the docking approach. MoeA is shown in light 
blue and MogA in pale yellow. The resulting models are based on a balance of electrostatic-favoured, hydrophobic-
favoured and van der Waals electrostatics  
 
Next to the non-guided docking, the two identified cross-linked MoeA-MogA peptides were 
subsequently used as restrains in a guided docking using HADDOCK (Koukos et al., 2020). 
HADDOCK workflow presented in this work is shown in figure 12. The solved MoeA and 
MogA structures were used as input files for modelling after editing them using Coot and 
PHENIX (Emsley et al., 2009; Liebschner et al., 2019) (see 2.2.7.3). The final model is 
presented in figure 22. TBL files (files containing the information required for modelling) 
were prepared with only two restraints of residue 140 and 147 of MogA cross-linked with 





Figure 22. MoeA-MogA complex model based on restraints. (a) Surface representation of the restraint model generated 
using HADDOCK, MoeA is represented in light blue and MogA in pale yellow. The structures in the model used were the 
crystal structures solved in this work (figure 19). (b) Cartoon representation of the HADDOCK model highlighting the 
restrains used for modelling in yellow. The residues cross-linked are within the 18.9 and 19.7 Å range (red), all other lysine 
residues are represented in blue, and they all are within more than 28 Å distance as displayed in a magnified view of the 
restraints zone that is framed in a dashed line. 
 
Importantly, with the exception of the two lysine residues that are highlighted in figure 22b, 
the lysine surface distribution on the model did not show any lysine residues in close 
proximity (the allowed distance of the cross-linker to interact with two residues). Moreover, 
the distance of the closest lysine residues in-between MoeA-MogA (excluding the identified 
cross-links) in the current model is 37 Å, which is beyond the span of the linker. The global 
docking approach was finally compared to the restraints-guided approach, and the results 





3.1.7. Negative staining MoeA-MogA complex 
 
Negative staining of MoeA-MogA complex, which was purified from the chromatogram 
shown in figure 14, showed relative heterogeneity. Although the samples were slightly 
crowded, L-shaped particles are observed in the micrographs (Figure 23a, 23b and 23c). 2D 
classification of the particles showed classes that resembled an elongated or inverse ‘’L’’-
shape. These findings, in turn, are similar to the results coming from the global docking 
(Figure 21) and the crosslinking-based model (Figure 22). The organization of the E- and G- 
domain are derived from the results obtained from the 2D classes is shown in figure 23f. 
Consistently findings from the 2D classification are in complete agreement with results from 




Figure 23. Negative staining of MoeA-MogA complex. All samples were cross-linked in 100 mM HEPES, 300 mM NaCl 
and 1mM EDTA and have a particle size of 90 to 150 Å (a) Negative staining of MoeA-MogA large complex (e.g. two MoeA 
dimers and 2 MogA trimers) of the expected size of 250 to 300 kDa. The analyzed samples 8100 µg/µl) showed a relatively 
high degree of heterogeneity. (b) First negative staining of MoeA-MogA complex (trimer-dimer) of the expected size of 161 
kDa. The samples were in 200 µl/ml concentration and relatively homogenous. 102 micrographs were taken, and 
approximately 70000 particles were used for auto picking. (c) Second negative staining of MoeA-MogA complex (trimer-
dimer) of the expected size of 161 kDa. The samples were in 100 µl/ml concentration. 47 micrographs were taken, and 
approximately 24000 particles were used for auto picking. (d) Autopicking of the first negative staining micrographs. 192 
boxsize, 250 Å mask used and 100 classes were selected. Selected classes used as a trial for further classification are 
highlighted in red. (e) Autopicking and classes of second negative staining done. 192 boxsize, 250 Å mask used and 5140 
particles selected. Single particle picking was possible, and it was visually possible to see the inverted ‘’L’’-shaped particles 
as well as the elongated shapes. (f) Schematic representation of MoeA and MogA model, which shares a mutual 
resemblance to the single particles picked (Negative staining EM results obtained and processed with the help of T. Beck 
and P. Wendler). 
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3.1.8. Complementation of prokaryotic Mo-insertases complex 
with plant Mo-insertase domains 
 
It is previously shown that gephyrin reconstitutes Moco biosynthesis in prokaryotes and 
plants (Schwarz et al., 1999). Nevertheless, the protein complex assembly of Mo-insertases 
was not shown to be complemented formerly. In the following, I tested for the ability of 
Cnx1E and Cnx1G to complement MoeA and MogA within the Mo-insertase complex. 
Therefore, the following co-expression constructs were created: Cnx1E-MogA and MoeA-
Cnx1G as well as Cnx1E-Cnx1G and MoeA-MogA. All constructs were expressed in E. coli 
strain RK5204. For subsequent crosslinking, a 100-fold molar excess of DSSO was applied. 
The cross-linked products were then analyzed via SDS-PAGE (Figure 24a) and native gel 
electrophoresis (Figure 24b). To confirm the identity of the cross-linked products, an anti-
step tag antibody (Ringel et al., 2013) was used for immunoblot-based detection. As 
documented in figure 24a, the formation of Mo-insertase protein complexes was traceable 
for all expression strains analyzed. Remarkably, the documented sizes of the different 
complexes identified are highly comparable to that of the MoeA-MogA co-expression strain 
serving as control here (Figure 24a). On the other hand, analysis via native gel 
electrophoresis revealed differences amongst the expression strains analyzed. Here the 
Cnx1E-MogA co-expressing strains were found to possess a relatively more Mo-insertase 
complex as estimated from the band intensity (size ≈ 235 kDa) compared to the control 














Figure 24. SDS PAGE and native gel of complementing G- and E- domains from plants and bacteria.  All proteins were 
co-expressed in RK5204 and cross-linked in vivo with 100-fold excess DSSO cross-linker. (a) SDS gel shows that the 
respective strains were used for an in vivo crosslinking approach upon co-expression of E- and G- domains. Here, the 100-
fold excess (+) was used. As a control, no cross-linker was applied (-). (b) Native gel using crude extracts of the analyzed 
strains in (a). Prior to analysis, the indicated strains were used for an in vivo crosslinking approach using the 100-fold excess 
DSSO. Additionally, MoeA-MogA were cross-linked upon expression in E. coli strain SE 1581. 
 
The results indicate that the Mo-insertase complex formation occurs even when the E- and 
G domain of different species are involved. However, the results obtained require further 














In summary, a MoeA-MogA complex of ≈ 161 kDa size was identified and characterized in 
this work by employing different techniques, including native MS, XL-MS, negative staining 
and computational modelling. For modelling, two approaches (XL-MS based docking and 
global docking) have been employed, which both yielded essentially the same results. Each 
of the approaches was found to be consistent with the negative staining EM approach. 























In Cnx1, the G- and E- domains are connected via a short linker of 23 amino acid residues 
(Schwarz et al., 2000). However, since evolutionarily preserved proteins tend to form 
homologues complexes (Landry et al., 2013), it can be assumed that the prokaryotic E- and 
G-domain form a comparable protein complex assembly in comparison with plants. If not 
identical, minor movements are expected of the domains when comparing different Mo-
insertase complexes from different species. For Cnx1, I recombinantly expressed and 
purified the full-length protein, applied XL-MS, modelled the complex as well as negative 
staining and Cryo-EM to visualize the complex assembly of Cnx1. A summary of Cnx1 XL-
MS and modelling is shown in figure 25. 
 





3.2.2. Expression and purification of Cnx1 full-length 
 
The recombinant expression and purification of full-length eukaryotic proteins are not often 
feasible and, in some cases, unachievable in E. coli. This is due to several factors, including 
unsuitable expression and purification conditions as well as proteases activity leading to low 
protein yield and/or the vast majority of the protein to be degraded (Rosano & Ceccarelli 
2014). To establish a Cnx1 purification protocol that allows the production of (non-
degraded) full-length protein, I initially expressed and purified the protein as C-terminal 
StrepII Tag fusion, following the parameters established for MoeA / MogA expression and 
purification (See 2.2.2.1 and 2.2.2.2). Nevertheless, doing so yielded protein preparations 





In order to further enhance the homogeneity of the obtained 
protein preparation, I introduced an additional His6-tag on the 
C-terminus of the protein. However, the SDS-PAGE showed 
degradation product regardless of the double-tag purification 
(on both C- and N- terminus) of the protein. Therefore, 
subsequent downstream purification steps were included in 
the protocol (Figure 27). The inevitable presence of 
degradation products could be explained by the binding of the 
degradation products (fragments of G- and E- domain) with the 
full-length protein leading to the trapping of these products in 
a complex that can be co-purified by affinity chromatography.  
Figure 26 SDS PAGE of the initial 
purification of Cnx1 full-length. The 
proteins were loaded in 20 µg and 
10 µg amount for comparison. Full-
length Cnx1 can be observed at 
approximately 90 kDa and plenty of 
degradation products can be shown 





Figure 27. Summary of the new expression and purification protocol of full-length proteins used in this work.  
 
Precisely, upon two-step affinity tag-based purification, the obtained protein preparations 
were subsequently purified by gel filtration (Figure 28 and 29). and anion exchange 





Figure 28. Gel filtration chromatogram from the Cnx1 full-length purification. The proteins were loaded on a Superdex 
200 increase analytical column. All proteins were eluted in 100 mM HEPES, 300 mM NaCl, 1 mM EDTA and 5% glycerol. 
The fractions eluted for further SDS-PAGE analysis are labelled A3, A4, A5, A9, A10 and A11.  
 
 
Figure 29. SDS PAGE of the gel filtration fractions taken from the Cnx1 full-length purification. A control sample of 
unpurified Cnx1 was loaded as a comparison. Fractions A3 to A11 were taken from the gel filtration run with the 
chromatogram shown in figure 28. The two main peaks of the Ion-exchange chromatogram were loaded on the gel, the 
early peak from the chromatogram was from A3 to A5, while the late peak was from A9 to A11. Fraction A3, A4 and A5 
showed more full length compared to fraction A9, A10 and A11. Therefore, A3, A4 and A5 fractions were pooled and used 
for further ion-exchange chromatography step. 
Afterwards, the interesting fractions A1 to A5 were pooled and used for the subsequent IEX. 
Prior to IEX, the proteins were cross-linked with 100-fold excess DSS cross-linker. The cross-
linked protein samples were loaded on the IEX column with an 80 min salt gradient as 
described in section 2.2.2.2.5, and all fractions were collected. The IEX chromatogram 
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showed two distinct peaks appearing from a conductivity of 20 mS/cm (Figure 30). The 
fractions were collected and checked on SDS-PAGE (Figure 31). The late fractions of the first 
peak of the chromatogram showed degradation, yet, the early peak in the chromatogram 
showed full-length proteins and almost abolished degradation products. 
 
Figure 30. Ion exchange chromatogram from the Cnx1 full-length purification. The proteins were loaded on a Source 
Q15 analytical column. The 80 min gradient started with 20 mM Tris-HCl buffer and eluted with 20 mM Tris-HCl and 1M 







Figure 31. SDS PAGE of the ion-exchange fractions taken from the Cnx1 full-length purification. Fractions from A1 to A8 
were obtained from the ion-exchange with the chromatogram shown in figure 30. Fraction A4, A5, A6 and A8 showed 
significant degradation products as well as less amount of full-length proteins. The Cnx1 full-length is of an approximate 
size of 90 kDa, while band A6 and A8 show a size of approximately 45 kDa, which is equivalent to the E-domain. In A4, 
A5, A6 and A8, bands of G-domain approximate size can be seen. Finally, A1 and A2 show no degradation product 
demonstrating the successful purification of the full-length protein (labelled by a checkmark). 
 
Upon successful establishing a purification regime that allowed for the purification of 
recombinant full length Cnx1 without any significant degradation products, unless stated 
otherwise, thus obtained protein was used for crosslinking and negative staining EM 
experiments. In some cases, for significantly homogenous sample preparation for the EM, a 
cross-linker was added before or after gel filtration to ensure an intact complex and avoid 
dissociation over time.  
   
3.2.3. XL-MS of full-length Cnx1 
 
Chemical crosslinking of Cnx1 full length was performed with the DSBU cross-linker 
described in (2.2.4). Checking the protein complex on a SDS-PAGE after cross-linking is 
crucial to evaluate the correct protein folding, which can be distorted by over-cross-linking 
(Yu & Huang 2018), especially in the case of highly flexible proteins such as Cnx1. 
Therefore, SDS-PAGE was used, which documented the DSBU-dependent formation of two 
high molecular weight complex (≈ 200 kDa and ≥ 300 kDa). The corresponding protein 
bands were excised from the gel, enzymatically digested, and then used for the LC/MS/MS 
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analysis. Using MeroX to identify the cross-linked amino acid residues, all the cross-linked 
products were manually checked (Iacobucci et al., 2018).  
 
Figure 32. SDS-PAGE of crosslinking Cnx1 with DSBU for LC-MS/MS. A 12% SDS-PAGE visualized with TGX stain-free 
of crosslinking Cnx1 full-length. DSBU was used for the crosslinking reactions (Cnx1FL XL). High molecular weight 
complexes of ≥200 kDa is observed in the cross-linked sample compared to the control sample with full-length protein at 
≈ 90 kDa (Cnx1FL). The high molecular weight complexes (marked with asterisks) were excised, enzymatically digested 
and subjected to LC-MS/MS. 
As briefly discussed in 3.1.5, MS-cleavable cross-linkers are cleaved at their labile bonds in 





experiments are performed on the reporter ions of the cross-linker. CID 
(collision-induced dissociation) and ETD (electron-transfer dissociation) experiments could 
be done as an alternative by combining information from two complementary approaches 




nor CID and ETD 
experiments are necessary to be conducted, which is advantageous for this cross-linker. 
Unlike other MS-cleavable cross-linkers, the labile bonds of DSBU are cleaved at the same 
energy regime necessary to cleave the peptide backbone, allowing the detection of the 
unique fragments of the peptide and the linker at the MS/MS level (Ihling et al., 2020) (Figure 
32). Accordingly, this gives information about both the cross-linking site and the amino acid 




Figure 33. DSBU structure and cross-linking workflow. The urea-based cross-linker is 12.5 Å in length, which could be 
cleaved during the collision-induced dissociation (CID) in 2 γ-aminobutyric acids that fragment in a unique pattern in the 
gas phase of the LC-MS/MS. This makes it easily identifiable because of its 26-u doublets. The Peptide backbone fragments 
are essential for peptide identification. 
  
After MS/MS, the cross-linked peptides are reassembled computationally from the identified 
peptides which are used to provide distance constraints from individual proteins and protein 
assemblies (Götze et al., 2019). As shown in figure 33, an inter-peptide cross-link will have 
two distinct doublets of 25.979-u when the cleavage occurs at any of the two NH-CO bonds 
located at the urea moiety. Therefore, peptides will be modified, with the fragment of the 
cross-linker in the MS/MS spectra, showing signals from the two doublets.  
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Obtained primary MS/MS data was subsequently evaluated computer-based using MeroX. 
However, each data set was inspected manually for quality and unambiguity. The cross-
linking sites were manually compared by selecting various combinations and inspecting the 
spectrum. Notably, the spectrum should contain fragment ions of both peptides, fragment 
ions from the fragmentation of the cross-linker (DSBU), ion series with high intensities, and 
a minute number of unassigned peaks (which could be due to co-isolation or neutral losses) 
(Götze et al., 2019). All fragment ions have unique colours in the detailed result sheet, which 
further helped in the inspection. Scores are generated by MeroX depending on the presence 
and intensity of the reporter ions. Additionally, the length of the ion series of the peptide 
backbone and the number of ion fragments in comparison to the theoretical peptide pairs 
generated (Yu & Huang 2018). 
The list generated of all cross-links had high scores from 110 down to 10 of a total of 246 
cross-links. However, a cut-off score was used, and no cross-link was considered below 50.  
Analysis of the ≥ 300 kDa band revealed 50 intermolecular cross‐links (between two 
different domains) and 37 intramolecular cross-links (within the same domain) 
(Supplemental table 23). However, analysis of the ≈ 200 kDa band revealed three 
intermolecular cross‐links and 21 intramolecular cross-links (Supplemental table 24). Thus, 
the identified cross-links are shown as a circos diagram using CX-Ciros (Chait Lab) (Figure 
34a and 34b). The diagram shows all inter-and intra- molecular cross-links. Furthermore, 
the degree of conservation of each residue was included in figure 34 using ConSruf 
(Ashkenazy et al., 2016). All intermolecular cross-linked residues were manually checked 
using Cnx1 sequence with identifier: Q39054 to ensure that the correct numbers are 
correlated to the correct residues. The numbers and domain location for all cross-links were 
tabulated for modelling (Supplemental table 24). Upon their identification, the structural 





Figure 34. Circular plots of the cross-links identified for Cnx1 full-length. The circus diagram shown were generated based 
on the cross-linking mass spectrometry data obtained for the ≥ 350 kDa complex (a) and the ≈ 200 kDa complex (b), 
respectively. All intermolecular cross-links were highlighted in purple, and the intramolecular cross-links were highlighted 
in grey. All lysine residues are highlighted in blue in the diagram, and the degree of conservation of the residues is coloured 
from highly conserved (red) to non-conserved (white) (Ashkenazy et al., 2016). (a) The circular plot shows a total of 87 
cross-links, either intra cross-links between E-domain (bright orange), G-domain (teal), and linker (brown), or inter cross-
links within the domain itself. (b) The circular plot shows a total of 21 cross-links, either intra cross-links between E-domain 
(bright orange), G-domain (teal), and linker (brown), or inter cross-links within the domain itself. The circular plot was 
generated by CX-Circos (Chait Lab). 
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3.2.4. Modelling Cnx1 
 
Based on the results obtains from XL-MS, the structure of the Cnx1 full-length protein was 
reconstructed using HADDOCK (Koukos et al., 2020). Therefore, the available crystal 
structures for Cnx1E PDB: 5G2R (Krausze et al., 2017) and the Cnx1G PDB: 1UUY (Kuper 
et al., 2004) were used (see 2.2.7.3.). Notably, the crystal structures of Cnx1E and Cnx1G 
lacks parts of the sequence (Figure 35), including part of the Cnx1E N-terminus, the Cnx1G 
C-terminus and the domain linker. These gaps of structural knowledge turned out to make 
modelling of the full-length protein very challenging. Additionally, the structural nature of 
the domains as homomers provides another challenge to model since the modellers are not 
equipped to adequately make a distinction between the monomers of a homomeric 
structure. Therefore, extensive manual validation needed to be done. 
 
 
Figure 35. Structured regions in Cnx1 full-length. (a) Schematic representation of full-length Cnx1. The structure of Cnx1E 
(bright orange) (PDB: 5G2R) and Cnx1G (Teal) (PDB: 1UUY) are shown above the schematic domain organization of Cnx1. 
For parts of the Cnx1 sequence, no structural information is available. These parts are coloured in dark grey, while 
structurally resolved parts of the sequence are highlighted in yellow and green, respectively. (b) The amino acid sequence 
of Cnx1 showing the structured E-domain part (bright orange) and structured G- domain part (Teal). Sequence regions for 
which no structural information is available are coloured in grey (see (a) for comparison). 
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As described in 2.2.7.3, to prepare TBL files that include the restraints, the cross-linked 
residues were first marked on the structures. Ambiguously, the crosslinking results from the 
XL-MS approach showed residue numbers from Cnx1 sequence (with identifier number 
Q39054) without showing which specific residue on the tertiary structure is linked to which. 
For instance, residue 158 from the E-domain is cross-linked with residue 521 from the G-
domain (on the full-length sequence). As a dimer, the E-domain with residue 158 would be 
present twice (on the structure). For residue 521, it would appear three times on the trimeric 
G-domain. This means that the interruption of the cross-links cannot be directly proclaimed 
on the modeller unless a particular manual visualization is done using structural insights 
(Figure 36). For this purpose, the modelling was done using all possible realistic 
combinations. For example, residue 468 in the sequence, which is 7 on the structure of 
Cnx1G as the first monomer, is also in the other monomer as 171 And third monomer as 
335. However, all three cannot be included simultaneously with the same cross-linked 




Figure 36. Restraints modelling interpretation. For modelling using the obtained restrains, it is essential to differentiate 
between structure numbering and sequence numbering. The identified cross-linked peptides from the mass spectrometry 
approaches are given as a number in the full-length sequence without taking into account the 3D structural information 
(examples are given in the figure). For example, if the results showed that lysine number 46 is inter-cross-linked with lysine 
468. This means that residue 468 on the Cnx1 sequence is number 7, 171 and 335 in the trimeric Cnx1G, while 46 is 31 
and 442 on the dimeric Cnx1E. All possible scenarios were taken into consideration for modelling. The most realistic 
scenario was considered to cover the highest number of cross-links.  
 
The cross-links identified for the high molecular weight band are shown in the circos 
diagram in figure 34 (details in supplemental table 23). Cross-linked amino acid residues 
99 
 
were highlighted in the structures of Cnx1E and Cnx1G using PyMOL (Schrödinger, Inc.), 
which showed the following:  
1) The amino acids identified to be involved in the crosslinking reactions were all traced 
back to two opposing patches on the Cnx1G surface, 2) Also for Cnx1E, two patches were 
identified that are located far from each other, 3) Some intra cross-links cannot be directly 
explained due to irrationality (e.g. intra cross-link that connects a residue with another 
residue on the other side of the structure, or distance that is not accessible within the 
structure), 4) some intra cross-links show trimeric or dimeric formation by being crosslinked 
with the same exact residue (e.g. residue 575 and 556  are cross-linked with residue 575 
and 556). 
The distance constraints are defined by the distance allowed by the DSBU cross-linker, 
which has a spacer length of 12.5 Å. This allows the connection between residues with a 
Cα-Cα range from 4 to 30 Å (Figure 37). 
 
Figure 37. The range of DSBU cross-linker in cross-linking from 4 to 30 Å Cα-Cα. DSBU (light green) can cross-link two 
lysine residues (light cyan). The distance of DSBU is 12.5 Å in fully stretched form. As an example, with the interaction of 
two lysine residues, each of 6.8 Å the distance, DSBU and the two lysine residues can be cross-linked to 26.1 Å in length 
Cα-Cα. Another example is in the case of a compact form, DSBU can be in a 5.6 Å range when two parallel lysine residues 
are interacting closely. 
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For comparison, the distances were shortened to 4 to 10 Å if necessary to check the 
modelling results manually. An example of the TBL files prepared can be seen in 
supplemental table 27. 
Due to the different locations of the two sets of cross-links on each side of the protein 
structure, it was impossible to model all cross-links in one file. These results suggest at least 
two different orientations of G-domain binding. Therefore, two different TBL files were 
prepared. Prior to modelling, Cport was used to identify all the active and passive residues 
involved in the modelling. The active residues are solvent-accessible residues, and passive 
residues are residues near the active residues identified (Vries et al., 2011). These residues 
were obtained using the two edited PDB files of Cnx1E and Cnx1G, PDB 5G2R and 1UUY, 
respectively. The PDB files were edited using coot (rename all chains and numbering if 
necessary) and PHENIX (to remove all alternative conformations – see 2.2.7.3.) (Emsley et 
al., 2009; Liebschner et al., 2019). 
The results of the active and passive residues of both protein structures are shown in 
supplemental table 28. The modelling was set to unambiguous, which means all restraints 
would be enforced. As a comparison, ambiguous modelling was also done, which does not 
necessarily enforce all restraints in the TBL file uploaded. Afterwards, the model cluster with 
the lowest energy minimization scores was chosen. The final model was manually checked 
using selection criteria by checking the distances of all the crosslinks (within the 4 to 30 Å 
range) using PyMOL as quality control. 
The results showed two possible binding sites of the G-domain to the E-domain (Figure 38). 
As a quality control of the model obtained, I measured the distance from the linker or the 
distance of the unsolved parts of the E- and G-domain to the solved part of the structures. 
For example, the C-terminus of Cnx1E (the start of the linker) was measured to the N-
terminus of Cnx1G (the end of the linker), the distance was close enough to cover the length 
of the linker (e.g. ≈ 40 Å). Similarly, with the unsolved C-terminus of Cnx1G, the distance 
was checked as quality control in the final models to cover an adequate expect distance 





Figure 38. Modelling the cross-links in Cnx1. Crystal structures for Cnx1E PDB: 5G2R (Krausze et al., 2017) and 
the Cnx1G PDB: 1UUY (Kuper et al., 2004) was used as structure input. (a) Schematic representation of restraint 
modelling. Cnx1E (bright orange) bound to two Cnx1G (teal) molecules from two different orientations. The active site of 
the E-domain and the G-domain is pointed out with orientation 2 of Cnx1G. (b) Cartoon representation of Cnx1E (bright 
orange) bound to Cnx1G (teal). Orientation 1 is shown on the left-hand side, while orientation 2 is on the right-hand side. 
(c) Surface representation of the restraint modelling, including both orientations of Cnx1G bound to Cnx1E. 
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Further checks for the models were done by checking the intra cross-links (that were not 
included in modelling). Each intra-domain cross-link was manually measured. However, 
few of the cross-links showed impossibility. For instance, residue 307 and 158 are cross-
linked within the E-domain, however, on the structure, these two residues are 53.1 Å apart 
(Figure 39). Furthermore, the intra cross-link of residue 501 to 556 within Cnx1G is 
impossible to be explained since the cross-linker has to go within the structure itself. These 
unexplained intra-domain cross-links became explainable upon analysis of the 
oligomerization of the model. As shown in figure 39, an oligomer of the two orientation 
model with two added Cnx1E molecules explained the riddling intra-cross-links. Residues 
307 and 158 that are cross-linked in Cnx1E showed 53.1 Å within the same molecule but 
35.2 Å within two different molecules. In Cnx1G, residues 501 and 556 are 38.3 Å apart 
within the same molecule, however, the distance is 27 Å from the two different molecules. 
 
Figure 39. Assisting the intra cross-links using the oligomerization of the restraint model. Three molecules of Cnx1E dimer 
(bright orange) and two Cnx1G (trimers) were used. For Cnx1E dimer 2, both orientation 1 and orientation 2 was included 
as the model previously shown in figure 38, which is used as the base to assemble the oligomer shown here. The labelled 
orientation 1 and 2 is based on the two orientations from Cnx1E dimer 2 perspectives. Cnx1E dimer 1 is bound to Cnx1G 
in the orientation 2 conformation, while, Cnx1E dimer 3 is bound to Cnx1G in the orientation 1 conformation. By 
considering the Cnx1E-Cnx1G oligomerization states, it was possible to confirm all hitherto non explained cross-link 
results. Two examples of intra cross-links that agree with the oligomer but not with the structures individually are shown. 
Residue307 is intra cross-linked with 158 in Cnx1E, which could not be explained assuming the cross-linker to stretch in 
a distance of 53.1 Å within one Cnx1E molecule, however, 35.2 Å within two different Cnx1E molecules is possible. 
Another example is residue 501, which is intra cross-linked to 556. The distance within one Cnx1G molecule would be 
38.3 Å while 27 Å within two different Cnx1G molecules.  
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The oligomerization of the resulted model can show an extended super complex. This can 
be vertically elongated or horizontally extended as a mesh-like complex (as seen in figure 
40). Moreover, for Cnx1 full-length oligomer to be formed, the ratio of Cnx1G to Cnx1E 
must be 1:1.5 (trimer: dimer). If one monomer of Cnx1G is connected to a monomer of 
Cnx1E, then 3 dimers of Cnx1E is needed with 2 Cnx1G trimers for a sealed assembly unit. 
As shown in figure 40a, this oligomerization needs at least 2 trimers of Cnx1G and 3 dimers 
of Cnx1E to form the basic building block, which means 6 monomers of Cnx1G (3x 2) and 
6 monomers of Cnx1E (2x 3). The assembly of this building block with another identical one 
(Figure 40b) can be explained by one intra-crosslink that is found on the E-domain (residue 
307 to residue 401 in the E-domain – supplemental table 23). This complex assembly would 
be a closed unit of 4 Cnx1G and 6 Cnx1E. Using this building block (2 Cnx1G and 3 Cnx1E), 
different complexes can be formed. 
However, in vitro experiments with minimal degradation products can still give rise to more 
fragmented complexes (Figure 41). For instance, the presence of 2 trimeric Cnx1G in the 
degradation (without the linker or with incomplete linker region), the Cnx1 complex would 
be composed of 1:1 or 1:2 (trimer: dimer) ratio instead of 1:1.5 when the linker is present. 
Additionally, one cannot exclude the presence of an indigenous MogA (from the expression 




Figure 40. Oligomerization of full-length Cnx1. The oligomer shown is based on the final restraint modelling of Cnx1. The 
basic building block of full-length Cnx1 would be composed of Cnx1E dimer (bright orange) bound to two different Cnx1G 
(Teal) (orientation 1 and 2). Each Cnx1G trimer would be bound to an additional Cnx1E dimer. (a) The basic building block 
of the Cnx1 complex including two Cnx1G trimers and 3 Cnx1E dimers. This complex is composed of six full-length Cnx1 
molecules. (b) Complex assembly of two building blocks together highlighting one intra-cross-link between two different 






Figure 41. Cnx1E-Cnx1G complex assembly in the presence of free G-domain. The oligomer shown is based on the final 
restraint modelling of Cnx1. Each Cnx1E dimer (bright orange) is bound to two different Cnx1G (Teal) (orientation 1 and 
2), which is bound to another Cnx1E (the other orientation). The protein complex assembly shown here consists of six 
Cnx1E dimers and six Cnx1G trimers. (a) Top and bottom view of the oligomer model highlighting two additional Cnx1G 
(red dotted circle). (b) side view of the oligomer showing plenty of space for other interacting partners to bind to the 
oligomer. 
 
Remarkably, the modelling of the XL-MS resembles only a snapshot of what happens in 
reality. In a dynamic cellular context, there is continuous motion and conformational 
changes of the proteins (Yu & Huang 2018). Therefore, the two models of the various 
orientations shown do not necessarily mean the absolute and only existence of the complex 
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in this form. A slight movement or transition is possible for both domains, and perhaps a 
transient complex is present or multiple complex forms exist simultaneously in nature as 
previously shown in other protein complexes (Bullock et al., 2018). The complex formed 
when Cnx1 takes MPT from the MPT-synthase may be a complex that is different from what 
it looks like when it adenylates MPT to form Moco-AMP and releases Moco. It is technically 
impossible to establish fully defined conditions that would allow the elucidation of an MPT-
AMP transfer complex. 
Moreover, with different interaction partners, the complex may be rearranged. It cannot be 
excluded that minor re-arrangments that occur would result in a different orientation of E- 
and G-domain interactions during the different stages of Moco biosynthesis. Considering 
varying orientations of E- and G-domain interactions, the linker has to allow certain 
flexibility enabling domain re-arrangements. In gephyrin, it was shown that truncating the 
linker leads to a decrease in Moco activity while removing the linker leads to depletion 
(Belaidi & Schwarz 2013). However, it is not clear how a shortened linker affects Cnx1 
functionality. The modelling data from the MoeA-MogA complex also resembles the 
metabolic transformation model of Cnx1. 
It is essential to model the Cnx1 linker to understand how Cnx1 would look in a cellular 
biological context. The structure of Cnx1 full-length was predicted using ab-initio modelling 
by I-TASSER or Robetta (Roy et al., 2010; Simons et al., 1999). I-TASSER or iterative 
threading assembly refinement is an approach in a hierarchical form in order to predict 
protein structure. Initially, the template of the known part of Cnx1 (Cnx1E and Cnx1G 
structures) is considered by a multiple threading approach called LOMETS (Roy et al., 2010). 
The models are then constructed via iterative assembly simulations. The resulted models of 
full-length Cnx1 were manually checked using PyMOL (Figure 42). The model that showed 
no clashes in a protein complex assembly of Cnx1 was taken into consideration. In a second 
line of work, Robetta was used for comparative modelling and ab-initio modelling. Structure 
prediction is made using a deep learning-based method called TrRosetta or Rosetta CM 
(Simons et al., 1999). For Rosetta CM, four independent methods are involved, including 
RaptorX, HHpred, Sparks-X, and Map align (Chivian et al., 2003; Kim et al., 2004). Rosetta 
AB is used for ab-initio modelling, and the resulting models were compared to I-TASSER, 





Figure 42. The ab initio modelling of Cnx1 linker. Modelling was done with I-TASSER (Roy et al., 2010) and Robetta 
(Simons et al., 1999). The final restraint model was used as a template for the structure part of Cnx1. (a) Orientation 2 
(metabolic transfer) of Cnx1G (teal) bound to Cnx1E (bright orange). The linker modelled is highlighted in red (b) Schematic 
representation of orientation 1 and 2 with the linker in red and incomplete linker in purple. (c) Model of the resulting full-
length Cnx1 using I-TASSER. (d) Modelling of the Cnx1 linker using Robetta. 
 
Both models generated from I-TASSER and Robetta were compatible with the 
oligomerization models. However, Robetta model showed a lower RMSD compared to the 
model from I-TASSER. 
Upon assembly, the E-G domain complex must be fully capable of interacting with both, 
upstream and downstream enzymes involved in the cellular Mo-metabolism. Considering 
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the G-E domain complex reported in this work is existent in the cell under conditions of 
Moco demand, the MPT-synthase must be capable of interacting with it to ensure the supply 
with the substrate, i.e. MPT. To give an answer to this question, docking of the Cnx1 model 
generated in this work with MPT synthase complex (PDB 3BII) was done. Due to the lack of 
a crystal structure of a plant (A. thaliana) MPT synthase complex, a template-based PHYRE2 
model was predicted based on the structure of the prokaryotic (E. coli) MPT-synthase 
complex was used for the docking approach (see 2.2.7.). Both docking results were almost 
identical since PHYRE2 probably used PDB: 3BII as a template due to the high homology 
between both sequences of the MPT synthase in E. coli and A. thaliana. The Modelling was 
done with three different Cnx1 models. Firstly, orientation 1 only, secondly, orientation 2 
only, and finally, both orientation as a final model (Figure 43). Some of the resulting models 
were excluded due to clashes with the model (e.g. the unsolved part of Cnx1G would clash 
with the MPT synthase docking site). Thus placed, the MPT-synthase active site was 





Figure 43. Docking Cnx1 complex with MPT synthase complex. Modelling was done using ClusPro using three different 
approaches. Firstly, docking using orientation 2 (Cnx1E in bright orange and Cnx1G in Teal) as a receptor and MPT- 
synthase (PDB: 3BII) (Large subunit in light pink and small subunit in marine blue) as a ligand. Secondly, using orientation 
1 of the Cnx1 complex as receptor and MPT- synthase as a ligand. Finally, using both orientations as receptor and MPT- 
synthase as a ligand. The figure highlights the active site of Cnx1E, Cnx1G and the MPT- synthase. 
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MPT synthase, the MPT-forming complex of the second step in Moco biosynthesis, is 
composed of two subunits, which shows great structural homology to the eukaryotic 
ubiquitin. MPT synthase is a heterotetramer of a large dimerized subunit and two small 
subunits on opposite ends on the large subunit. In close proximity to the negatively charged 
C-terminus of the large subunit, the active site of MPT synthase lies (Rudolph et al., 2001). 
With each of the two small subunits, a large positively charged pocket is present, forming 
the cavity in which MPT is formed. The Cnx1-MPT-synthase model revealed some highly 
conserved amino acids of opposing charges which were opposing each other (G-domain – 
MPT-synthase) (Figure 43). It is expected that the MPT synthase interacts with the Cnx1 G-
domain to supply the latter with MPT, however, interaction with the E-domain cannot be 
excluded. Since MPT was shown to bind to Cnx1G with high affinity (Schwarz et al., 1997; 
Kaufholdt et al., 2016), it can be deduced that the MPT-synthase interact with orientation 1 
of Cnx1G bound to Cnx1E, as in this position MPT maybe first adenylated, yielding MPT-
AMP. This can be transferred only when Cnx1G interacts in orientation 2 manner with 
Cnx1E (Figure 44). Importantly, since Cnx1 was shown to be the core of the Moco 
biosynthesis complex (Kaufholdt et al., 2016), the protein complex assembly shown in figure 





Figure 44.  Schematic illustration of how MPT synthase would interact with Cnx1 to transfer MPT. The illustration is 
based on the model shown from docking the Cnx1 complex with MPT synthase complex. MPT synthase complex is 
represented in light pink (large subunits) and marine blue (small subunits). Initially, MPT synthase (with MPT bound) would 
interact with one monomer (grey) of the Cnx1G trimer in orientation 1. The MPT is then transferred to the Cnx1G monomer. 
After adenylation of MPT by Cnx1G (to form MPT-AMP), another Cnx1E dimer would interact with Cnx1G in orientation 
2 manner. Subsequently, MPT-AMP is transferred to Cnx1E. Simultaneously, another (or the same) MPT synthase carrying 
MPT would interact with another monomer of Cnx1G (black). Subsequently, the cycle is repeated for other Cnx1E and 
Cnx1G molecules.     
 
As one would expect, the active site of Cnx1E is shown to be highly conserved. For 
interaction with other partners (e.g. Actin), there are few highly conserved and surface-
exposed residues in Cnx1E and Cnx1G (Figure 45). These residues are not in the active site 
directly, in some cases, in close proximity. For instance, the highly conserved set of residues 
FSKVLMKPGKPLTF (highly conserved residues highlighted in bold) of surface-exposed 
phenylalanine (F), methionine (M) and threonine (T). These three residues, when strictly 
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conserved, showed to be a possible ‘’hot spot’’ for binding of other potential protein 
interaction partners (Ma et al., 2003). Although the lysine (K) was shown to be important in 
the structural integrity of Cnx1E (Krausze et al. 2017), however, the phenylalanine, 
methionine and threonine could possibly be a binding site for other Moco-receiving 
enzymes such as NR (if in close proximity to the binding site of Cnx1E) or the cytoskeleton 
(not necessarily near the active site of Cnx1E). Importantly, further detailed investigation of 
the residues needed for complex formation is needed to be addressed as a confirmation to 
the Cnx1 complex model. 
 
Figure 45. Subdomain annotation of the E-domain/ conservation of residues. The structures shown was prepared using 
Cnx1E PDB: 6Q32. (a) The four Cnx1E subdomains I to IV are shown in red, blue and green for subdomain I-II, III and IV, 
respectively. Both active site and site of Cnx1G interaction are pointed at with arrows. (b) Cnx1E conservation is done 
using Consurf (Ashkenazy et al., 2016) with HMMER homolog search algorithm with 1 iteration and E-value cutoff of 
0.0001 and UNIREF-90 protein database. The degree of conservation is ranged from variable (cyan), average (white) and 








3.2.5. Product-substrate exchange 
 
Based on the model generated in this work, the two orientations in which Cnx1G interact 
with Cnx1E represent a model of how product-substrate exchange could exist. For 
orientation 1, the Cnx1G binding site for MPT or MPT-AMP respectively is far apart (≈35 Å) 
from the Cnx1E active site. Conversely, for orientation 2, both active sites are 15 Å Angstrom 
apart. Precisely, the distance of the Cnx1G bound petrin moiety (found in MPT-AMP) to the 
Cnx1E pterin moiety (found in Moco-AMP) is ≈ 16.5 Å (Figure 46a). Therefore, the 
orientation 2 interaction model may be considered as a metabolite transfer model. However, 
defined distance excludes the direct transfer of MPT-AMP from the G-domain active site to 
the E-domain active site. Earlier work showed that Cnx1E is a functional dimer (Krausze et 
al., 2018), suggesting that Moco-AMP is bound to subdomain III of one dimer and stabilized 
by the flexible subdomains I+II of the other dimer. Notably, the hitherto presented 
interaction models did not take into account the all flexible hinge region present in 
subdomains I+II, which is causal for the flexibility of the subdomain I+II head as documented 
by large b-factors. Assuming this, I suggest that this flexible head moves apart and hence 
allows the G-domain and E-domain active sites to align in a productive orientation which 
allows metabolite transfer between the active sites 
 
Figure 46. Close up on the metabolic site of both Cnx1E and Cnx1G. (a) The model presented in this work of the orientation 
2 is shown wherein Cnx1E (bright orange) used with PDB: 6Q32 and Cnx1G (teal) used with PDB: 1UUY. The distance of 
the Cnx1G bound petrin moiety (found in MPT-AMP) to the Cnx1E pterin moiety (found in Moco-AMP) is ≈ 16.5 Å. (b) 
Close-up on the hinge region of the E-domain. Superimposition of Geph-E (4TK3), Cnx1E (52GR) and MoeA (this work)  
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The hinge region of the E-domain protects the active site of Cnx1E (Krausze et al., 2018). 
The model built does not explain how MPT-AMP is transferred from G-to E-domain, as the 
distance between the two active sites (G- and E-domain) precludes its directed transfer. A 
likely explanation was obtained upon analysis of the b-factors and structural characteristics 
of subdomains I+II (E-domain), which are known to be highly flexible. As shown in figure 
46b MoeA (structure solved in this work), the most opened conformation of the hinge region 
in the different E- domain structures are known. In my model, I suggest that a minor 
movement of the latter (≈ 3 Å) is required to allow MPT-AMP transfer from G- to E-domain. 
I cannot exclude that this movement is triggered by the presence of G-domain bound MPT-
AMP and/or the simultaneous presence of molybdate. 
Therefore, for a successful transfer of MPT-AMP (product of Cnx1G) to Cnx1E, firstly, the 
hinge region opens for Cnx1G (in orientation 2) to come in close proximity to the active site 
of Cnx1E. With or without the help of the Cnx1 linker, the MPT-AMP is transferred to the 
active site cavity of Cnx1E, where Mo is inserted. A schematic illustration of the possible 
transfer is shown in figure 47. 
 
 
Figure 47. Schematic representation of how product-substrate channelling propagate. The two orientation presented in 
this work is schematically represented of two Cnx1G trimers (teal) bound to one Cnx1E dimer (bright orange). Three-step 
schematic diagram shows that firstly the closed conformation of the hinge region of Cnx1E with Mo bound and MPT-AMP-
bound Cnx1G of orientation 2 interacting with Cnx1E (After receiving MPT from MPT- synthase and adenylation). In the 
second step (metabolic transfer step), the hinge region is opened, and further movement of Cnx1G from orientation 2 
towards the active sites of Cnx1E. MPT-AMP is then transferred to Cnx1E. The third step is the insertion of Mo to form 
Moco-AMP/ Moco and the closing of the hinge region to protect the product until delivery to user enzymes or further 




Notably, the cross-links used for modelling support the proposed metabolic transfer model, 
as the estimated movements of subdomain I+II would be within the range the cross-linker 
covers. However, the available docking software did not allow it to define the hinge region 
as such, which excluded precise modelling of the metabolic transfer complex. 
Native MS data of MoeA-MogA showed that a complex is formed in a free environment of 
Moco metabolites. Although this was previously shown to be the case of plants, however, 
for Cnx1 as a platform for the Moco biosynthesis complex to be formed, the assembly is 
needed regardless of the metabolic transfer. Since all cross-linking in Cnx1 was in TP1000 
(eukaryotic Moco-biosynthesis containing strain – see 2.1.10.), only one orientation of the 
Cnx1 model may be present when lacking Moco metabolites, and the other is present only 
when the metabolites are present (Figure 48). These two orientations of Cnx1G bound to 
Cnx1E could be existing based on the presence of ligands and the presence of other 
interaction partners, such as Actin or NR. In order to give the first experimental based insight 
into the underlying principles of the Mo-insertase E- and G-domain interaction I initially 
carried out a structural proteomics approach. This approach revealed that the interaction of 
the prokaryotic and eukaryotic E- and G-domains involves essentially the same parts of the 
proteins. Notably, for the prokaryotic E- and G-domain, a single interaction model was 
supported by the evaluated MS-data, while for eukaryotes, a second interaction model 
became evident. This second interaction model has no apparent function for metabolic 




Figure 48. The final models of Orientation 2 in plants and bacteria. Models generated from XL-MS –based modelling. 
Structures used of PDB: 52RS (Cnx1E) and 1UUY (Cnx1G) with MoeA-MogA structures solved in this work (blue). (a) Side 
by side comparison of MoeA-MogA complex next to Cnx1 complex (resembling orientation 2). (b) Superimposition of both 
Cnx1 complex (orientation 2) and MoeA-MogA complex. 
 
The fully defined in vitro conditions I applied ensured that no Moco-metabolite was present 
in the analyzed approaches, hence documenting that even in the absence of Moco 
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metabolites occurs (at least in vitro). However, I cannot exclude that complex formation is 
enhanced in the presence of either MPT (MPT-Synthase) or MPT-AMP (Cnx1G). Earlier 
reports (Magalon et al., 2002) reported that this may well be the case for prokaryotes. My 
subsequent work (3.3) analyzed both orientations of Cnx1G to investigate if they have a 
putative role as they may be essentially required for the directed interaction with the MPT-
synthase.  
 
3.2.6. Negative staining of Cnx1  
 
Modelling the Cnx1E-G complex (Figure 38 and 40) using XL-MS restraints for the computer-
based docking approach resulted in two different Cnx1G orientations to bind to Cnx1E. 
However, since this approach essentially depends on the structural information available for 
Cnx1E and Cnx1G it naturally has limits as, e.g. the linker region and flexible parts of the 
proteins may not be considered for model building. To circumvent this possible occurring 
problem, I next employed negative staining-EM to solve the complex assembly of E-and G 
domain using recombinant and highly pure Cnx1 full-length protein. The proteins from the 
Cnx1 purified proteins (as described in 2.2.2.2) was centrifuged prior to negative staining to 
avoid the possible aggregation formation, which was tested (see supplemental figure 70). 
From the ≈ 200 electron micrographs that were recorded, particles were manually selected 
and subsequently classified (Figure 49). 
For the negative staining EM approach, all fractions obtained from the gel filtration 
purification step for initial negative staining. Doing so revealed fractions A4 and A5 
possessed minor heterogeneity compared to the other samples. The subsequently carried out 
particle 2D classification showed inverted ‘’L’’ and ‘’T’’-shaped particles that resemble the 
two orientation model generated from HADDOCK (see 3.2.4.) (Figure 49c and 49d). 




Figure 49. Negative staining of Cnx1 complex. All samples were cross-linked in 100 mM HEPES, 300 mM NaCl and 1mM 
EDTA and particle sized of 120 to 200 Å, which became visible upon negative staining. (a) Negative staining of the Cnx1 
complex using recombinant protein with a concentration of 100 µg/ml. (b) Negative staining of the Cnx1 complex using 
recombinant protein with a concentration of 200 µl/ml. From the data are shown in (b) 129 micrographs were collected, 
and approximately 45000 particles have been used for classification. (c) Schematic representation of the Cnx1 complex 
(two orientations) showing two Cnx1G trimers (teal) and one Cnx1E dimer (bright orange). Next to the schematic 
representation of the Cnx1 complex, representative ‘’T’’ (upper figure) or ‘’L’’- shaped (lower figure) particles obtained from 
particle classification are shown. (d) Results from the 2D classification of the Cnx1 complexes shown in (b). The following 
parameters were applied: Boxsize = 200, mask diameter = 300 A. In total, from 45077 particles selected (from b), 25 classes 





In summary, a Cnx1 full-length complex was identified and characterized in this work by 
employing different techniques, including XL-MS, negative staining and computational 
modelling. Interestingly, the XL-MS-based modelling suggests two Cnx1G binding sites on a 
single Cnx1E dimer. These results were found to be consistent with results coming from the 
negative staining EM approach. Thus, any model bias could be excluded.  
Side by side comparison with the prokaryotic E-/G-domain interaction allowed it to attribute 
functions to the different orientations in which Cnx1G interacts with Cnx1E. The orientation 
1 model was suggested to serve for the complex assembly and may be required for the 
upstream interaction of the Mo-insertase complex with the MPT-synthase, while the 
orientation 2 model was suggested to be required for metabolite transfer between G- and E-
domain. 
Within the metabolite transfer models (MoeA-MogA and Cnx1E-Cnx1G orientation 2), the 
E- and G-domain active sites face each other, but the distance between them excludes a 
direct occurring metabolite transfer. Notably, the Cnx1E / MoeA active sites are shielded by 
a flexible subdomain of the protein, which prevents the close contact of the two active sites 
in the computer-based model. Assuming a minor re-arrangement of this subdomain would 
allow both active sites to come in close proximity towards each other, which is the 














The models generated from the previous approaches shown above gave hints on what exact 
residues are essential for the complex formation and essential residues required in the 
substrate-product transfer. To further validate results from structural proteomics / the 
preliminary Cryo-EM data, I analyzed the Cnx1E and Cnx1G protein surface concerning 
conserved residues putatively involved in the E-G domain interaction. As expected, the 
Cnx1E/G active site residues (LIamas et al., 2004; Krausze et al., 2018) are highly conserved. 
However, next to these, it becomes evident that also on the protein surface, non-active site 
residues are conserved in both E- and G-domain.  
In order to confirm the Cnx1E-G interaction models, I went on and carefully analyzed the 
interaction interfaces of both interaction models: Cnx1E-G orientation 1 and 2. Doing so 
revealed numerous strictly or highly conserved residues. Manual inspection of the 
interaction interfaces identified likely candidates for a site-directed mutagenesis approach, 
which was subsequently carried out. In the following section, I will describe the 
identification of E- and G-domain surface-exposed conserved residues that are likely 
involved in complex formation. 
 
3.3.2. Selection of residues for mutation 
 
The selection of the residues was done by initially identifying the residues in the interface of 
Cnx1G and Cnx1E from the generated model in figure 38. This was done using proteins, 
interfaces, structures and assemblies or PISA (EMBL-EBI), which results in acquiring 
structural properties of the quaternary structure assembly as well as their interface (Krissinel 
& Henrick, 2007). The result shows information such as multimeric state, symmetry number, 
space group, free energy, accessible or buried surface area, residues, and salt bridges. 
Fundamentally, oppositely charged residues that are sufficiently close to each other can form 
a salt bridges bond. For example, the anionic carboxylate group of glutamic (E) or aspartic 
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acid (D) can form bonds with the cationic ammonium group from lysine (K) or the 
guanidinium of arginine (R) (Bosshard et al., 2004).  
Notably, the control and base for all mutations was a double mutant Cnx1E construct with 
S269A, D274A mutations (Probst et al., 2021). This double mutant showed high saturations, 
upon analysis with the HPLC, compared to wild type Cnx1E, which had very low saturations. 
To see the impact of the complex mutations, high saturations are required in order to see 
significant alterations. For positive control, D548A mutant was generated, which lies in the 
active site of Cnx1G (LIamas et al., 2004). This mutant serves as a standard for a substantial 
MPT-AMP/Moco-AMP reduction. Each of the Cnx1E-G interaction models (Figure 38) was 
analyzed independently. A summary of the workflow I applied to select residues for 
mutagenesis is shown in figure 50a.  
For orientation 1, 42 residues were identified in the interface of Cnx1E-G, 438 surface-
exposed residues, and solvent-accessible area of the interface of 1312.5 Å out of 19195.8 Å 
in total, 17 possible hydrogen bonds, and seven salt bridges between Cnx1E and Cnx1G. 
For orientation 2, 53 residues were identified in the interface of Cnx1E-G, 441 surface-
exposed residues, and solvent-accessible area of the interface of 1814.7 Å out of 19591.8 Å 
in total, ten possible hydrogen bonds, and four salt bridges between Cnx1E and Cnx1G. 
After identifying the interface residues and all possible salt bridges formed, an alignment was 
done to mine for conserved residues. Using plants, metazoa, fungi, and bacteria, an 
alignment of all G- and E- domains was done using one class from every phylum in the 
taxonomy rank. All protein sequences were aligned using cluster omega (EMBL-EBI) while 
keeping Cnx1E or Cnx1G, Nit-9E or Nit-9G, and MoeA or MogA as a reference. In a second 
selection round, the identified candidate residues were checked manually for their possible 






Figure 50. Summary of the mutants selected for mutagenesis in the metabolic transfer orientation 2. (a) The workflow 
describes how candidate residues for structure-guided mutagenesis have been selected. Upon identification of the E-G 
domain interfaces, conserved residues in Cnx1E and G were identified. These were subsequently used for a manual 
assessment which comprised structural, functional and biochemical information available for Cnx1E and G. (b) All mutants 
generated for orientation 2 in the Cnx1 model complex. S269D D274AS is used as a control, six mutants are generated for 
Cnx1E (pale orange), two combined Cnx1E and Cnx1G mutants, and six Cnx1G mutants were generated. (c) Schematic 
representation of Cnx1 full-length, all mutants in Cnx1E (pale orange) and Cnx1G (teal) are numbered referring to the Cnx1 
(protein identifier Q39054). (d) Orientation 2 of the modelled Cnx1 complex showing Cnx1E (bright orange) bound to 
Cnx1G (pale green). All residues mutated are highlighted in sticks on the structure. Residues mutated from Cnx1E are 




For orientation 1, the seven salt bridges identified from the G-domain were used as the 
candidates for mutagenesis. The residues were E518, K521, D522, R547, K556 and E559. 
One of the six residues to be mutated showed a capability of salt bridge formation in two 
different monomers of the G-domain. Thus, six residues mutated should result in seven salt-
bridge disruptions (Figure 51). A gene was synthesized (BioCat) with the six mutated 
residues. On the other hand, for orientation 2, highly conserved and/or potential salt bridge 
forming residues in Cnx1E were K144, K145, R150A, R151, D155, E157, K158 and R402, 
while Cnx1G included E500, K501, D548, N601, N603, E607 and E610 (Figure 50b, 50c 
and 50d).  
The nomenclature used is based on Cnx1 full-length sequence with identifier number: 
Q39054. All residues of orientation 2 were exchanged to alanine. Alanine was the amino 
acid residue of choice since it is a non-bulky, short amino acid that tends to form alpha 
helices and can exist in beta sheets but can also act as a truncated side chain back to the Cβ 
(Bosshard et al., 2004). However, one of the disadvantages of exchanging multiple alanine 
residues in a protein is that it leads to a decrease in the solubility of the proteins (Hou et al., 
2018). That is the reason that the genes synthesized for orientation 1 had serine exchanges 










Figure 51. Summary of the orientation 1 residues targeted by structure-guided mutagenesis. Orientation 1 of the model 
generated in this work is shown in a cartoon representation using PDB: 5G2R for Cnx1E (bright orange) and PDB: 1UUY 
for Cnx1G (teal). Cnx1E residues targeted by mutagenesis are shown as yellow sticks, while Cnx1G residues targeted by 
mutagenesis are shown as red sticks. The six residues shown for Cnx1G (including E559, K521, R457, D522, K556 and 
E518) are responsible for a possible 7 salt bridges, with K521 responsible for two different salt bridges on two different 
Cnx1G monomers with two different residues on Cnx1E. (a) Front view Cnx1G residues K521, K556 and E518, are shown 
(green). The Cnx1E interacting residues are R351 and D378, respectively. (b) Back view highlighting D522 (Cnx1G) with 
R461 (Cnx1E), and R457, K521 and E559 (Cnx1E) with R454, E450 and E451 (Cnx1G). All mutants are numbered using 
the Cnx1 full-length (Q399054) numbering. 
3.3.3. Site-directed mutagenesis results and discussion  
 
In the following, all variants created (Figure 50 and 51) were expressed, purified, and 
analyzed with respect to protein purity and Moco metabolite loading. The results obtained 







Figure 52. Results of site-directed mutagenesis. All results shown are of 3 technical replicates. (a) FormA-based detection 
results showing the relative saturations on the X-axis and the different mutants on the Y-axis, including S269D, D274S 
double mutant as control and D458A as a positive control. The control (Cnx1E variant S269D D274S) was set to 100%. 
All proteins where of comparable purity as documented for the control except for D155A. All proteins were checked with 
an SDS PAGE and western blotting for purity (Supplemental 69 and 70). For western blotting, an Anti-strep tag antibody 
was used (Ringel et al., 2013). All bands showed at the size of ≈ 45 kDa that is equivalent to the size of Cnx1E.  Additionally, 
both R151A and N603A showed high molecular weight bands. (M. Baldauf BA) (b) FormA-based detection results of 
S269D, D274S mutant used as a control with normal molybdate (1mM) and high molybdate concentration added (10 mM) 
during protein expression. (c)SDS PAGE of control, R151A, N603A and both 7 salt-bridges constructs. The SDS showed 
stabilized high molecular weight complexes without cross-linking in the case of R151A and N603A.    
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With the exception of D155A, R151A and N603A, SDS-PAGE and Anti-strep blotting results 
of the mutants showed identical behaviour to the control (Figure 52a). D155A showed 
abnormal minimal Cnx1E in the SDS gel with some degradation products. This was observed 
during the expression, which can be explained that D155A had improper protein folding. 
These results observed excludes D155A from the final analysis that would be incomparable 
to the other mutants and the controls used. For R151A and N603A, the SDS PAGE showed 
high molecular weight complexes that are stabilized on the denaturing gel without cross-
linker addition (Figure 52c). Moreover, Anti-strep blotting showed these high molecular 
weight bands to be present. Disturbing single surface exposed residues showed to enhance 
complex formation (Tadokoro et al., 2013). 
To monitor the Moco-metabolites, a well-established quantification HPLC method was done 
(Krausze et al., 2017; Krausze et al., 2018) as described in section 2.2.3. All mutants were 
done as 3 technical replicates. Amongst the variants compared (orientation model 1 and 2) 
from the 16 tested variants, E607A, E610A, N601A, R402A_E610A turned out to be co-
purified with a significantly reduced Moco-AMP content as documented by p values <0.001. 
 
Analysis of the Cnx1G septuplet variant (7salt bridges) revealed that when co-expressed with 
Cnx1E variant S269D D274S the accumulating Moco-AMP amount is comparable to the 
control (Cnx1G wild type co-expressed with Cnx1E Moco-AMP accumulating variant S269D 
D274S). As co-expression of Cnx1E S269D D274S with the Cnx1G septuplet variant does 
not result in any measurable decrease in accumulating Moco-AMP, I conclude that this 
variant does not affect the MPT-AMP metabolite transfer (orientation 1). This finding is 
consistent with the fact that the interaction interface targeted here involves orientation 2. I 
further conclude that when expressed separately, E- and G-domain interact only via 
orientation 2. This finding is consistent with the fact that in prokaryotes, the structural 
proteomic approach only revealed a single interaction variant (similar to orientation 2). 
Assuming orientation 1 is essential for oligomerization and complex assembly of eukaryotic 
Mo-insertases, in bacteria, this orientation would not be necessary for the transfer of MPT-
AMP from MogA to MoeA. This orientation may be for the interaction of Cnx1 with other 
interaction partners.     
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However, clearly it cannot be excluded, that the Cnx1G septuplet variant is still fully 
interaction competent with the E-domain. Subsequent studies could be carried out to clarify 
this. 
The HPLC results showed a significantly reduced amount of relative saturation in the case 
of high molybdate (10 mM) compared to the standard control of 1mM. These results can 
confirm the hypothesis of two molybdate binding sites in Cnx1E, including the entry site and 
insertion site (Krausze et al., 2018). In the case of normal molybdate amount, the Cnx1E 
binds molybdate initially at the entry site and afterwards at the insertion site. The crystal 
structures showed molybdate bound to Cnx1E in the two different binding sites, which 
showed that the presence of molybdate in the insertion site would not allow the binding of 
MPT-AMP to Cnx1E (Krausze et al., 2018. In the case of high molybdate, the high influx of 
molybdate in Cnx1E surrounding would lead to a rapid turnover of molybdate from the entry 
site to the insertion site (low occupancy and high occupancy). This will result in hindering 
the binding of MPT-AMP to Cnx1E.  
Next to Cnx1E / Cnx1G variants that resulted in an overall decrease of detectable Moco-
AMP co-purified with Cnx1E S269D D274S, some variants were identified to result in an 
increase in Moco/MPT-AMP detectable. However, amongst these variants, high p values and 
correspondingly high standard deviations exclude – at least in most cases – a robust 
conclusion. Although the loss of a conserved salt bridge was shown to improve substrate 
binding (Mhaindarkar et al., 2018), however, in the case of R402A_E607A and R151A, the 
high saturations shown are not reliable since both mutants had high standard deviation 











In summary, the results presented of the interaction models (orientation 1 and 2) were used 
to generate a set of residues potentially essential for E- and G-domain interaction, which was 
targeted by structure-guided mutagenesis. Unexpectedly, none of the variants targeting 
interaction model 1 (orientation 1) resulted in a decrease of detectable, Cnx1E bound Moco-
AMP. Hence it was evident that this interaction model plays no role when both domains are 
expressed separately. On the contrary, when targeting interaction model 2, it became 
evident that some residues (i.e. E-domain: R402, G-domain E607 and E610) play an essential 
role in the functional interaction of both domains, as documented by the finding that Cnx1E 





















Whilst the prokaryotic Mo-insertases assemble from separately expressed E- and G-domains, 
eukaryotic E- and G-domains are fused, hence forming a single multi-domain protein. As a 
major difference between plant and fungal Mo-insertases, mammalian Mo-insertases possess 
an enlarged linker region, which is considered as a third domain (Schwarz et al., 2000). 
Mammalian Mo-insertases have a central role in the cellular Mo-metabolism essential for 
the clustering of GABA receptors in the post-synapsis. This function however, is independent 
of G-domain but is associated with the E-domain or C-domain (linker) of gephyrin (Choii & 
Ko, 2015). In the cell, different gephyrin variants exist from which recent work identified a 
variant being involved in the Mo-insertion reaction. In the following, I recombinantly 
expressed this variant and used the pure protein preparations obtained for an itial cryo-EM 
approach. 
 
3.4.2. Expression and purification of gephyrin 
 
The full-length Homo sapien gephyrin (splice variant P2) was recombinantly expressed and 
purified from E. coli according to the established protocols for recombinant Cnx1 full-length 
production shown in section 3.2.2 (Figure 27). SDS PAGE was done to monitor the purity of 
the purification (Figure 53). Next to human gephyrin, I also recombinantly expressed and 
purified R. norvegicus full-length gephyrin for comparison. Splice varient P1 and P2 of R. 
norvegicus were purified as a comparison. In general, both splice variants, P1 and P2, are 
involved in the Moco biosynthesis, and other splice variants do not have Moco activity and 
dictate other neuronal functions (Tyagarajan & Fritschy, 2014). For this reason, P1 or P2 is 
the most commonly used gephyrin splice variants when studying Moco and Mo-insertases 




Figure 53 SDS PAGE of recombinant full-length gephyrin from Homo sapiens and Rattus norvegicus. Full-length proteins were 
purified from Homo sapiens isoform 2 (HS P2), Rattus norvegicus isoform 2 (RN P2) and Rattus norvegicus isoform 1 (RN 
P1). The bands showed at the expected band size of approximately 90 kDa for all three proteins. (Gephyrin results are 
prepared with the help of M. Baldauf and J. Plate, BA Milena Baldauf) 
 
The general expression conditions were initially adopted from previously published work 
(Babu et al., 2019). Nonetheless, expression conditions were checked in order to optimize 
the purification of the full-length proteins with minimal degradation products. To evaluate 
the expression conditions, various expression parameters were conducted, including 
different IPTG concentrations and temperatures. Afterwards, cell lysate was loaded on SDS-
PAGE (Figure 54). Initially, gephyrin was expressed with 0.5 mM IPTG at 16 C◦ overnight. 
IPTG concentration was optimized by using 3 different IPTG concentrations including 0.1 
mM, 0.5 mM and 1 mM. Additionally, different expression temperatures include maintaining 
a 37 C◦ for 3 hrs after induction to express the protein. As a result, the SDS-PAGE showed 
that after 3 hrs of induction, at 16 ◦C, no protein is expressed, however at 37 ◦C, full-length 
proteins are observed as well as high molecular weight complexes with minimal 
degradation, regardless of IPTG concentration (higher IPTG concentration showed 
complexes while 0.1 mM did not show complexes). On the next day at 16 ◦C (the conditions 
used in this work), minimal degradation products are observed with high molecular weight 





Figure 54 Anti-strep western blot of the various expression parameters tested for recombinant gephyrin expression. The 
western blot was prepared by loading lysate from different conditions. Three different IPTG concentrations were added to 
each condition, including 0.1 mM, 0.5 mM, and 1 mM. Samples were taken at 0 hr, 3 hrs and the next day after induction. 
The temperature was kept at 37 ◦C or decreased to 16 ◦C. The results show minimal protein expression in general at 0 hrs 
induction. After 3 hrs of induction, at 16 ◦C, no protein is expressed, however at 37 ◦C, full-length protein is observed as 
well as high molecular weight complexes with minimal degradation regardless of IPTG concentration. At 16 ◦C after 
overnight cultivation, minimal degradation products were observed with high molecular weight bands above 200 kDa. 
 
3.4.3. Crosslinking gephyrin 
 
In order to stabilize the E-G domain interactions within gephyrin, the samples were routinely 
cross-linked with DSS prior to negative staining EM. For cross linking, I used DSS´due to the 
similarity of chemical structure and reactivity to DSBU, DSS was used to monitor the 
successfulness of the crosslinking of the human gephyrin. Upon crosslinking, SDS PAGE 
analysis revealed high molecular weight complexes of ≈ 300 kDa (Figure 55).  
Notably, crosslinking of MoeA-MogA and Cnx1 likewise resulted in formation of complexes 
with comparable molecular weights (see figure 20 and 32). Additionally, anti-Nit-9E (E-
domain of N. crassa Mo-insertase) blots of non-crosslinked N. crassa extract showed the 





Figure 55 . SDS PAGE of cross-linked recombinant Homo sapiens gephyrin isoform 2. DSS was used to cross-link gephyrin. 
Therefore, a 50- and 100-fold excess of the cross-linker was applied. Full-length gephyrin was detected as a 90 kDa sized 
protein. As documented in the lane I (control), a higher molecular weight gephyrin complex was readily present in the 
non-cross linked protein preparation. Upon cross-linking, the full-length gephyrin was hardly detectable, while the higher 
molecular weight complex became clearly detectable. 
 
3.4.4. Negative staining of gephyrin 
 
As described in 2.2.8, gephyrin was negative stained and particles were manually selected 
with a mask dimeter of 250 Å circular range. Auto-picking with a 200 Å range and a 2D 
classification was done with limiting of resolution to 30 Å for 50 classes. Surprisingly, 
compared to the MoeA-MogA complex and Cnx1, gephyrin showed more homogeneity. 
This made 3D modelling easier as a better data set could be obtained. The data was then 




For 3D modelling of gephyrin, 3 to 5 sub-classes we selected, and an initial 3D model was 
done using a mask diameter of 220 Å. All models were visualized using Chimera (RBVI). The 





Figure 56 Modelling gephyrin from the classification of the negative staining. The four models shown are based on 
different 2D classes selected for 3D modelling. Each model was generated based on various sub-classes with similar shapes. 
The structures used for modelling were PDB 1JLJ for Geph-G (white) and PDB 4TK3 for Geph-E (dark blue). The linker is 
schematically shown in red, while incomplete linkers are shown in purple. The linkers were drawn but not calculated 
based on the estimated length of the sequence of the linker in Å. All structures were fitted in the envelope map derived 
from cryo-EM using Chimera. The top two models resemble the two orientation model from the Cnx1 complex, and the 




Figure 57 . 3D model of gephyrin highlighting GlyR/GABAA site of interaction. The model presented is based on different 
2D classes selected for 3D modelling. Each model was generated based on various sub-classes with similar shapes. The 
binding site of the glycine receptor (GlyR) and GABAA receptor are highlighted. The structures used for modelling were 
PDB: 1JLJ for Geph-G (white) and PDB: 4TK3 for Geph-E (Dark blue). The linker was schematically represented in red, 
while incomplete linkers were represented in purple in the vacant space of the envelope. All structures were fitted in an 
envelope map using Chimera (RBVI). 
 
Using Robetta as described in 2.2.7., the gephyrin linker was modelled de novo (Figure 58). 
The result presented five models of which the top two models were selected for further 
analysis. The two models were selected based on the modelling scores and the manual 
assessment done by checking the similarity of the structured regions (E- and G- domain) with 
the overall model shape. The final models resembled the two orientations resulting from the 
Cnx1 modelling. However, for gephyrin, the long linker gives the G-domain (Geph-G) 
further flexibility and movement when interacting with the E-domain (Geph-E) as the model 
shows in figure 58. This movement allows the binding of E-domain to G-domain in a relaxed 




Figure 58 Modelling the linker of full-length gephyrin. Modelling was done using Robetta (Simons et al., 1999). The 
modelling included Geph-E (E- domain, blue), Geph-G (G-domain, grey) and the linker (C-domain, red). Superimposition 
of the ab initio modelled linker was done using PDB: 4TK3 (Geph-E) and PDB: 1JLJ (Geph-G). (a) The first model of gephyrin 
full-length. (b) Superimposition of Geph-E dimer and Geph-G trimer over the first Robetta model (resembling orientation 
2). (c) The second model of gephyrin full-length. (d) Superimposition of Geph-E dimer and Geph-G trimer over the second 




The capability of gephyrin to synthesize Moco more efficiently in full-length than the 
separate domains (Belaidi & Schwarz et al. 2013) hints at the evolutionary importance of 
this fusion to give novel functions. Interestingly, a loop that is surface-exposed in the E-
domain regulates postsynaptic clustering in an absolute manner (Lardi-Studler et al., 2008; 
Meyer et al., 1995). The binding site for GlyR β-loop is on the E-domain as well. The model 
shown gives the possibility for the interaction with other proteins and GlyR due to the 
possible access (Figure 57). The models shown in figure 56 and 57 are more similar to 
orientation 2 in Cnx1 rather than orientation 1 (in agreement with the modelling of the 
linker). Since all interactions know with gephyrin are mainly with the E-domain and not the 
G-domain, the G-domain is for the sole function of Mo-insertion and possibly structural 
reasons. With a long flexible linker, a dynamic-flexible complex is expected (Marsh & 
Teichmann, 2015). Notably, the addition of the cross-linker constricts the possible complex 
flexibility leading to the presence of further confirmations of the complex (Bullock et al., 
2018). This explains the problematic particle classification with negative staining EM that is 
inevitable in the gephyrin samples. The linker showed in figure 56 and 57 was illustrated in 
the approximate distance with the ab initio gephyrin modelled linker shown in figure 58. 
Due to the low resolution of the models, it is hard to explain the vacant space around both 
domains and the linker. This could be avoided when freezing gephyrin samples and applying 













Next to the prokaryotic Mo-insertase MoeA/MogA and the plant Mo-insertase Cnx1 also the 
human Mo-insertase gephyrin was characterized within this work. For doing so, no XL-MS 
based approach was employed, however, the highly pure full-length protein was 
successfully used for negative staining EM, which was used for subsequent 3D 
reconstruction modelling.  
As a major finding, the two G-domain binding sites were also identified for the GephE-
domain, hence rendering also this interaction model to comprise both functional (metabolite 






















3.5. Interaction of Mo-insertase with Mo-dependent enzyme 
 
Hitherto, I focused on the assembly of E- and G-domain within the Mo-insertase complex. 
However, upon synthesis, Moco requires the protein protected transfer either to a carrier 
protein or to the user enzyme directly (Kruse et al., 2010; Mendel 2013 Krausze et al., 2020; 
Hercher et al., 2020). Previous work readily showed the interaction of recombinant Cnx1E 
with A. thaliana Moco binding proteins (Kruse et al., 2010) and in vivo work complemented 
these data sets (Kaufholdt et al., 2017). 
In my work, I used the N. crassa system to test for the directed interaction of its Mo-insertase 
(Nit-9) with the major user of Moco in N. crassa which is the nitrate reductase (Wajmann et 
al., 2020). To do so, I carried a fully defined in vitro approach, and I used recombinant Nit-
9 and the Moco-dimer domain (Ringel et al., 2013) of the N. crassa NR. In the following, I 
describe the results obtained for the fully defined in vitro approach. 
To investigate direct Mo-insertase interaction with user enzymes, full-length Nit-9 (N. crassa 
Mo-insertase) was recombinantly expressed and purified as described in 2.2.2.1 and 2.2.2.2 
with the protocol generated in this work. The recombinant full-length proteins were then 
tested with Nit-9E anti-bodies (Ringel et al., 2015) (Supplemental figure 78). The 
recombinant Nit-9 full-length protein was in vitro cross-linked with the Moco-binding 
domain of N. crassa’s NR (expressed and purified as full-length protein for the first time in 
this work). Therefore, equimolar amounts of both proteins were co-incubated for 60 min at 
room temperature prior to adding the 100-fold excess of the DSS-cross linker (Crosslinking 
described in 2.2.4).  
As a control, cross-linking was done for the individual proteins. Next to this, A. thaliana 
Cnx1 full length was used for cross-linking following the experimental setup described for 
Nit-9 (See 2.2.2.2). Doing so did not reveal Cnx1-NR complex-formation. However, full-
length Nit-9 and NR were identified to form two complexes with estimated molecular 




Figure 59 Analysis of N. crassa NR interactions with Cnx1 and Nit-9. The blot shown was stained with Ponceau S. DSS was 
used for all crosslinking with a 100-fold excess of the cross-linker to the protein. Full-length proteins were detected with a 
≈ 90 kDa size. Controls were loaded in the first (Cnx1), second (Nit-9) and third lane (Moco binding domain of NR). Cnx1 
crosslinking with NR did not show any high molecular weight complexes. However, Nit-9-NR crosslinking resulted in high 
molecular weight complexes of ≥250 kDa (marked with asterisks). 
 
This interaction is selective, at least for N. crassa, and cannot be complemented with the 
Mo-insertase of A. thaliana. Additionally, the binding site of the Mo-insertase would be, as 
expected, in the binding site of Moco in the NR. There is no crystal structure yet available 
for Nit-9 individual domains. NR would bind to the E-domain of the Mo-insertase as it 
contains the substrate for NR. The crosslinking result shows selectivity in terms of binding of 
NR to the Mo-insertase of N. crassa.  
Speculatively, in an initial approach to give a possible explanation for this finding, an amino 
acid sequence alignment was carried out using various plant E- domains and Nit-9. 
Hypothetically, Nit-9E was found to contain a sequence stretch comprising residues 117 to 
128, which is lacking in any of the compared plant E-domains. As structural information for 
Nit-9E is missing, I carried out a PHYRE2-based modelling approach, which revealed a 
sequence stretch to be located in subdomains I+II (see Fig.60). However, another possible 
binding site may be formed by a non-conserved N. crassa NR sequence stretch, which is not 
present in other plant species (Figure 60). The sequence stretch is located in the Moco-
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binding domain of N. crassa NR. However, based on the available results, none of the two 
models can be excluded. 
 
Figure 60 . N. crassa Nit-9E specific sequence stretch. (a) Partial amino acid sequence alignment of plant Mo-insertases from 
Cv, (Chlorella variabilis), Gp (Gonium pectoral), Mn (Monoraphidium neglectum), At (Arabidopsis thaliana), Ca (Capsicum 
annum), Cs (Coccomyxa subellipsoidea) and Kn (Klebsormidium nitens) with Neurospora crassa (Nit-9E) and (b) Phyre2 










3.6. Overall conclusion 
 
In this work, I elucidated the principles behind Mo-insertase complex assembly of different 
eukaryotic and one prokaryotic species. This was possible by combining different 
techniques, i.e. structure-based proteomics, cryo-EM, native mass spectrometry and 
recombinant biochemistry. As a major finding, a common mode of how E- and G-domains 
are assembled in the Mo-insertase complexes of prokaryotes and eukaryotes was suggested 
to exist. In this complex, the active sites of both G- and E-domain face each other. Structure-
based evidence suggested that the metabolite transfer between both domains involves the 
reversible movement of one flexible subdomain found in all prokaryotic and eukaryotic E-
domains. Therefore, I conclude that the primary mechanism of metabolite transfer between 
G- and E-domains of prokaryotic and eukaryotic Mo-insertases is conserved. This finding is 
consistent with earlier work from the Mendel group (Stallmeyer et al., 1999), which 
identified the E- and G-domain associated Mo-insertase activity to be complemented 
between different species (Figure 61). 
 
Figure 61 . Schematic representation of the Mo-insertase complex in different species. Mo-insertase of bacteria composed 
of MoeA dimer (grey) bound to one MogA trimer (brown) in orientation 2 manner. For plants, Mo-insertases composed of 
two orientation of the G-domain presented in this work as two trimers (teal) bound to one Cnx1E dimer (bright orange). In 
mammals, the gephyrin E- domain (blue) interacts with G- domain (grey). MoeA-MogA does not contain a linker between 
both E-G domains. Cnx1 has a short linker, while gephyrin contains a long linker. All Mo-insertases were shown to be 





Notably, next to the universally present E-G domain assembly within the Mo-insertase 
complex, the E-domain possesses a second G-domain binding site in eukaryotes. This in 
turn, allows the formation of a bigger sized complex (comprising 3 E-domains and 2 G-
domains). However, using this complex as a building unit, in principle also complexes 
consisting of 6 E-domains and 4 G domains could exist. Accepting that in cellula Cnx1G 
trimers exist (as a result of Cnx1 full length degradation), would even allow the formation of 
complexes with other stoichiometries of E- and G-domains. 
I assume that the formation of Mo-insertase complexes containing non-Cnx1E linked trimeric 
G-domains is beneficial for the cellular Moco-synthesis activity, as additional MPT-synthesis 
capacity would be incorporated into the complex. As a direct consequence, this would 
enhance the rate of Moco-synthesis. Assuming this to be true, I conclude that the formation 
of the eukaryotic Mo-insertase complex is a dynamic and potentially also a demand-driven 
process. 
Potentially, the linker length impacts complex assembly and dynamics, as naturally, a 
prolonged linker region will allow for variations of the E-G domain assembly. Thus, altered 
assembly units may subsequently result in other E-/G-domain stoichiometries and 
orientations within the Mo-insertase complex. 
The results of my work provide the first structural insights into the overall architecture of the 
Mo-insertase complex, which may serve as a groundwork upon which future structural and 


































































































































































































































































3.7. Outlook and further research 
 
The results shown here have opened the door to further biochemical and structural studies 
on Mo-insertase complexes. Further exploration into the structure of Cnx1 and gephyrin 
can explain the exact structural mechanism of the linker. Importantly, biochemical 
approaches can identify how exactly does the linker impact the metabolic transfer. Further 
Cryo-EM data, with the support of biochemical data, from the Mo-insertases can give us 
more detailed information about the complex. With the support of the data here, it is 
possible to visualize the dynamic motion of how MPT-AMP is precisely transferred from 
Cnx1G to Cnx1E by further structural and biochemical experiments. 
Moreover, since it is easier to study larger complexes with Cryo-EM, Cnx1 and MPT-
synthase complex can be envisioned. Direct interaction of Nit-9 or Cnx1 with the Nitrate 
reductase can be structurally investigated with the information that is presented in this work. 
From the neuroscientific perspective, the overall shape of the complex can also be used as 
a platform for structural input with the other interactors, such as the actin, glycine and 
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Supplemental figures and tables 
 
 Cnx1 XL-MS list  
 
Table 23. Cross-linking Mass spectrometry of Cnx1 full-length higher molecular band. Table generated from Mass 
spectrometry results of the higher molecular weight band of the SDS PAGE generated from crosslinking Cnx1 full-length 
with DSBU. The table shows the residue number based on Cnx1 with identifier number Q39054. The cross-linking results 
generated from MeroX are tabulated as the first residue (from residue) to the partner residue (to residue) with domain 
location, structural availability, type of cross-link and if included in the final modelling step. 
Higher molecular weight Band on the SDS-PAGE Cnx1 identifier: Q39054 


























domain 158 Yes Intra No  





















domain 556 No Intra No  





domain 575 Yes Intra No  
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model 
G-
domain 501 Linker 458 No Inter No  




domain 506 No Inter No  









domain 556 Yes Intra No  







































domain 307 Yes Intra No    
Linker 444 
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domain 521 No Inter No  





domain 378 Yes Intra No    
Linker 444 
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domain 378 No Inter No  
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Linker 452 
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domain 556 Yes Inter Yes   
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domain 501 Linker 444 No Inter No  
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domain 364 Yes Intra No    
 
Table 24. Cross-linking Mass spectrometry of Cnx1 full-length lower molecular band. Table generated from Mass 
spectrometry results of the lower molecular weight band of the SDS PAGE generated from crosslinking Cnx1 full-length 
with DSBU. The table shows the residue number based on Cnx1 with identifier number Q39054. The cross-linking results 
generated from MeroX are tabulated as first residue (from residue) to the partner residue (to residue) with domain location, 
structural availability, type of cross-link and if included in the model. 
Lower molecular weight Band on the SDS-PAGE Cnx1 identifier: Q39054 












































































































domain 285 Yes Intra No   
 
 
Table 25. Residues used for modelling. Table generated from Mass spectrometry results of the higher molecular weight 
band of the SDS PAGE generated from crosslinking Cnx1 full-length with DSBU. The table shows the residue number based 
on Cnx1 with identifier number Q39054. The cross-linking results generated from MeroX are tabulated as the first to second 
residue used in the final model. 
 
Inter-domain crosslinks used for Model building 
Cnx1 identifier: Q39054 







































































 MeroX software and crosslinking results 
 









Figure 64. Screenshot of Cnx1 cross-linking results on MeroX. All cross-links shown are intra protein but inter-domain 
















































 Screenshot showing MoeA-MogA cross-linking with other 
proteins and keratin  
 
 
Figure 65. Screenshot showing MoeA-MogA cross-linking with other proteins and keratin. Proteome discoverer 




 Western blot of MoeA-MogA with different cross-linkers 
 
Figure 66. Western blot of MoeA-MogA crosslinking with different crosslinkers. The blot generated from MoeA-MogA 
5-fold excess crosslinking and visualized using Anti-strep tag antibodies. In the case of DSS+DST, a 10-fold excess was 




 Native MS screenshot 
 
 





 E. coli crosslinking with DSSO and DSBU 
 
 
Figure 68. SDS PAGE of in vivo and in vitro MoeA-MogA crosslinking with DSBU. All crosslinking was done using DSBU 
in 100-fold excess to the protein. For in vivo crosslinking, RK5204 was used. All in vivo crosslinking was done with co-
expression of MoeA and MogA. This was done with either MoeA or MogA C-terminus strep tagged. High molecular weight 




Figure 69. SDS PAGE of in vivo MoeA-MogA 
crosslinking with DSSO. All crosslinking was done 
using DSSO in 100-fold, 500-fold and 1000-fold 
molar excess to the proteins. For in vivo 
crosslinking, RK5204 was used. All in vivo 
crosslinking was done with co-expression of MoeA 
and MogA. This was done with either MoeA or 
MogA C-terminus strep tagged. Bands used for LC-
MS/MS are marked in blue from 1 to 5. Table 26 are 









 MS results of E. coli crosslinking with DSSO  
 
Table 26. MS results of MoeA-MogA crosslinking with DSSO. The table generated from the SDS PAGE shown in figure 65. 
The table shows coverage of each band excised from the gel. Control band was used as a control from the lower molecular 
weight bands, showing only MoeA. All high molecular weight bands showed both MoeA and MogA. (These results are 























































































































































































1 44 8 
Oxidation [M1; M8; M17; M58; 
M99; M113; M120; M212] 
P0CE
47 
Elongation factor Tu 1 OS=Escherichia coli (strain K12) OX=83333 
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Aldehyde-alcohol dehydrogenase OS=Escherichia coli (strain K12) 
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Elongation factor G OS=Escherichia coli (strain K12) OX=83333 





























D-tagatose-1,6-bisphosphate aldolase subunit GatZ OS=Escherichia coli 



































Formate acetyltransferase 1 OS=Escherichia coli (strain K12) OX=83333 


























Oxidation [M194; M430; M477; 
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Molybdopterin adenylyltransferase OS=Escherichia coli (strain K12) 
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Phosphoenolpyruvate-protein phosphotransferase OS=Escherichia coli 
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Aconitate hydratase B OS=Escherichia coli (strain K12) OX=83333 




































Transcription termination/antitermination protein NusA OS=Escherichia 
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Proline--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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.4 2 Oxidation [M96; M103] 
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99 
Phosphoglycerate kinase OS=Escherichia coli (strain K12) OX=83333 
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B2 
Glyceraldehyde-3-phosphate dehydrogenase A OS=Escherichia coli 
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Alanine--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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Lysine--tRNA ligase, heat inducible OS=Escherichia coli (strain K12) 
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Lactose operon repressor OS=Escherichia coli (strain K12) OX=83333 
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Phenylalanine--tRNA ligase beta subunit OS=Escherichia coli (strain 
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Galactitol 1-phosphate 5-dehydrogenase OS=Escherichia coli (strain 
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Glutamine--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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Aspartate--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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Autonomous glycyl radical cofactor OS=Escherichia coli (strain K12) 
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Succinate dehydrogenase flavoprotein subunit OS=Escherichia coli 
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Fructose-bisphosphate aldolase class 2 OS=Escherichia coli (strain K12) 
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Adenylosuccinate synthetase OS=Escherichia coli (strain K12) 
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Pyruvate dehydrogenase E1 component OS=Escherichia coli (strain K12) 
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Glycine dehydrogenase (decarboxylating) OS=Escherichia coli (strain 
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Oligopeptidase A OS=Escherichia coli (strain K12) OX=83333 GN=prlC 
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Ribosome-recycling factor OS=Escherichia coli (strain K12) OX=83333 
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Citrate synthase OS=Escherichia coli (strain K12) OX=83333 GN=gltA 
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Alkyl hydroperoxide reductase C OS=Escherichia coli (strain K12) 
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PTS system galactitol-specific EIIA component OS=Escherichia coli 
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DNA-directed RNA polymerase subunit beta OS=Escherichia coli (strain 
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Purine nucleoside phosphorylase DeoD-type OS=Escherichia coli (strain 
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PTS system galactitol-specific EIIB component OS=Escherichia coli 
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Thiol peroxidase OS=Escherichia coli (strain K12) OX=83333 GN=tpx 
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Thioredoxin/glutathione peroxidase BtuE OS=Escherichia coli (strain 
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Chaperone protein HtpG OS=Escherichia coli (strain K12) OX=83333 
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Phosphoenolpyruvate carboxylase OS=Escherichia coli (strain K12) 
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GTP-binding protein TypA/BipA OS=Escherichia coli (strain K12) 
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Superoxide dismutase [Fe] OS=Escherichia coli (strain K12) OX=83333 
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Cysteine synthase A OS=Escherichia coli (strain K12) OX=83333 
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Respiratory nitrate reductase 1 alpha chain OS=Escherichia coli (strain 
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Chaperone protein DnaK OS=Escherichia coli (strain K12) OX=83333 
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DNA topoisomerase 1 OS=Escherichia coli (strain K12) OX=83333 
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Isoleucine--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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Valine--tRNA ligase OS=Escherichia coli (strain K12) OX=83333 
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Pyruvate kinase II OS=Escherichia coli (strain K12) OX=83333 
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2-oxoglutarate dehydrogenase E1 component OS=Escherichia coli (strain 
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Acyl carrier protein OS=Escherichia coli (strain K12) OX=83333 
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Isocitrate dehydrogenase [NADP] OS=Escherichia coli (strain K12) 
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PTS system mannose-specific EIIAB component OS=Escherichia coli 
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4 3.4 1 1 1 35 1 Oxidation [M241] 
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30S ribosomal protein S4 OS=Escherichia coli (strain K12) OX=83333 
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DNA gyrase subunit A OS=Escherichia coli (strain K12) OX=83333 
GN=gyrA PE=1 SV=1 2 
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58 
30S ribosomal protein S6 OS=Escherichia coli (strain K12) OX=83333 
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Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 
OS=Escherichia coli (strain K12) OX=83333 GN=glmS PE=1 SV=4 2         
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Y6 
Cold shock-like protein CspC OS=Escherichia coli (strain K12) 
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Anaerobic glycerol-3-phosphate dehydrogenase subunit A 
OS=Escherichia coli (strain K12) OX=83333 GN=glpA PE=1 SV=1 3               2.08 1 1 1 
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83 
PTS system glucose-specific EIIA component OS=Escherichia coli (strain 
K12) OX=83333 GN=crr PE=1 SV=2 9 
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E+0
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.2 1 Oxidation [M144] 
P765
58 
NADP-dependent malic enzyme OS=Escherichia coli (strain K12) 
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82
.4 0   
P0A6
T1 
Glucose-6-phosphate isomerase OS=Escherichia coli (strain K12) 









4         0 1 1 1 
61
.5 0   
P0A7
K2 
50S ribosomal protein L7/L12 OS=Escherichia coli (strain K12) 









4   
6.05
E+0
4     4.72 1 2 1 
12
.3 0   
P003
50 
6-phosphogluconate dehydrogenase, decarboxylating OS=Escherichia 
coli (strain K12) OX=83333 GN=gnd PE=1 SV=2 3 
1.77
E+0






4   
5.75
E+0
4   2.15 1 1 1 
51
.4 0   
P0A8
T7 
DNA-directed RNA polymerase subunit beta' OS=Escherichia coli (strain 






4           2.74 1 1 1 
15
5.
1 1 Oxidation [M180] 
P694
41 
Adenylate kinase OS=Escherichia coli (strain K12) OX=83333 GN=adk 






5     
4.35
E+0
4     0 1 1 1 
23
.6 0   
P756
78 
Uncharacterized protein YkfA OS=Escherichia coli (strain K12) 















6     0 1 7 1 
31
.9 0   
P0A9
P0 
Dihydrolipoyl dehydrogenase OS=Escherichia coli (strain K12) 





















5 3.42 1 1 1 
50
.7 0   
P0AF
G0 
Transcription termination/antitermination protein NusG OS=Escherichia 






4     2.42 1 1 1 
20
.5 0   
P0AF
R4 
Uncharacterized protein YciO OS=Escherichia coli (strain K12) 
OX=83333 GN=yciO PE=1 SV=1 5               1.95 1 2 1 
23

























4 0 1 2 1 
84
.6 0   
P625
17 
Glucans biosynthesis glucosyltransferase H OS=Escherichia coli (strain 





















5 1.7 1 3 1 
96
.9 0   
P242
30 
ATP-dependent DNA helicase RecG OS=Escherichia coli (strain K12) 












5 0 1 2 1 
76

















4         1.98 1 2 1 
12
.9 0   
P242
16 
Flagellar hook-associated protein 2 OS=Escherichia coli (strain K12) 






4         5.05 1 5 1 
48
.4 0   
P0A9
53 
3-oxoacyl-[acyl-carrier-protein] synthase 1 OS=Escherichia coli (strain 


















4 2.03 1 1 1 
42
.6 0   
P336
50 
Fe(2+) transporter FeoB OS=Escherichia coli (strain K12) OX=83333 























2 1 10 1 
84
.4 0   
P0A9I
3 
Glycine cleavage system transcriptional repressor OS=Escherichia coli 























5 1 5 1 
20
.8 0   
P082
01 
Nitrite reductase (NADH) large subunit OS=Escherichia coli (strain K12) 












4       2.03 1 1 1 
93
.1 0   
P0A6
F3 
Glycerol kinase OS=Escherichia coli (strain K12) OX=83333 GN=glpK 















5   
1.39
E+0
4 2.5 1 1 1 
56
.2 0   
 
 
 Cnx1 SDS Gel aggregation & expression parameters 
 
 
Figure 70. SDS-PAGE of testing Cnx1 full-length freezing stability. All Cnx1 full-length proteins were identical, testing the 
different conditions, including freeze shocking and glycerol addition. Additionally, after centrifugation of proteins, the 
proteins were transferred to a new eppi, 5x SDS loading buffer was added to the used eppi to evaluate the presence of 





Figure 71. Anti-strep western blot of the various expression parameters tested for full-length Cnx1. The western blot was 
prepared by loading lysate from different conditions. Three different IPTG concentrations were added to each condition, 
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including 0.1 mM, 0.5 mM, and 1 mM. Samples were taken at 0 hr, 3 hrs and the next day after induction. The temperature 
either stayed at 37 ◦C or dropped to 16 ◦C. The results show minimal protein expression in general after 3 hrs induction. 
At 0 hrs of induction, at 37 or 16 ◦C, plenty of proteins are expressed as well as high molecular weight complexes with 
minimal degradation regardless of IPTG concentration. At 16 ◦C in the next day, degradation products are observed with 
high molecular weight bands above 200 kDa. 
 
 Example of TBL file prepared 
 
Table 26. Example of TBL files prepared for HADDOCK modelling. 
assi (segid A and resid 95 and name CA) (segid B and resid 364 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 365 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 378 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 380 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 394 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 401 and name CA) 04.0 30.0 0.0
  
assi (segid A and resid 60 and name CA) (segid B and resid 364 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 60 and name CA) (segid B and resid 365 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 60 and name CA) (segid B and resid 394 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 60 and name CA) (segid B and resid 380 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 145 and name CA) (segid B and resid 278 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 40 and name CA) (segid B and resid 31 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 40 and name CA) (segid B and resid 285 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 160 and name CA) (segid B and resid 307 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 45 and name CA) (segid B and resid 307 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 37 and name CA) (segid B and resid 145 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 114 and name CA) (segid B and resid 145 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 442 and name CA) (segid B and resid 364 and name CA) 04.0 30.0 0.0 
assi (segid A and resid 95 and name CA) (segid B and resid 31 and name CA) 04.0 30.0 0.0 






















 Active and passive residues identified by Cport 
 
Table 27. Active and passive residues for Cnx1E and Cnx1G that is identified by Cport for HADDOCK 
modelling. 
1. For the modified PDB 1UUY or Cnx1G:  
 Predicted residues (active residues in HADDOCK): 
14, 15, 16, 19, 20, 21, 23, 24, 25, 28, 29, 79, 82, 86, 87,  
88, 111, 112, 115, 116, 117, 118, 122, 138, 139, 140, 141, 142, 143, 145,  
146, 149, 443 
 Surrounding residues (passive residues in HADDOCK):  
17, 18, 22, 31, 32, 33, 49, 50, 51, 53, 55, 56, 80, 84, 85,  
91, 110, 113, 114, 119, 152, 153, 430, 438, 439, 440, 441, 442, 444, 445,  
470, 474, 481, 485, 489 
2.  For the modified PDB 5G2R or Cnx1E: 
 Predicted residues (active residues in HADDOCK):  
15, 16, 17, 18, 19, 21, 23, 37, 65, 66, 69, 78, 83, 87, 95,  
104, 107, 108, 120, 122, 123, 148, 149, 150, 233, 266, 269, 270, 292, 450,  
451, 454, 456, 458, 471, 513, 518, 530, 555, 557, 558, 668, 701, 702, 704,  
705, 709, 710, 712, 732, 733, 759, 760, 833, 834, 835 
 Surrounding residues (passive residues in HADDOCK):  
20, 24, 25, 27, 28, 35, 36, 39, 42, 50, 58, 60, 62, 75, 76,  
77, 79, 81, 82, 84, 85, 89, 90, 91, 96, 101, 111, 112, 113, 115,  
116, 121, 124, 125, 126, 135, 140, 141, 144, 146, 147, 151, 152, 153, 154,  
184, 186, 190, 192, 198, 231, 232, 234, 235, 242, 257, 267, 271, 272, 273,  
274, 277, 287, 289, 297, 298, 324, 325, 343, 351, 354, 368, 369, 370, 452,  
453, 455, 459, 460, 462, 463, 469, 470, 472, 484, 501, 504, 510, 511, 512,  
514, 516, 517, 519, 520, 531, 536, 539, 542, 547, 548, 556, 559, 560, 570,  
575, 576, 583, 621, 624, 625, 627, 633, 635, 636, 650, 666, 667, 669, 670,  
676, 677, 678, 679, 680, 692, 706, 707, 708, 713, 716, 717, 721, 724, 727,  














 Cnx1 Mutants 
 
Figure 72. SDS-PAGE of the Cnx1 mutants. Protein purity was checked using a 12% gel which was prepared and visualized 
by TGX stain-free. 10 µg of each protein was loaded (M. Baldauf BA).  
 
 
Figure 73. Anti-strep western blot of the various Cnx1 mutants. 10 µg of each protein was loaded and blotted using anti-
strep tag antibody (M. Baldauf BA). 
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 Gel filtration of MoeA-MogA 
 
Figure 74. Gel filtration chromatograms of in vitro mixed MoeA-MogA with sodium tungstate, sodium molybdate and in 
different strains. The proteins were loaded on a Superdex 200 increase column. All proteins were eluted in 100 mM 
HEPES, 300 mM NaCl, 1 mM EDTA and 5% glycerol. In the first chromatogram, the MoeA-MogA complex is observed 
with sodium tungstate added as well as the second chromatogram with sodium molybdate added (expressed in RK5204). 
For KJW2-A and KJW3-A strains (knock-outs of MoaA and MoaC, respectively), the MoeA-MogA complex is not observed. 









 Gephyrin HS gel filtration 
 
Figure 75. Gel filtration chromatograms of Homo sapien gephyrin isoform 2. The proteins were loaded on a Superdex 
200 increase column. All proteins were eluted in 100 mM HEPES, 300 mM NaCl, 1 mM EDTA and 5% glycerol. The 
chromatogram shows full-length gephyrin at 12.63 ml, however, at 10.71 ml, a full-length protein complex is present. At 












 Gel filtration of complex forming mutants in comparison to 
MoeA-MogA  
 
Figure 76. Gel filtration chromatograms of Cnx1 mutants forming higher molecular weight complexes as well as in vitro 
mixed MoeA-MogA. The proteins were loaded on a Superdex 200 increase column. All proteins were eluted in 100 mM 
HEPES, 300 mM NaCl, 1 mM EDTA and 5% glycerol. In the first and second chromatogram, the mutants show complex 
formation at ≈ 11.0 ml and 9.80 ml. The exact size is correlated to the MoeA-MogA complex showing at 11.53 ml at the 



















Figure 78 Western blot of full-length Nit-9 visualized using 
Anti-Nit-9E. The blot shows the detection of Nit-9 full-length 
with different protein amounts loaded (10 µg to 78.12 ng). The 
used primary antibody is Anti-Nit-9E (Ringel et al., 2013). Full-
length protein appears at ≈ 95 kDa. 
 
Figure 77 Western blot of the cell extract of Neurospora crassa using Anti-Nit-9E. 
The blot shows the detection of full-length Nit-9 in ≈ 30 μg crude extracts of the 
mycelia. The primary antibody used is Anti-Nit-9E (Ringel et al., 2013). Full-length 
protein appears at ≈ 95 kDa. High molecular weight complexes of ≥160 kDa 
(marked with asterisks). 
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